<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70818</article-id><article-id pub-id-type="doi">10.7554/eLife.70818</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Astrocyte GluN2C NMDA receptors control basal synaptic strengths of hippocampal CA1 pyramidal neurons in the <italic>stratum radiatum</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-242184"><name><surname>Chipman</surname><given-names>Peter H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-242186"><name><surname>Fung</surname><given-names>Chi Chung Alan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-242185"><name><surname>Pazo Fernandez</surname><given-names>Alejandra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-254327"><name><surname>Sawant</surname><given-names>Abhilash</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa2">§</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242187"><name><surname>Tedoldi</surname><given-names>Angelo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-242188"><name><surname>Kawai</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-242189"><name><surname>Ghimire Gautam</surname><given-names>Sunita</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa3">#</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242190"><name><surname>Kurosawa</surname><given-names>Mizuki</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-91418"><name><surname>Abe</surname><given-names>Manabu</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-91423"><name><surname>Sakimura</surname><given-names>Kenji</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-182664"><name><surname>Fukai</surname><given-names>Tomoki</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-17746"><name><surname>Goda</surname><given-names>Yukiko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0352-9498</contrib-id><email>yukiko.goda@riken.jp</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><label>1</label><institution>RIKEN Center for Brain Science</institution><addr-line><named-content content-type="city">Wako-shi, Saitama</named-content></addr-line><country>Japan</country></aff><aff id="aff2"><label>2</label><institution>Neural Coding and Brain Computing Unit, Okinawa Institute of Science and Technology Graduate University</institution><addr-line><named-content content-type="city">Onna-son</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution>Department of Animal Model Development, Brain Research Institute, Niigata University</institution><addr-line><named-content content-type="city">Niigata</named-content></addr-line><country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Gray</surname><given-names>John A</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Davis</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Chen</surname><given-names>Lu</given-names></name><role>Senior Editor</role><aff><institution>Stanford University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Department of Neuroscience, University of Wisconsin-Madison, Madison, United States</p></fn><fn fn-type="present-address" id="pa3"><label>#</label><p>Shikhar Biotech Pvt. Ltd, Lalitpur, Nepal</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>25</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e70818</elocation-id><history><date date-type="received" iso-8601-date="2021-05-31"><day>31</day><month>05</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-10-22"><day>22</day><month>10</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-05-29"><day>29</day><month>05</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.05.28.446253"/></event></pub-history><permissions><copyright-statement>© 2021, Chipman et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Chipman et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70818-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-70818-figures-v2.pdf"/><abstract><p>Experience-dependent plasticity is a key feature of brain synapses for which neuronal N-Methyl-D-Aspartate receptors (NMDARs) play a major role, from developmental circuit refinement to learning and memory. Astrocytes also express NMDARs, although their exact function has remained controversial. Here, we identify in mouse hippocampus, a circuit function for GluN2C NMDAR, a subtype highly expressed in astrocytes, in layer-specific tuning of synaptic strengths in CA1 pyramidal neurons. Interfering with astrocyte NMDAR or GluN2C NMDAR activity reduces the range of presynaptic strength distribution specifically in the <italic>stratum radiatum</italic> inputs without an appreciable change in the mean presynaptic strength. Mathematical modeling shows that narrowing of the width of presynaptic release probability distribution compromises the expression of long-term synaptic plasticity. Our findings suggest a novel feedback signaling system that uses astrocyte GluN2C NMDARs to adjust basal synaptic weight distribution of Schaffer collateral inputs, which in turn impacts computations performed by the CA1 pyramidal neuron.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>basal synaptic strength</kwd><kwd>hippocampus</kwd><kwd>astrocytes</kwd><kwd>NMDA receptors</kwd><kwd>GluN2C</kwd><kwd>stratum radiatum</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Overseas Research Fellow (P14760)</award-id><principal-award-recipient><name><surname>Chipman</surname><given-names>Peter H</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Core-to-Core Program (JPJSCCA20170008)</award-id><principal-award-recipient><name><surname>Goda</surname><given-names>Yukiko</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>MEXT Grants in Aid for Scientific Research</institution></institution-wrap></funding-source><award-id>15H04280</award-id><principal-award-recipient><name><surname>Goda</surname><given-names>Yukiko</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>MEXT Grants in Aid for Scientific Research</institution></institution-wrap></funding-source><award-id>18H05213</award-id><principal-award-recipient><name><surname>Fukai</surname><given-names>Tomoki</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013107</institution-id><institution>RIKEN Center for Brain Science</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Goda</surname><given-names>Yukiko</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008732</institution-id><institution>Uehara Memorial Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Goda</surname><given-names>Yukiko</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>Japan AMED Brain/MINDS</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Goda</surname><given-names>Yukiko</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>MEXT Grants in Aid for Scientific Research</institution></institution-wrap></funding-source><award-id>19K16885</award-id><principal-award-recipient><name><surname>Fung</surname><given-names>Chi Chung Alan</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Electrophysiology experiments with genetic and pharmacological manipulations identify a role for astrocyte GluN2C NMDA receptors in maintaining the broad range of presynaptic strengths, which is suggested by numerical simulations to enhance the expression of synaptic plasticity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Plasticity is a fundamental feature of neuronal connections in the brain, where experience-dependent changes in synaptic strengths over different time scales are crucial for a variety of processes ranging from neural circuit development, circuit computations to learning and memory (<xref ref-type="bibr" rid="bib35">Feldman and Brecht, 2005</xref>; <xref ref-type="bibr" rid="bib12">Bliss and Collingridge, 1993</xref>; <xref ref-type="bibr" rid="bib1">Abbott and Regehr, 2004</xref>; <xref ref-type="bibr" rid="bib26">Collingridge et al., 2010</xref>; <xref ref-type="bibr" rid="bib83">Nicoll, 2017</xref>). Deciphering how neurons dynamically express different forms of synaptic plasticity while ensuring the optimal performance of the circuit remains a key challenge (<xref ref-type="bibr" rid="bib116">Vitureira and Goda, 2013</xref>; <xref ref-type="bibr" rid="bib115">Turrigiano, 2017</xref>; <xref ref-type="bibr" rid="bib83">Nicoll, 2017</xref>; <xref ref-type="bibr" rid="bib18">Brunel, 2016</xref>). In particular, the distribution of synaptic strengths is thought to reflect the capacity or the state of information storage of neural circuits (<xref ref-type="bibr" rid="bib8">Barbour et al., 2007</xref>; <xref ref-type="bibr" rid="bib20">Buzsáki and Mizuseki, 2014</xref>; <xref ref-type="bibr" rid="bib17">Bromer et al., 2018</xref>). A better understanding of the cellular mechanisms that regulate synaptic strength distribution could therefore provide novel insights into the basis for the effective execution of circuit operations (<xref ref-type="bibr" rid="bib8">Barbour et al., 2007</xref>).</p><p>The N-methyl-D-aspartate receptors (NMDARs) are a major ionotropic glutamate receptor type mediating excitatory synaptic transmission (<xref ref-type="bibr" rid="bib88">Paoletti et al., 2013</xref>; <xref ref-type="bibr" rid="bib102">Sanz-Clemente et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Hansen et al., 2018</xref>). NMDARs are heteromeric assemblies consisting of four subunits, and seven NMDAR subunit genes have been identified that fall into three subfamilies: <italic>Grin1</italic> encoding the obligatory GluN1 subunit, four <italic>Grin2</italic> genes encoding GluN2A-D, and two <italic>Grin3</italic> genes encoding GluN3A-B (<xref ref-type="bibr" rid="bib88">Paoletti et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Hansen et al., 2018</xref>). The differing subunit compositions confer NMDARs with distinct biophysical and pharmacological properties and contribute to their diverse biological activities. NMDARs are expressed throughout the central nervous system (CNS) and are crucial for normal brain function and plasticity. In particular, NMDARs that are typically composed of two GluN1 and two GluN2 subunits and are present postsynaptically, have been extensively studied for their role in memory mechanisms (<xref ref-type="bibr" rid="bib88">Paoletti et al., 2013</xref>; <xref ref-type="bibr" rid="bib102">Sanz-Clemente et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">Nicoll, 2017</xref>). NMDARs are also involved in pathological conditions such as epilepsy, ischemia, and traumatic brain injury (<xref ref-type="bibr" rid="bib50">Hansen et al., 2017</xref>). In stark contrast to the multifaceted functions of neuronal NMDARs, very little is known of NMDAR functions in glial cells in the CNS. Amongst the better characterized glial NMDARs, NMDARs in oligodendrocytes play a role in axonal energy metabolism (<xref ref-type="bibr" rid="bib99">Saab et al., 2016</xref>) and exacerbate pathological conditions (<xref ref-type="bibr" rid="bib57">Káradóttir et al., 2005</xref>). In astrocytes, NMDARs have been long thought to be absent except following ischemia in vivo or under anoxia in vitro that promote their aberrant expression (<xref ref-type="bibr" rid="bib63">Krebs et al., 2003</xref>; <xref ref-type="bibr" rid="bib45">Gottlieb and Matute, 1997</xref>). Nevertheless, there are reports of GluN2C mRNA expression in astrocytes in the adult brain (<xref ref-type="bibr" rid="bib117">Watanabe et al., 1993</xref>; <xref ref-type="bibr" rid="bib58">Karavanova et al., 2007</xref>; <xref ref-type="bibr" rid="bib93">Ravikrishnan et al., 2018</xref>), and several studies provide physiological evidence in support of astrocyte NMDAR expression under non-pathological conditions (<xref ref-type="bibr" rid="bib103">Schipke et al., 2001</xref>; <xref ref-type="bibr" rid="bib107">Serrano et al., 2008</xref>; <xref ref-type="bibr" rid="bib65">Lalo et al., 2006</xref>; <xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>). The precise function for astrocyte NMDARs, however, has remained a matter of debate (e.g. <xref ref-type="bibr" rid="bib61">Kirchhoff, 2017</xref>), and the role for astrocyte GluN2C has not yet been identified.</p><p>Astrocytes regulate a diverse set of essential brain activities, from neurovascular coupling, metabolic support, and ionic homeostasis (e.g. <xref ref-type="bibr" rid="bib6">Attwell et al., 2010</xref>; <xref ref-type="bibr" rid="bib42">Giaume et al., 2010</xref>; <xref ref-type="bibr" rid="bib109">Simard and Nedergaard, 2004</xref>) to synaptic connectivity and function (e.g. <xref ref-type="bibr" rid="bib5">Araque et al., 2014</xref>; <xref ref-type="bibr" rid="bib25">Clarke and Barres, 2013</xref>). Recent studies have highlighted a role for astrocytes in the bidirectional control of basal synaptic transmission (<xref ref-type="bibr" rid="bib86">Panatier et al., 2011</xref>; <xref ref-type="bibr" rid="bib91">Perea and Araque, 2007</xref>; <xref ref-type="bibr" rid="bib32">Di Castro et al., 2011</xref>; <xref ref-type="bibr" rid="bib78">Martin-Fernandez et al., 2017</xref>; <xref ref-type="bibr" rid="bib105">Schwarz et al., 2017</xref>), which likely involves signaling via their perisynaptic processes (<xref ref-type="bibr" rid="bib11">Bindocci et al., 2017</xref>; <xref ref-type="bibr" rid="bib9">Bazargani and Attwell, 2016</xref>). Moreover, mounting evidence suggests that astrocytes are not only capable of either simply potentiating (<xref ref-type="bibr" rid="bib86">Panatier et al., 2011</xref>; <xref ref-type="bibr" rid="bib91">Perea and Araque, 2007</xref>; <xref ref-type="bibr" rid="bib56">Jourdain et al., 2007</xref>) or depressing synaptic transmission (<xref ref-type="bibr" rid="bib77">Martín et al., 2015</xref>; <xref ref-type="bibr" rid="bib90">Pascual et al., 2005</xref>), but a single astrocyte, which contacts tens of thousands of synapses, can concurrently mediate bi-directional synapse regulation at separate synaptic contact sites (<xref ref-type="bibr" rid="bib105">Schwarz et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Covelo and Araque, 2018</xref>). Astrocytes likely regulate neural circuit functions at multiple levels, as suggested by observations of both local and global astrocyte signaling that are triggered in a synapse, neuron, or circuit-specific manner (<xref ref-type="bibr" rid="bib78">Martin-Fernandez et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Martín et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Chai et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Deemyad et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Dallérac et al., 2018</xref>; <xref ref-type="bibr" rid="bib101">Santello et al., 2019</xref>). However, despite these advances, the basic mechanisms by which astrocytes detect and adjust synaptic transmission and the extent of their impact on local synaptic circuit activity are not fully understood.</p><p>Astrocytes express a plethora of neurotransmitter receptors and membrane transporters that are thought to modulate synaptic transmission (<xref ref-type="bibr" rid="bib5">Araque et al., 2014</xref>; <xref ref-type="bibr" rid="bib9">Bazargani and Attwell, 2016</xref>), including perisynaptic astrocyte glutamate transporters that influence the magnitude and kinetics of postsynaptic glutamate receptor activation and membrane depolarization (<xref ref-type="bibr" rid="bib87">Pannasch et al., 2014</xref>; <xref ref-type="bibr" rid="bib80">Murphy-Royal et al., 2015</xref>) and astrocyte metabotropic glutamate receptors (mGluRs) whose activation promote gliotransmitter release to provide feedback control of synaptic transmission (<xref ref-type="bibr" rid="bib86">Panatier et al., 2011</xref>; <xref ref-type="bibr" rid="bib105">Schwarz et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Covelo and Araque, 2018</xref>; <xref ref-type="bibr" rid="bib5">Araque et al., 2014</xref>; <xref ref-type="bibr" rid="bib9">Bazargani and Attwell, 2016</xref>). Given the often shared expression of neurotransmitter receptors and transporters between astrocytes and neurons, an important challenge is to decipher the synaptic activity-dependent functions of astrocyte receptors and transporters independently of the functions of their neuronal counterparts. Notably, many of the prior studies have focused on pathological brain states (<xref ref-type="bibr" rid="bib63">Krebs et al., 2003</xref>; <xref ref-type="bibr" rid="bib45">Gottlieb and Matute, 1997</xref>) or used young brain tissue (e.g. <xref ref-type="bibr" rid="bib86">Panatier et al., 2011</xref>) or culture preparations (e.g. <xref ref-type="bibr" rid="bib105">Schwarz et al., 2017</xref>) in which the expression pattern of the astrocyte receptors and channels differ substantially from the adult brain in basal conditions (<xref ref-type="bibr" rid="bib111">Sun et al., 2013</xref>; also see <xref ref-type="bibr" rid="bib13">Boisvert et al., 2018</xref>). Consequently, the cellular basis and the network consequences of astrocyte-synapse interactions mediated by the astrocyte receptors and channels in the healthy adult brain remain to be clarified.</p><p>In a previous study, we identified a role for astrocyte signaling in regulating synaptic strength heterogeneity in hippocampal neurons, which involved astrocyte NMDARs (<xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>). Heterogeneity was assessed by comparing the presynaptic strengths of two independent inputs to pyramidal neurons, which was estimated by the paired-pulse ratio (PPR) of excitatory postsynaptic current (EPSC) amplitudes, a parameter inversely related to presynaptic release probability (<xref ref-type="bibr" rid="bib33">Dobrunz and Stevens, 1997</xref>). Although basal PPRs were uncorrelated between the two inputs, surprisingly, inhibiting astrocyte NMDARs promoted the correlation of PPRs. This indicated that astrocyte NMDARs contributed to enhancing the differences in basal presynaptic strengths represented by the two different inputs (<xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>). Such pair-wise comparison of PPRs, however, is limited to providing an indirect measure of variability, and it remains unclear how astrocyte NMDARs control the overall shape of the PPR distribution. Furthermore, the crucial roles for neuronal NMDARs in regulating synaptic transmission and plasticity have confounded the interpretation of astrocyte NMDAR functions, which still remain enigmatic (<xref ref-type="bibr" rid="bib61">Kirchhoff, 2017</xref>). Here, we further investigated astrocyte NMDAR-dependent regulation of synaptic strength in hippocampal CA1 pyramidal neurons in adult mice, focusing on the mode of regulation of presynaptic strength distribution, the NMDAR type responsible, and probing the potential layer specific regulation in area CA1. Our findings identify a role for astrocyte GluN2C NMDARs in maintaining broad presynaptic strength diversity specifically in the <italic>stratum radiatum</italic> (SR) by enhancing both strong and weak synapses. Mathematical modeling suggests that presynaptic strength diversity strongly influences the expression of long-term synaptic plasticity, which in turn, is important for network stability and learning and memory (<xref ref-type="bibr" rid="bib72">Malenka and Bear, 2004</xref>; <xref ref-type="bibr" rid="bib26">Collingridge et al., 2010</xref>; <xref ref-type="bibr" rid="bib97">Royer and Paré, 2003</xref>; <xref ref-type="bibr" rid="bib119">Zenke and Gerstner, 2017</xref>). Our findings suggest astrocyte GluN2C NMDARs as a key player in linking the regulation of synaptic strength distribution to the expression of synaptic plasticity that promotes optimal circuit performance.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>NMDAR-dependent regulation of PPR variability in hippocampal CA1 pyramidal neurons</title><p>In order to characterize the properties of astrocyte NMDAR-dependent modulation of synaptic strength, here we devised a simplified assay using a single stimulating electrode to monitor PPR variability of Schaffer collateral synapses. Hippocampal slices were prepared from adult mouse brain (P60-120), and EPSCs to a pairwise stimulation (50 ms inter-stimulus interval) of Schaffer collateral axons were recorded in CA1 pyramidal neurons (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). MK801 (1 mM) was infused into the postsynaptic cell via the patch pipette, and after 10–15 min but prior to starting the experiment, Schaffer collaterals were stimulated at 0.1 Hz for at least 45 times to pre-block synaptic NMDARs. This resulted in over 92 % inhibition of synaptic NMDAR currents (<xref ref-type="bibr" rid="bib10">Bender et al., 2006</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>; see Materials and Methods). Upon confirming the block of postsynaptic NMDARs, the baseline EPSC recordings were taken; subsequently, NMDAR inhibitors were bath applied to test their effects on PPR variance. Under the block of postsynaptic NMDARs, any effects of NMDAR inhibitors, if observed, would be expected to reflect the influence of NMDARs present either in astrocytes or the presynaptic neurons. Notably, in mature brains which we used for our experiments, the contribution of presynaptic NMDARs in general had been suggested to be minimal (<xref ref-type="bibr" rid="bib108">Shih et al., 2013</xref>). Upon bath applying MK801 (50 µM) or AP5 (50 µM), the population variance (δ<sup>2</sup>) of PPRs was reduced without a significant change in the mean (<inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi>x</mml:mi><mml:mo>−</mml:mo></mml:mover></mml:mrow></mml:mstyle></mml:math></inline-formula>)(<xref ref-type="fig" rid="fig1">Figure 1B–D</xref>; MK801 δ<sup>2</sup> <italic>P</italic> = 0.016, <inline-formula><mml:math id="inf2"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula><italic>P</italic> = 0.856; AP5, δ<sup>2</sup> <italic>P</italic> = 0.047; <inline-formula><mml:math id="inf3"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula><italic>P</italic> = .162). This overall decrease in PPR variance, when examined at the level of individual inputs, was associated with a change in PPR (ΔPPR) that was negatively correlated to the baseline PPR: PPR of some inputs increased while others decreased by the NMDAR antagonist application (<xref ref-type="fig" rid="fig1">Figure 1E–G</xref>). Furthermore, consistent with a lack of change in the mean PPR upon blocking NMDARs, a linear fit to the data intercepted the x-axis near the baseline mean PPR (x-axis intercept: MK801 = 1.97; AP5 = 1.95).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>NMDARs contribute to synaptic strength diversity of Schaffer collateral synapses.</title><p>(<bold>A</bold>) Experimental scheme to assess the role of non-postsynaptic NMDARs. MK801 was perfused through the patch pipette (iMK801) to the CA1 pyramidal neuron for 10–15 min, and pairs of stimuli (Δt = 50 ms) were applied at least 45 times at 0.1 Hz to pre-block postsynaptic NMDARs prior to bath applying NMDAR antagonists (bottom). (<bold>B–D</bold>) Left: representative EPSC traces (average of 20 sweeps) to pairs of pulses (Δt = 50 ms) applied to Schaffer collateral axons before (baseline) and after wash-on of vehicle control (<bold>B</bold>), external MK801 (eMK801: 50 µM) (<bold>C</bold>), or AP5 (50 µM) (<bold>D</bold>). Right: histograms of the PPRs recorded during the baseline and vehicle or drug application periods were fit with single Gaussian curves. The p values for the comparison of the baseline to the experimental periods for the population mean (<inline-formula><mml:math id="inf4"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>) and variance (δ<sup>2</sup>) were obtained by two-tailed paired sample t-test and one-tailed f-test for equal variances, respectively. (<bold>E–G</bold>) Scatterplots of the change in PPR vs. the initial PPR in vehicle control (<bold>E</bold>), MK801 (<bold>F</bold>), or AP5 (<bold>G</bold>) where ΔPPR = PPR<sub>experimental</sub>-PPR<sub>baseline</sub>; linear fits, Pearson’s correlation coefficients (<bold>r</bold>) and p values are as indicated. X intercept: MK801 = 1.97, AP5 = 1.95. (<bold>H–J</bold>) Plots of normalized EPSC amplitudes before and during the application of NMDAR antagonists (shaded area); n, number of inputs examined for each experiment. Baseline and experimental periods are indicated (black bars). Right: summary bar graph. * p &lt; 0.05, Mann-Whitney U-test. Control = 30 inputs, 15 cells, 13 mice; MK801 = 28 inputs, 14 cells, 9 mice; AP5 = 24 inputs, 12 cells, 11 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>MK801 (1 mM) in the patch pipette (iMK801) completely blocks postsynaptic NMDARs.</title><p>(<bold>A–B</bold>) Representative traces of EPSC recorded at a holding potential (V<sub>h</sub>) of –70 mV using control (<bold>A</bold>) or MK801-containing (<bold>B</bold>) pipette solution to measure AMPAR-mediated currents. EPSCs were recorded at a V<sub>h</sub> of +40 mV and in the presence of NBQX (10 μM) to measure isolated NMDAR-mediated currents. AP5 (20 μM) was subsequently added to the bath to confirm the NMDAR-dependence of EPSCs. EPSCs were sampled following a pre-experiment stimulation period that consisted of at least 45 pairs of pulses delivered at 0.1 Hz at a V<sub>h</sub> of –70 mV. (<bold>C</bold>) AMPA-mediated EPSCs are no different between control and iMK801experiments. (<bold>D</bold>) NMDAR-mediated EPSCs are completely abolished by the presence of iMK801. (<bold>E</bold>) Paired pulse ratios (PPRs) measured at V<sub>h</sub> –70 mV are not altered by iMK801. Control n = 7 cells, 7 slices, 2 mice; control+ AP5 n = 7 cells, 7 slices, 2 mice; iMK801 n = 9 cells, 9 slices, 3 mice; iMK80+ AP5 n = 3 cells, 3 slices, 2 mice. ns p &gt; 0.05, ** p &lt; 0.0001 two-tailed t-test (<bold>D, E</bold>) or Mann-Whitney U test (<bold>C</bold>). Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Antagonists of GluN2B-containing NMDARs (Ro25-6981) or mGluR5 (MPEP) do not alter synaptic weight diversity.</title><p>(<bold>A–C</bold>) Histograms of PPR distributions during the baseline (<italic>top histogram</italic>) and control aCSF or drug application (<italic>bottom histogram</italic>) were fit with single Gaussian curves. The p values obtained for the population mean (<inline-formula><mml:math id="inf5"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>) (two tailed paired sample t-test for <italic>A, B</italic>, Wilcoxon signed rank test for <italic>C</italic>) and variance (δ<sup>2</sup>) (one-tailed f-test for equal variances) comparing the baseline to the aCSF/drug application periods are shown in the graphs. (<bold>D–F</bold>) Plots of EPSC amplitudes (normalized to the baseline average) before and during the application of NMDAR antagonists (shaded area) where n is the number of inputs examined. Baseline and experimental periods are indicated (black bars). Box plots to the right show the summary of normalized EPSC amplitudes during the application of indicated inhibitors. p-Values are the result of Mann-Whitney U tests comparing EPSC change drug application period to the corresponding period in control experiments. (<bold>G–I</bold>) Left: Mean (dark circles) and individual (light circles) CV<sup>–2</sup> of EPSCs during the baseline and aCSF/drug application periods. p-Values shown are the result of Wilcoxon signed rank tests. Right: Scatterplot of the relative change in CV<sup>–2</sup> (CV<sup>–2</sup> <sub>experimental</sub>/CV<sup>–2</sup><sub>baseline</sub>) against the relative change in EPSC amplitude (EPSC <sub>experimental</sub>/EPSC<sub>baseline</sub>) for the mean (dark circles) and individual inputs (light grey circles). Pearson’s correlation coefficients (<bold>r</bold>) and p values are shown in the graph. Control n = 12 inputs, 24 cells, 11 mice; Ro25-6981 n = 30 inputs, 17 cells, 11 mice; MPEP n = 26 inputs, 13 cells, 5 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>NMDAR antagonists differentially influence presynaptic function.</title><p>(Related also to <xref ref-type="fig" rid="fig6">Figure 6</xref>) (<bold>A</bold>) Averaged (dark colors) and individual (light grey) EPSC traces during the baseline and experimental periods from a representative experiment. (<bold>B</bold>) Mean (dark circles) and individual (light grey circles) CV<sup>–2</sup> of EPSCs during the baseline and aCSF/drug application periods. P-values are the result of Wilcoxon signed rank tests. (<bold>C–F</bold>) Scatterplot of the relative change in CV<sup>–2</sup> (CV<sup>–2</sup> <sub>experimental</sub>/CV<sup>–2</sup><sub>baseline</sub>) against the relative change in EPSC amplitude (EPSC <sub>experimental</sub>/EPSC<sub>baseline</sub>) for the mean (dark circles) and individual inputs (light circles). Pearson’s correlation coefficients (<bold>r</bold>), p values, and the unity line (dashed) are shown in scatter plots. (<bold>G–J</bold>) Scatterplot of the difference in PPR (PPR <sub>experimental</sub>-PPR<sub>baseline</sub>) against the relative change in EPSC amplitude (EPSC <sub>experimental</sub>/EPSC<sub>baseline</sub>) for the mean (dark symbol) and individual inputs (light symbols). Linear fits (grey lines), Pearson’s correlation coefficients (<bold>r</bold>), and p values are shown in scatter plots. Control = 30 inputs, 15 cells, 13 mice; MK801 = 28 inputs, 14 cells, 9 mice; AP5 = 24 inputs, 12 cells, 11 mice; QNZ46 = 22 inputs, 11 cells, 7 mice; Ro25-6981 n = 30 inputs, 17 cells, 11 mice; MPEP n = 26 inputs, 13 cells, 5 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>NMDAR antagonists have little effect on spontaneous neurotransmission and the waveform of evoked EPSCs.</title><p>[Related also to <xref ref-type="fig" rid="fig6">Figure 6</xref>] (<bold>A–E</bold>) Representative traces and quantification of spontaneous EPSC amplitude and frequency recorded during the baseline and after applying control aCSF (<bold>A</bold>), MK801 (<bold>B</bold>), AP5 (<bold>C</bold>), QNZ46 (<bold>D</bold>), and Ro-256981 (<bold>E</bold>). Control n = 12 cells, 10 mice; MK801 n = 14 cells, 9 mice; AP5 n = 10 cells, 9 mice; QNZ46 n = 11 cells, 8 mice; Ro25-6981 n = 15 cells, 10 mice. ns p &gt; 0.05 one way ANOVA (amplitude), and Kruskal-Wallis ANOVA (frequency) comparing the normalized change during experimental periods across treatment conditions. (<bold>F–J</bold>) Left: Grand average waveforms of EPSCs recorded. Right: Box plots of EPSC risetime (top) and EPSC decay time constant (single exponential fit)(bottom) for baseline and control aCSF or drug application. ns p &gt; 0.05 two tailed t-test or Mann-Whitney U tests. Control n = 24 inputs, 12 cells, 10 mice; MK801 n = 16 inputs, 11 cells, 11 mice; AP5 n = 26 inputs, 13 cells, 9 mice; QNZ46 n = 18 inputs, 9 cells, 6 mice; Ro25-6981 n = 32 inputs, 16 cells, 11 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig1-figsupp4-v2.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 5.</label><caption><title>NMDAR antagonists that target GluN2C-containing NMDARs reduce PPR disparity in the <italic>stratum radiatum</italic> (SR).</title><p>[Related also to <xref ref-type="fig" rid="fig6">Figure 6</xref>] (<bold>A</bold>) Illustration of the two-input stimulation configuration. Two independent inputs in the SR were sampled with interleaved stimulation. (<bold>B</bold>) The absolute difference between the PPRs of the two inputs sampled during a 2.5 min window (average of 5 sweeps) is referred to as ΔPPR (|PPR<sub>S1</sub>-PPR<sub>S2</sub>|) and is taken as a measure of variability of presynaptic strength. (<bold>C–H</bold>) Left: Time course of ΔPPR before and after application of antagonists. Middle: Summary plots of individual experiments comparing ΔPPR in baseline and during antagonist treatment. Right: Scatter plots comparing PPR of the two independent inputs normalized to the first EPSC amplitude for baseline and in the presence of the antagonists. ΔPPR is reduced by MK801 (<bold>D</bold>), AP5 (<bold>E</bold>), QNZ46 (<bold>F</bold>), but not by Ro25-6981 (<bold>G</bold>) or MPEP (<bold>H</bold>). Similarly, the scatterplots demonstrate distribution of average PPR values across pairs of inputs (<bold>S1 and S2</bold>) of PPRs by MK801, AP5 and QNZ46, all of which target GluN2C-containing NMDARs, but not by Ro25-6981 or MPEP that target GluN2B-NMDAR or mGluR5, respectively. ns p &gt; 0.05, ** p &lt; 0.01 Wilcoxon signed ranks test comparing baseline to drug application period. Control n = 15 pairs of inputs, 15 cells, 13 mice; MK801 n = 14 pairs of inputs, 14 cells, 9 mice; AP5 n = 12 pairs of inputs, 12 cells, 11 mice; QNZ46 n = 11 pairs of inputs, 11 cells, 7 mice; Ro25-6981 n = 15 pairs of inputs, 15 cells, 11 mice; MPEP n = 13 pairs of inputs, 13 cells, 5 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig1-figsupp5-v2.tif"/></fig></fig-group><p>We also tested for the contribution of GluN2B NMDAR and also of mGluR5 in maintaining PPR variance. Bath applying Ro25-6981 (10 µM), a GluN2B-specific NMDAR antagonist (<xref ref-type="bibr" rid="bib36">Fischer et al., 1997</xref>), and MPEP (25 µM), an mGluR5-specific antagonist (<xref ref-type="bibr" rid="bib41">Gasparini et al., 1999</xref>), had little effect on PPR variance (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A-C</xref>; Ro256981 p = 0.362, MPEP p = 0.349). MPEP, however, significantly increased the mean PPR (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>; p = 0.033), which is consistent with a reported role for mGluR5 in presynaptic strength regulation (<xref ref-type="bibr" rid="bib86">Panatier et al., 2011</xref>).</p><p>We next examined whether the changes in PPR elicited by the extracellularly applied NMDAR inhibitors accompanied changes in the EPSC amplitude and the coefficient of variation (CV) of EPSC amplitude, the latter as an additional measure of the change in presynaptic release probability (<xref ref-type="bibr" rid="bib73">Malinow and Tsien, 1990</xref>; <xref ref-type="bibr" rid="bib67">Larkman et al., 1992</xref>). On average, bath applied MK801 did not substantially alter the amplitude of the first EPSC to the pair of stimuli relative to control slices, despite a small tendency for an increase with a time delay (<xref ref-type="fig" rid="fig1">Figure 1I</xref>; p = 0.657). MK801 also had little effect on CV<sup>–2</sup> of EPSC amplitudes (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>; p = 0.991), although the responses of individual inputs to MK801, albeit small in magnitude, were positively correlated to CV<sup>–2</sup> (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D</xref>; Pearson’s <italic>r</italic> = 0.420, p = 0.026) and negatively correlated to PPR (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3H</xref>; Pearson’s <italic>r</italic> = –0.474, p = 0.011). These data are consistent with the possibility that the observed reduction in PPR diversity by MK801 application is associated with normalization of presynaptic release probability.</p><p>In contrast to MK801, AP5 significantly increased EPSC amplitudes within 10 min of application (<xref ref-type="fig" rid="fig1">Figure 1J</xref>; p = 0.026), and the increase in CV<sup>–2</sup> (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>; AP5 p = 0.003) suggested that the change in EPSC amplitude involved a presynaptic change. Notably, Ro25-6981 that had no effect on PPR variance, did produce a significant increase in CV<sup>–2</sup> (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2H</xref>; CV<sup>–2</sup> p = 0.002), and produced a small but non-significant increase in EPSC amplitudes (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>; EPSC p = 0.261), which was consistent with the observed increase in PPR (above). None of the NMDAR antagonists caused substantial changes in the amplitude or frequency of spontaneous EPSCs (sEPSCs) or evoked EPSC waveforms (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>).</p><p>We next sought to confirm the NMDAR-dependent modulation of presynaptic strength diversity as described in our previous study by comparing PPRs across two independent Schafer collateral inputs that converge onto a target CA1 pyramidal neuron (<xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>), and to observe the time course of PPR population variance change by NMDAR antagonists. In this method, the absolute difference of PPRs between the two inputs (PPR disparity) is taken as a proxy for presynaptic strength variability, with lower PPR disparity indicating lower PPR variability and vice versa (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5A</xref>,B). Note that graphs of the PPR difference contain a regression-to-the-mean component, which is however effectively cancelled out when making direct graph comparisons, within the same parametric space. Consistent with our analysis thus far, bath application of MK801 and AP5 reduced PPR disparity (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5D</xref>,E; MK801 p = 0.001, AP5 p = 0.004), while Ro25-6981 and MPEP did not (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5G</xref>,H; Ro25-6981 p = 0.670, MPEP p = 0.263).</p><p>Collectively, these findings support the idea that NMDARs play a role in regulating presynaptic strengths to broaden the variability of PPR without appreciably impacting the mean PPR. Moreover, such an involvement of NMDARs in presynaptic regulation is distinct from the presynaptic regulation by mGluR5 that potentiates synaptic strength across a synapse population.</p></sec><sec id="s2-2"><title>Astrocyte NMDARs mediate the effects of NMDAR antagonists on PPR diversity</title><p>To test the extent to which bath applied NMDAR antagonists affected synaptic transmission by targeting astrocyte NMDARs, we knocked down in astrocytes, the <italic>Grin1</italic> gene that encodes GluN1, a requisite subunit for the cell surface expression of NMDARs (<xref ref-type="bibr" rid="bib38">Fukaya et al., 2003</xref>; <xref ref-type="bibr" rid="bib2">Abe et al., 2004</xref>). AAV carrying either mCherry-tagged nlsCre (Cre) or a control nls-mCherry lacking Cre or in some experiments control EGFP lacking Cre (Control), all of which were expressed under the GFAP104 promoter, was injected bilaterally into the dorsal hippocampus of adult <italic>Grin1</italic> floxed mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>; see Materials and Methods section and E-phys statistics report for details)(<xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>). We used low titer AAVs (~0.4–4⨯10<sup>10</sup> genome copies/injection) to avoid potential reactive astrocytosis, and although the extent was modest, we obtained a highly specific mCherry expression in astrocytes throughout the area CA1 with little expression in neurons (<xref ref-type="fig" rid="fig2">Figure 2B</xref>: Cre, 41.1% ± 2.4% of GFAP+ ve cells [n = 3,529], 0.3% ± 0.1% of NeuN+ ve cells [n = 1,150] from 5 mice; Control, 40.7% ± 1.9% of GFAP+ ve cells [n = 3,309], 0.5% ± 0.1% of NeuN+ ve cells [n = 1,217] from 5 mice). The efficacy of GluN1 knock-down in astrocytes was assessed electrophysiologically by patch-clamping astrocytes and monitoring slow depolarizing responses elicited by puff applying NMDA and glycine (1 mM each) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) which were mediated by NMDARs but were also contributed in part by voltage-gated calcium channels in astrocytes (<xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>). Astrocytes that expressed Cre as identified by the mCherry fluorescence in <italic>stratum radiatum</italic> (SR) where Schaffer collateral synapses were present, showed depolarizing responses to NMDA-glycine puff that were significantly decreased compared to controls (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>; <italic>P</italic> = 0.006). Given that mCherry-positive astrocytes were present throughout the CA1, we also monitored NMDA-glycine puff responses in astrocytes in <italic>stratum oriens</italic> (SO) and <italic>stratum lacunosum moleculare</italic> (SLM). In contrast to mCherry-positive astrocytes in SR, mCherry-labeled astrocytes in SO or SLM showed depolarizing responses to NMDA-glycine puff that were not different between Cre and Control slices (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B, C</xref>; SO p = 0.247; SLM p = 0.268), despite the fact that viral transduction efficiencies were comparable amongst astrocytes across the three layers (SR: Cre 39.8% ± 2.4%, Control 40.2% ± 2.0%; SO: Cre 44.8% ± 3.0%, Control 39.3% ± 5.9%; SLM: Cre 39.1% ± 4.9%, Control 40.0% ± 4.0%). The input resistance of patched astrocytes was not altered by Cre expression in any layer (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Notably, NMDA-glycine responses in SLM were substantially smaller than those in SR or SO (<italic>P</italic> = 0.001, one way ANOVA, Bonferroni post-hoc tests). Nevertheless, AP5 bath application blocked NMDA-glycine puff-induced depolarizing responses in astrocytes in all three layers. This observation suggests that NMDARs are broadly expressed across hippocampal CA1 astrocytes. Moreover, the differential sensitivity of the slow depolarizing responses to astrocyte GluN1 knock-down between layers supports the possibility that the cumulative actions of signaling downstream to NMDAR activation including the contribution of voltage-gated conductances (<xref ref-type="bibr" rid="bib107">Serrano et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>; <xref ref-type="bibr" rid="bib108">Shih et al., 2013</xref>) could be heterogeneous across layers. We will return to this layer-specific differences later.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Astrocyte NMDARs mediate the antagonist-induced decrease in synaptic strength diversity.</title><p>(<bold>A</bold>) Astrocyte GluN1 was conditionally knocked down by injecting AAV-GFAP104-nls-mCherry-Cre (Cre), or as a control, AAV-GFAP104-nls-mCherry (Control), to the dorsal hippocampus of adult <italic>Grin1<sup>flx/flx</sup></italic> mice. (<bold>B</bold>) Representative image of hippocampal area CA1 immunolabeled for GFAP (green) and mCherry (red) and counterstained with DAPI (blue), 21 days after virus injection. SO, <italic>stratum oriens</italic>; SPy, <italic>stratum pyramidale</italic>; SR, <italic>stratum radiatum</italic>; SLM, <italic>stratum lacunosum moleculare</italic>; MOL, molecular layer; GCL, granule cell layer. Right: magnified view in SR showing restricted expression of mCherry to GFAP-positive astrocytes (arrowheads). Scale bar, 20 µm. (<bold>C</bold>) Recording scheme: CA1 pyramidal neurons were patched in acute slices prepared 21 days after Control or Cre AAV infection. EPSCs were elicited by placing the stimulating electrode in the SR. Patch pipette contained MK801 (iMK801) for experiments in <italic>E-H</italic>. (<bold>D</bold>) Left: Averaged EPSC traces from representative recordings in slices from Control (top) or Cre (bottom) virus-infected mice. Individual traces are shown in grey. Right: Histograms of PPRs recorded from control (top) and Cre slices (bottom) were fit with single Gaussians. The p values were obtained for the population mean (<inline-formula><mml:math id="inf6"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>) (two-tailed t-test) and variance (δ<sup>2</sup>) (one-tailed f-test for equal variances) comparing PPR distributions from control (n = 72 inputs, 43 cells, 14 mice) and Cre (n = 74 inputs, 46 cells, 12 mice) slices. (<bold>E,F</bold>) Left: average EPSC traces in baseline (grey) and after drug treatment (color) from a representative experiment. Right: PPR histograms (top) and ΔPPR vs. baseline PPR plots (bottom) in baseline and after bath applying AP5 (50 µM) to control (<bold>E</bold>) and Cre (<bold>F</bold>) slices. The p values for the population mean (<inline-formula><mml:math id="inf7"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>) and variance (δ<sup>2</sup>) are as in <italic>D</italic>, comparing PPRs before and after the drug treatment. Linear fits and Pearson’s correlation coefficients (<bold>r</bold>) and p values are shown in scatter plots. (<bold>G,H</bold>) Plots of normalized EPSC amplitudes before and during the application of AP5 to control (<bold>G</bold>) and Cre-infected (<bold>H</bold>) slices (shaded area); n is the number of inputs examined. Right: summary bar graph. **p = 0.005, Mann-Whitney U-test. Control+ AP5 = 22 inputs, 12 cells, 5 mice; Cre+ AP5 = 24 inputs, 14 cells, 5 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Puff application of NMDA and glycine triggers the depolarization of astrocytes in hippocampal CA1 in acute slices.</title><p>(<bold>A</bold>) Left: experimental setup. Middle: Local puff application (100 ms, black bar) of NMDA and glycine (1 mM each) to astrocytes that are whole-cell patch clamped in the <italic>stratum radiatum</italic> (SR) elicits slow membrane depolarization (Control, blue), which is prevented in the presence of AP5 (arrow). Once the depolarization is triggered, not only NMDARs but also other voltage-gated channels such as L-type calcium channels contribute to the slow depolarization (<xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>). The depolarization is substantially reduced when the same experiment is carried out in Cre-expressing astrocytes as monitored by mCherry expression in slices infected with the AAV-GFAP104-nls-mCherry-Cre virus to knock-down astrocyte NMDARs in <italic>Grin1<sup>flx/flx</sup></italic> mice (Cre, red). Right: Summary plot of the peak membrane depolarization in control virus infected (Control) or NMDAR knock-down (Cre) slices in control aCSF or in the presence of AP5. (<bold>B–C</bold>) Same as (<bold>A</bold>) except NMDA and glycine puff was applied to astrocytes patch-clamped in the <italic>stratum oriens</italic> (SO)(<bold>B</bold>) and <italic>stratum lacunosum moleculare</italic> (SLM)(<bold>C</bold>). NMDA/glycine puff-mediated depolarizations elicited in SO and SLM astrocytes are not sensitive to astrocyte NMDAR knockout. SR Control n = 14 cells, 3 mice; SR Cre n = 14 cells, 3 mice. SO Control n = 8 cells, 3 mice; SO Cre n = 8 cells, 3 mice. SLM Control n = 9 cells, 2 mice; SLM Cre n = 8 cells, 2 mice. (<bold>D</bold>) Cre expression does not alter the input resistance (R<sub>in</sub>) of astrocytes in any layer. IV relationships of Control and Cre positive astrocytes in the SR, SO, and SLM to square voltage steps (left; 500 ms duration) and quantification of R<sub>in</sub> (right). SR Control n = 17 cells, 8 mice; SR Cre n = 20 cells, 10 mice. SO Control n = 16 cells, 10 mice; SO Cre n = 16 cells, 11 mice. SLM Control n = 19 cells, 8 mice; SLM Cre n = 18 cells, 9 mice. ns p &gt; 0.05, p values shown are the result of two-tailed t-tests or Mann-Whitney U tests. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Knock-down of GluN1 in hippocampal astrocytes selectively alters the PPR disparity without affecting the basic properties of synaptic transmission.</title><p>[Related also to <xref ref-type="fig" rid="fig6">Figure 6</xref>] (<bold>A</bold>) Left: Illustration of the experimental configuration of two-pathway stimulation approach to estimate PPR disparity in slices from <italic>Grin1<sup>flx/flx</sup></italic> mice infected with Control or Cre virus. Right: Comparison of ΔPPR (|PPR<sub>S1</sub>-PPR<sub>S2</sub>|) between Control or Cre slices. PPR disparity (ΔPPR) is reduced in Cre infected slices compared to controls. p = 0.009, Mann-Whitney U test. Control n = 29 pairs of inputs, 29 cells, 8 mice. Cre n = 28 pairs of inputs, 28 cells, 6 mice. (<bold>B</bold>) Left: Grand average waveforms of EPSCs recorded. Right: Box plots of EPSC risetime and EPSC decay time constant (single exponential fit). Each data point represents the average waveform of at least 5 sweeps of EPSCs. Control n = 46 inputs, 23 cells, 8 mice. Cre n = 41 inputs, 21 cells, 6 mice. (<bold>C</bold>) Left: Representative traces of spontaneous EPSC (sEPSC) recordings from Control (blue) or Cre (red) slices. Right: Boxplots of sEPSC amplitude and frequency measured in Control or Cre-infected slices. P values shown are the result of Mann-Whitney U test. Control n = 23 cells, 5 mice. Cre n = 26 cells, 5 mice. (<bold>D–G</bold>) Normalized sEPSC amplitude (top) and frequency (bottom) during baseline and in the presence of AP5 or QNZ46 in Control or Cre-infected slices. Neither sEPSC amplitude nor frequency is not affected by AP5 or QNZ46. Two tailed t-test or Mann-Whitney U test, comparisons made between Control vs. Cre normalized values in post drug period indicated. (<bold>H–K</bold>) ΔPPR (|PPR<sub>S1</sub>-PPR<sub>S2</sub>|) measurements during baseline and in the presence of AP5 or QNZ46 in Control or Cre-infected slices. The decrease in PPR disparity triggered by AP5 (<bold>H</bold>) and QNZ46 (<bold>J</bold>) is prevented upon knock-down of astrocyte NMDARs. * p &lt; 0.05 Wilcoxon signed ranks test. Control+ AP5 n = 12 pairs of inputs, 12 cells, 6 mice. Cre+ AP5 n = 14 pairs of inputs, 14 cells, 5 mice. Control+ QNZ46 n = 12 pairs of inputs, 12 cells, 5 mice. Cre+ QNZ46 n = 12 pairs of inputs, 12 cells, 6 mice. (<bold>L–O</bold>) Scatterplot of the relative change of CV<sup>–2</sup> (CV<sup>–2</sup> <sub>experimental</sub>/CV<sup>–2</sup><sub>baseline</sub>) against the relative change in EPSC amplitude (EPSC <sub>experimental</sub>/EPSC<sub>baseline</sub>) for the mean (dark symbol) and individual inputs (light symbols). Dashed lines show positive unity line. Pearson’s correlation coefficients (<bold>r</bold>) and p values are shown in scatter plots. N values are the same as <italic>H-K</italic>. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig2-figsupp2-v2.tif"/></fig></fig-group><p>Having detected GluN1-dependent functional NMDAR activity in SR CA1 astrocytes, we next asked whether the GluN1 knock-down also affected synaptic transmission of Schaffer collateral synapses similarly to the bath applied NMDAR antagonists. Baseline PPR showed a significantly reduced PPR variance in Cre-infected slices compared to control slices without a change in the mean PPR (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>; δ<sup>2</sup> <italic>P</italic> = 0.033; <inline-formula><mml:math id="inf8"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula><italic>P</italic> = 0.725). Analysis of the relative PPR from two independent Schaffer collateral inputs also revealed lower PPR disparity in Cre injected slices compared to control slices (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>; p = 0.009). These observations are consistent with a reduced PPR variance upon compromising astrocyte NMDAR signaling as observed with bath applied NMDAR inhibitors. The amplitude and frequency of spontaneous EPSCs and the waveform of evoked EPSCs were unaltered by astrocyte-specific GluN1 knock-down (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>,C).</p><p>We next determined whether astrocyte GluN1 knock-down could occlude the effects of bath applied AP5 on PPR variance, by recording from postsynaptic CA1 neurons infused with MK801 in Control and Cre-infected slices. Similar to naive slices, in Control slices, AP5 decreased the population variance of PPRs by strengthening some synapses and weakening others (<xref ref-type="fig" rid="fig2">Figure 2E</xref>; Control + AP5 p = 0.017). In addition, AP5 caused also a variable increase in EPSC amplitudes (<xref ref-type="fig" rid="fig2">Figure 2G</xref>; AP5 p = 0.005) that occurred without a concomitant change in the amplitude or the frequency of spontaneous EPSCs (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D</xref>,E). In Cre slices, however, the decrease in PPR variance by AP5 was strongly attenuated, despite the modest extent of virus infection in Cre slices (<xref ref-type="fig" rid="fig2">Figure 2F</xref>; Cre + AP5 p = 0.789). The analysis of PPR disparity across two inputs also showed substantially decreased inhibitory effect of AP5 in Cre slices relative to controls (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2H</xref>,I; Control + AP5 p = 0.013, Cre + AP5 p = 0.315). Curiously, the small increase in EPSC amplitudes observed upon applying AP5 was also attenuated in Cre slices (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). This suggests that although the effect of NMDAR antagonists on PPR diversity and EPSC amplitudes are likely to target distinct compartments – presynaptic and postsynaptic – both mechanisms may involve astrocyte NMDARs. Together, these observations indicate that astrocyte NMDARs are the major mediators of the synaptic effects of acutely blocking NMDARs in our experimental conditions, and further support the view that astrocyte NMDARs help maintain the broad variability of presynaptic strengths across a synapse population.</p></sec><sec id="s2-3"><title>Modelling of release probability variability reveals its impact on synaptic plasticity</title><p>In order to gain an insight into the physiological role for the broad release probability distribution, we sought to assess the impact of reducing the presynaptic strength variability on a synaptic learning rule by constructing a mathematical model. We first modelled release probability variations based on gamma distributions (<xref ref-type="bibr" rid="bib20">Buzsáki and Mizuseki, 2014</xref>; <xref ref-type="bibr" rid="bib15">Branco and Staras, 2009</xref>; <xref ref-type="bibr" rid="bib81">Murthy et al., 1997</xref>). To achieve this, we experimentally obtained estimates of release probability using the styryl dye, FM1-43 in synaptic networks of hippocampal pyramidal neurons co-cultured with astrocytes. Briefly, neurons were extracellularly stimulated with 40 action potentials at 20 Hz in the presence of FM1-43 to label the readily releasable vesicle pool, a parameter related to release probability (<xref ref-type="bibr" rid="bib95">Rosenmund and Stevens, 1996</xref>; <xref ref-type="bibr" rid="bib69">Letellier et al., 2019</xref>). Two sets of data were obtained: one in control condition containing 10 μM CNQX to prevent recurrent activity (‘control’), and another in the additional presence of 50 μM AP5 (‘AP5’). Because the block of synaptic AMPARs by CNQX would compromise the activation of neuronal NMDARs, we reasoned that any changes to the FM1-43 signal in the AP5 condition (i.e. CNQX + AP5) relative to the control could suggest the contribution of astrocyte NMDARs to the readily releasable pool size. The gamma distributions that best fit the FM1-43 signal distributions in control and AP5 groups were then obtained to model the release probability distributions in the simulations; the optimal parameters for the gamma distributions were determined by maximizing the likelihood function for each case (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; see Materials and methods). Notably, the gamma distribution for the AP5 condition showed a smaller variance than that of the control condition, which was reminiscent of the effect of bath applied AP5 on PPR distribution. To facilitate the cross-check of whether the reduction in variance per se was an important factor affecting the synaptic learning rule in the simulations, we also considered a gamma distribution that best fit the FM1-43 signal distribution in the AP5 condition by fixing the mean of the gamma distribution to remain the same as for the control condition (‘AP5-with-control mean’; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>).</p><p>We next asked whether the influence of release probability variance on the efficacy of long-term synaptic plasticity could be observed in a computational model by simulating spike-timing dependent plasticity (STDP) using two leaky integrate-and-fire (LIF) neurons with a synaptic connection (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, see Materials and methods). The presynaptic neuron received a spike train of magnitude <italic>A</italic><sub>1</sub> = 500 pA, while the postsynaptic neuron received a spike train of variable magnitude <italic>A</italic><sub>2</sub>. Pairing 10 spikes at 20 Hz with a time difference between spike trains of Δ<italic>t</italic> resulted in LTP or LTD, with positive Δ<italic>t</italic> values producing LTP and negative Δ<italic>t</italic> values resulting in LTD (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Simulations using the decreased release probability variance of the AP5 condition showed little change in LTD whereas LTP was compromised compared to the control condition. Specifically, when the efficacy of synaptic weight change was compared as a function of the amplitude of the postsynaptic current injection <italic>A</italic><sub>2</sub>, a less variable release probability represented by the AP5 condition required higher levels of current injection to trigger LTP compared to a broad release probability distribution represented by the control condition (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, left versus middle panel). The effect of narrowed release probability variance in increasing the threshold for eliciting LTP persisted also for the AP5-with-control mean group (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, right panel). A further comparison was made by plotting the averages of the maximum change of synaptic weight for different <inline-formula><mml:math id="inf9"><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>t</mml:mi></mml:math></inline-formula> when the <inline-formula><mml:math id="inf10"><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> was between 180 pA and 200 pA for the three conditions (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The analysis clearly revealed that the potentiation was more sensitive for smaller input current impulses. In effect, the results showed that the control condition exhibited a higher propensity to undergo LTP compared to the two AP5 groups representing conditions of reduced release probability variance.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Synaptic neurotransmitter release probability diversity impacts long-term synaptic plasticity.</title><p>(<bold>A</bold>) Illustration of the model used in the simulation. There are two leaky integrate-and-fire neurons with a synaptic connection. Each neuron receives a current injection whose magnitude is <italic>A<sub>1</sub></italic> for neuron 1 and <italic>A</italic><sub>2</sub> for neuron 2. The input spike trains for neuron 1 and neuron 2 are misaligned by Δ<italic>t</italic>. <italic>A</italic><sub><italic>1</italic></sub> is set at 500 pA which is large enough to trigger neuron 1 to spike, while <italic>A</italic><sub>2</sub> is varied to test the sensitivity of STDP between neurons. The release probability of neuron 1 [subject to alteration by the neighboring astrocyte(s)] is modelled by different gamma distribution for three different conditions: ‘control’, ‘AP5’ representing narrowed release probability distribution, and ‘AP5-with-control mean’ in which the best fit distribution for the AP5 case has been obtained by fixing the mean to remain the same as the mean of the control distribution. (<bold>B</bold>) Summary of simulation illustrating the efficacy with which long-term synaptic plasticity is triggered as a function of the amplitude of postsynaptic current injection <italic>A</italic><sub>2</sub> . Changes in synaptic weight <italic>w</italic>(t) after giving 10 spike pairs at 20 Hz in which the current injection to the presynaptic neuron is 500 pA and the postsynaptic neuron is <italic>A</italic><sub>2</sub>, in control (left), in AP5 (middle), and in AP5-with-control mean (right). The current injection sequences to the presynaptic and the postsynaptic neurons are separated by a time difference Δ<italic>t</italic>. Color intensity shows the degree of potentiation (red) and depression (blue) of synaptic weight changes observed for variable amount of <italic>A</italic><sub>2</sub> injected to the postsynaptic neuron at each Δ<italic>t</italic> for the three different conditions represented by each panel. Horizontal green dashed line shows the minimum amount of current injection to the postsynaptic neuron <italic>A</italic><sub>2</sub> that is required to trigger long-term potentiation (LTP) in the control condition, and similarly, the small arrows in each panel indicate the minimum amount of current injection <italic>A</italic><sub>2</sub> that evokes LTP in control (left), in AP5 (middle), and in AP5-with-control mean (right). Gray-shaded area is the range of <italic>A</italic><sub>2</sub> used to calculate the average of the maximum change in <italic>w</italic>(t) among Δ<italic>t</italic>, which is shown in (<bold>C</bold>). For release probability distributions with the same mean, a smaller amount of current injection is needed to trigger LTP if the release probability distribution has a wider variance. (<bold>C</bold>) The averages of the maximum change in <italic>w</italic>(t) in the three different conditions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Additional data and corresponding fits to show how the effect on the variability of release probability distribution [subject to alteration by the neighboring astrocyte(s)] can be modelled by gamma distributions.</title><p>(<bold>A</bold>) Release probability was estimated in cultured hippocampal pyramidal neurons by the labelling of the readily releasable pool by FM1-43 (see Materials and Methods), and the histogram of FM1-43 signals (Δ<italic>F</italic>) observed in the control condition (550 synapses, n = 5 cells) is shown with the best-fitting gamma distribution (<italic>k</italic> = 1.4 and <inline-formula><mml:math id="inf11"><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mn>26.5</mml:mn></mml:math></inline-formula>). (<bold>B</bold>) A histogram of FM1-43 signals (Δ<italic>F</italic>) representing the readily releasable pool obtained in the presence of AP5 (302 synapses, n = 6 cells) with the best-fitting gamma distribution (<inline-formula><mml:math id="inf12"><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>3.12</mml:mn></mml:math></inline-formula> and <inline-formula><mml:math id="inf13"><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mn>10.1</mml:mn></mml:math></inline-formula>) and the best-fitting gamma distribution with control mean (<inline-formula><mml:math id="inf14"><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>2.94</mml:mn></mml:math></inline-formula> and <inline-formula><mml:math id="inf15"><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mn>12.6</mml:mn></mml:math></inline-formula>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Additional data and comparisons showing how the model can fit experimentally obtained EPSC peak responses recorded in CA1 pyramidal neurons.</title><p>Also, the reduction of PPR variance associated with blocking NMDARs as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref> can be reproduced in the simulations. (<bold>A</bold>) Peak amplitudes of EPSCs evoked by stimulating the Schaffer collaterals at 20 Hz in acute hippocampal slices were fit to the model reproducing the release probability distribution in the control condition (red line) and the condition of reduced release probability variance under the NMDAR-blocked condition (blue line). The two curves showed only a small difference between each other. The fitted parameters are <inline-formula><mml:math id="inf16"><mml:mi>w</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>5.5</mml:mn></mml:math></inline-formula>, <inline-formula><mml:math id="inf17"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">f</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1000</mml:mn></mml:math></inline-formula> ms and <inline-formula><mml:math id="inf18"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>35</mml:mn></mml:math></inline-formula> ms. (<bold>B</bold>) The experimentally observed reduction of PPR variance (blue bars; data from <xref ref-type="fig" rid="fig1">Figure 1B–D</xref>) is reproduced by the simulation (orange bars). The PPR variance in the NMDAR-blocked condition showed a smaller variance compared to the PPR variance in the control condition.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig3-figsupp2-v2.tif"/></fig></fig-group><p>We also explored the impact of narrowing the release probability variance under a more general STDP scenario by examining synaptic weight changes elicited in a pair of neurons receiving Poisson spike trains (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Specifically, the synaptic weights obtained in response to the same Poisson sequences in the control condition compared to the AP5 condition for independent simulations showed that the extent of potentiation was consistently smaller in the AP5 group (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, left panel). Similarly, the extent of depression was also found decreased in the AP5 group (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, left panel). These findings suggested that the reduced release probability variance could reshape the expression of long-term plasticity. Whether the reduced efficacy of plasticity expression could be attributed to the change in release probability variance per se was confirmed by testing also the AP5-with-control mean condition (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, right panel), which showed attenuation of both LTP and LTD. When the absolute average difference in the extent of LTP or LTD relative to control was compared between the two AP5 conditions, reducing the variance of the release probability distribution without a change in the mean had a stronger effect in compromising LTP than LTD, while in the AP5 condition, both potentiation and depression were similarly affected (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Collectively, the results of the simulations suggest that a broader distribution of release probability could serve to promote the expression of long-term plasticity.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Synaptic neurotransmitter release probability diversity impacts long-term synaptic plasticity triggered by Poisson spike input series.</title><p>(<bold>A</bold>) Illustration of the model used in the simulation. Two leaky integrate-and-fire neurons with a synaptic connection received independent Poisson spike trains. Similarly to <xref ref-type="fig" rid="fig3">Figure 3</xref>, the release probability of neuron 1 [subject to alteration by the neighboring astrocyte(s)] is modelled by three different gamma distributions representing control, AP5, and AP5-with-control mean conditions. (<bold>B</bold>) Summary of simulation. Major vertical axis (left, blue) shows the relative differences in the final synaptic weights in AP5 (left plot) or AP5-with-control mean (right plot) compared to the control condition. The relative differences (blue dots) are plotted against the final synaptic weight change in control condition (horizontal axis). The binned data are shown as green bars (minor vertical axis: right, green). The plots indicate that spike inputs that promote potentiation under control condition tend to favor weaker potentiation in either AP5 or AP5-with-control mean, and spike inputs that promote depression under control condition tend to favor weaker depression in either AP5 or AP5-with-control mean. (<bold>C</bold>) The reduction of long-term plasticity in AP5 and AP5-with-control mean representing situations of narrowed release probability variance, relative to the control condition. The reduction of plasticity is defined by the mean of the differences between the final weights in NMDAR-blocked conditions and the control condition with a sign correction since long-term potentiation and long-term depression change weights in opposite directions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig4-v2.tif"/></fig></sec><sec id="s2-4"><title>Hippocampal astrocytes express GluN2C NMDARs</title><p>Our results thus far point to astrocyte NMDARs, and in particular, the involvement of the obligatory subunit GluN1 in regulating the variability of presynaptic strengths. In order to obtain direct molecular evidence for the expression of NMDAR in hippocampal astrocytes and to clarify the relevant NMDAR subtype, we performed single cell RT-PCR to compare the expression of <italic>Grin1</italic>, <italic>Grin2a</italic>, <italic>Grin2b,</italic> and <italic>Grin2c</italic> mRNAs in CA1 astrocytes across SO, SR and SLM layers and in CA1 pyramidal neurons (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Acute hippocampal slices were prepared from adult mice as used for electrophysiology experiments, and after labelling astrocytes with sulforhodamine101 (<xref ref-type="bibr" rid="bib84">Nimmerjahn et al., 2004</xref>), RNA from single cells was extracted by patch-clamping. All putative astrocytes had low input resistances (SR 11.20 ± 0.36 MΩ; SO 13.24 ± 0.43 MΩ; SLM 10.60 ± 0.33 MΩ; n = 39 cells from 9 mice sampled for each layer), lacked action potentials, and displayed linear current-voltage relationships (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). CA1 pyramidal neurons expressed high levels of <italic>Grin1</italic>, <italic>Grin2a,</italic> and <italic>Grin2b</italic> subunit mRNAs but expressed substantially low levels of <italic>Grin2c</italic> mRNA. In contrast, astrocytes in all three layers showed robust expression of <italic>Grin2c</italic> mRNA. Moreover, astrocytes showed minimal expression of <italic>Grin2a</italic> and <italic>Grin2b</italic> mRNAs, and the <italic>Grin1</italic> mRNA expression in astrocytes was also substantially low compared to neurons (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). <italic>Grin2d</italic> mRNA in CA1 pyramidal neurons and astrocytes was also tested, and it was undetectable in RNA extracted from patch clamping both cell types while the probe itself could detect <italic>Grin2d</italic> mRNA in brain tissue extracts (data not shown). Inability to detect <italic>Grin2d</italic> mRNA in astrocytes is consistent with previous reports of single cell RNA-seq analysis (Khakh Lab database; also see <xref ref-type="bibr" rid="bib3">Alsaad et al., 2019</xref>). We also examined the levels of expression of NMDAR subunits in CA3 pyramidal neurons, and the pattern of subunit expression mirrored the pattern observed for CA1 pyramidal neurons (data not shown).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Adult mouse hippocampal astrocytes express GluN2C-NMDA receptors.</title><p>(<bold>A</bold>) Top: patch RT-PCR strategy. Bottom: representative voltage responses to current steps in CA1 pyramidal neuron (far left, black), and current responses to voltage steps in astrocytes in <italic>stratum radiatum</italic> (SR, green), <italic>stratum oriens</italic> (SO, yellow), and <italic>stratum lacunosum moleculare</italic> (SLM, blue). Scale bars: neuron, 40 mV, 500 ms; astrocytes, 6 nA, 200 ms. (<bold>B</bold>) Summary of I-V curves of astrocytes obtained before collecting RNA. N = 39 cells, 36 slices, 9 mice for each layer. (<bold>C</bold>) Summary of RT-PCR analysis for mRNA encoding indicated NMDAR subunits: <italic>Grin1</italic> (1), <italic>Grin2a</italic> (2A), <italic>Grin2b</italic> (2B), and <italic>Grin2c</italic> (2C). Control samples (no patch) were obtained by inserting the electrode into the slice without patching cells. Three technical replicates were performed for each condition. (<bold>D</bold>) Western blots of co-immunoprecipitations performed using adult mouse hippocampal extracts with the indicated antibodies where anti-Cre antibody is used as a negative control. The blots are probed for GluN2A/2B (top row), GluN2C (middle row) or GluN1 (bottom row). (<bold>E</bold>) Representative brain sections of <italic>Grin2c<sup>iCre/+</sup></italic> mice crossed to a tdTomato reporter line (Ai9), showing hippocampal area CA1 immunolabelled for GFAP, tdTomato and NeuN; scale bars, 160 μm (top), 25 μm (bottom). (<bold>F</bold>) Quantification of % cells that are positive for tdTomato amongst the counts of NeuN-labelled cells in <italic>stratum pyramidale</italic> (left, total n = 3155 cells) and SR (middle, total n = 619 cells), and GFAP-labelled cells (right, total n = 3149 cells). N = 10 fields of view of area CA1 from individual hippocampal sections (n = 10) obtained from 5 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig5-v2.tif"/></fig><p>The expression of GluN2C subunit protein in the hippocampus was confirmed by immunoprecipitation of mouse hippocampal extracts followed by Western blotting, using an antibody against the Cre recombinase that is not expressed in wild type mice, as a negative control (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). For characterizing the cellular expression pattern of GluN2C in the hippocampus, we were unable to identify an antibody against GluN2C that was suitable for immunofluorescence labelling experiments. Therefore, in order to visualize the cells that expressed GluN2C, we used a GluN2C mutant mouse line carrying an insertion of a codon-improved Cre recombinase immediately downstream of the translation initiation site in the <italic>Grin2c</italic> gene (<xref ref-type="bibr" rid="bib79">Miyazaki et al., 2012</xref>). <italic>Grin2c<sup>iCre/+</sup></italic> mice were crossed with a Cre reporter line (Ai9: <xref ref-type="bibr" rid="bib71">Madisen et al., 2010</xref>) that expressed tdTomato upon Cre-mediated recombination. The hippocampus of the offspring showed robust tdTomato fluorescence in astrocytes identified by GFAP labelling (81.6% ± 5.7% of GFAP+ ve cells; <xref ref-type="fig" rid="fig5">Figure 5E and F</xref>), which was consistent with the high expression level of GluN2C mRNA in astrocytes (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Moreover, some interneurons in SR identified by the NeuN labeling also expressed tdTomato (3.6% ± 1.6% of NeuN+ ve cells in SR, <xref ref-type="fig" rid="fig5">Figure 5E and F</xref>), which was in agreement with previous reports (<xref ref-type="bibr" rid="bib93">Ravikrishnan et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Gupta et al., 2016</xref>). Surprisingly, the pyramidal cell layer also showed sporadic tdTomato-labeled neuronal cell bodies, although such cells represented a limited proportion of pyramidal neurons (5.8% ± 1.0% of NeuN+ ve cells in <italic>stratum pyramidale</italic>, <xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). The RT-PCR, biochemical, and immunohistochemistry experiments collectively provide evidence in support of GluN2C-containing NMDAR as a major NMDAR type expressed in hippocampal CA1 astrocytes.</p></sec><sec id="s2-5"><title>Inhibition of GluN2C NMDARs reduces PPR variability in a manner sensitive to astrocyte GluN1 expression</title><p>Given the prominent expression of GluN2C in astrocytes, we wondered if the regulation of PPR could be attributed to GluN2C NMDARs. To test such a possibility, we examined whether pharmacological inhibition of GluN2C NMDARs could mimic the effects of bath applied AP5 and MK801 on PPR variance using QNZ46 (25 µM), an NMDAR antagonist specific for GluN2C/D (<xref ref-type="bibr" rid="bib49">Hansen and Traynelis, 2011</xref>). Similarly to MK801 and APV, QNZ46 reduced the population variance of PPRs without altering the mean PPR (<xref ref-type="fig" rid="fig6">Figure 6A</xref>; δ<sup>2</sup> <italic>P</italic> = 0.008; <inline-formula><mml:math id="inf19"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula><italic>P</italic> = 0.312). Again we observed the negative correlation between the change in PPR and the baseline PPR (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, bottom), with a linear fit to the data intercepting the x-axis near the baseline mean PPR (X intercept = 2.07). Additionally, in experiments monitoring two independent Schaffer collateral inputs, bath application of QNZ46 decreased the PPR disparity as found for AP5 and MK801 (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5F</xref>; p = 0.005). These observations suggest that GluN2C/D-containing NMDARs contribute to maintaining the broad PPR diversity. Given the lack of detectable expression of GluN2D in hippocampal CA1 cells, it is likely that NMDARs containing GluN2C mediate the observed effects of QNZ46 in modulating presynaptic strength to decrease the overall range of PPR variability.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Inhibiting GluN2C NMDARs reduces PPR variability in a manner dependent on astrocyte expression of GluN1.</title><p>(<bold>A–C</bold>) Left: representative EPSC traces (average of 20 sweeps) to pairs of pulses (Δt = 50 ms) applied to Schaffer collateral axons in baseline and after wash-on of QNZ46 (25 µM). Right: PPR histograms (top) and ΔPPR vs. baseline PPR plots (bottom) before and after bath applying QNZ46 to control uninfected (<bold>A</bold>), Control (<bold>B</bold>) and Cre (<bold>C</bold>) slices. The p values were obtained for the population mean (<inline-formula><mml:math id="inf20"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>) (paired sample t-test) and variance (δ<sup>2</sup>) (one-tailed f-test for equal variances) comparing PPRs before and after the drug treatment. Linear fits and Pearson’s correlation coefficients (<bold>r</bold>) and p values are shown in scatter plots. (<bold>D–F</bold>) Plots of EPSC amplitudes (normalized to the baseline average) before and during the application of QNZ46 to control uninfected (<bold>D</bold>), Control (<bold>E</bold>) and Cre-infected (<bold>F</bold>) slices (shaded area) where n is the number of inputs examined for each experiment. Baseline and experimental periods are indicated (black bars). Box plots show the summary of normalized EPSC amplitudes during the QNZ46 application. *p &lt; 0.05, **p = 0.005, Mann-Whitney U-test was used to compare the control to the drug conditions. No virus infection+ QNZ46 = 21 inputs, 11 cells, 7 mice; Control+ QNZ46 = 24 inputs, 12 cells, 5 mice; Cre+ QNZ46 = 20 inputs, 12 cells, 6 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig6-v2.tif"/></fig><p>When EPSC amplitudes were examined, QNZ46 bath application caused a significant increase, reminiscent of the changes observed upon AP5 and MK801 application (<xref ref-type="fig" rid="fig6">Figure 6D</xref>; p = 0.014). Moreover, similarly to AP5, QNZ46 significantly increased CV<sup>–2</sup> of EPSC amplitudes (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>; p = 0.009), which was suggestive of presynaptic alterations.</p><p>Next we asked whether QNZ46 acted on astrocyte NMDARs to control PPR variability. To address this point, we again tested for occlusion using astrocyte GluN1 knock-down slices. QNZ46 was bath applied to Cre and Control AAV-infected slices while recording EPSCs from CA1 neurons infused with MK801. In control slices QNZ46 decreased the PPR variance (<xref ref-type="fig" rid="fig6">Figure 6B</xref>; p = 0.065) and caused a variable increase in EPSC amplitudes (<xref ref-type="fig" rid="fig6">Figure 6E</xref>; p = 0.005) without a concomitant change in the amplitude or the frequency of spontaneous EPSCs (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2F</xref>). Crucially, as observed for AP5, QNZ46 was no longer effective in producing a significant change in the PPR variance in Cre slices (<xref ref-type="fig" rid="fig6">Figure 6C</xref>; p = 0.649). When PPR disparity across two inputs was monitored, QNZ46 decreased the PPR disparity in a manner that was sensitive to astrocyte GluN1 knock-down, which also supported the involvement for GluN2C-NMDARs in regulating presynaptic strength diversity (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2J</xref>,K; Control + QNZ46 p = 0.031; Cre + QNZ46 p = 0.126). Moreover, similarly to AP5, QNZ46-dependent increase of EPSC amplitudes was attenuated also in Cre slices (<xref ref-type="fig" rid="fig6">Figure 6F</xref>).</p><p>Together, these observations indicate that GluN2C NMDARs expressed in astrocytes function to maintain the broad variability of presynaptic strengths across a synapse population. While GluN2C NMDARs also play a role in regulating EPSC amplitudes, this is likely to involve a mechanism that is distinct from the presynaptic regulation but is engaged in parallel to target postsynaptic processes.</p></sec><sec id="s2-6"><title>Layer-specific regulation of synaptic strength by astrocyte NMDARs</title><p>Astrocytes are a highly heterogeneous cell type (<xref ref-type="bibr" rid="bib121">Zhang and Barres, 2010</xref>; <xref ref-type="bibr" rid="bib60">Khakh and Sofroniew, 2015</xref>) that influence synaptic transmission in a synapse- and circuit-specific manner (<xref ref-type="bibr" rid="bib78">Martin-Fernandez et al., 2017</xref>; <xref ref-type="bibr" rid="bib105">Schwarz et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Martín et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Lanjakornsiripan et al., 2018</xref>). Our RT-PCR analysis of NMDAR subtype expression showed relatively high expression of GluN2C mRNA across SR, SO, and SLM layers in CA1 astrocytes compared to CA1 pyramidal neurons. Nevertheless, despite the relatively even expression of GluN2C across layers, our experiments monitoring NMDA-glycine puff application responses in CA1 astrocytes revealed layer-specific differences in the GluN1-dependent component of the slow depolarizing responses triggered by the NMDA-glycine puff, with SR astrocytes showing the highest sensitivity to the astrocyte GluN1 knock-down (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). This raised the possibility that astrocyte NMDAR-dependent modulation of synaptic inputs to CA1 pyramidal neurons whose dendrites span across SR, SO, and SLM, might also differ across layers.</p><p>To test such possibility of layer-specific regulation, we compared astrocyte NMDAR-dependence of synaptic transmission in CA1 neurons across three layers in slices from astrocyte GluN1 knock-down and control mice. In contrast to the specific decrease in the PPR variance observed in Cre slices relative to Control slices for the SR input (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), neither the PPR variance nor its mean differed between Cre and Control slices for the SO and the SLM inputs (<xref ref-type="fig" rid="fig7">Figure 7A–D</xref>; SO: δ<sup>2</sup> <italic>P</italic> = 0.303, <inline-formula><mml:math id="inf21"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula><italic>P</italic> = 0.402; SLM: δ<sup>2</sup> <italic>P</italic> = 0.624, <inline-formula><mml:math id="inf22"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula><italic>P</italic> = 0.161). We also examined the layer-specificity of PPR diversity regulation using a pharmacological approach in slices from wild-type mice. The sensitivity of PPRs to bath applied NMDAR antagonists in CA1 pyramidal neurons intracellularly perfused with MK801, was monitored in response to pairwise stimulation of SO and SLM inputs as had been done for the SR input. Neither MK801 nor AP5 had any appreciable effect on PPR variance in SO (<xref ref-type="fig" rid="fig7">Figure 7E and G</xref>: MK801, p = 0.107; AP5 p = 0.472) and SLM (<xref ref-type="fig" rid="fig7">Figure 7I and K</xref>: MK801, p = 0.920; AP5, p = 0.741). MK801 modestly increased EPSC amplitudes at some inputs in SO (<xref ref-type="fig" rid="fig7">Figure 7F</xref>: p = 0.783) but it had no effect in SLM (<xref ref-type="fig" rid="fig7">Figure 7J</xref>: p = 0.915). Moreover, AP5 did not potentiate EPSC amplitudes as observed for the SR input, but instead it significantly depressed EPSC amplitudes in SO (<xref ref-type="fig" rid="fig7">Figure 7H</xref>: p = 0.028) while it caused no appreciable change in SLM (<xref ref-type="fig" rid="fig7">Figure 7L</xref>: p = 0.317). Collectively, these results suggest that regulation of PPR diversity by astrocyte NMDARs in CA1 pyramidal neurons is specific to the SR inputs.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Interfering with astrocyte NMDARs has little effect on synaptic strength diversity in the <italic>stratum oriens</italic> (SO) and the <italic>stratum lacunosum moleculare</italic> (SLM).</title><p>(<bold>A</bold>) Left: recording scheme. Right: confocal image from SO in CA1 showing nls-mCherry-Cre-positive astrocytes labelled with GFAP and DAPI. Scale bar, 20 µm. (<bold>B</bold>) Average (color) and individual (grey) EPSC sweeps from representative recordings by stimulating SO of Control and Cre infected slices from <italic>Grin1<sup>flx/flx</sup></italic> mice. PPR histograms from Control (top) and Cre slices (bottom) fit with single Gaussians. [p values: comparisons of population mean (<inline-formula><mml:math id="inf23"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>) (Mann-Whitney test) and variance (δ<sup>2</sup>) (one-tailed f-test for equal variances) between Control and Cre.] Control, n = 50 inputs, 25 cells, 7 mice; Cre, n = 50 inputs, 25 cells, 7 mice. (<bold>C,D</bold>) Same analysis as in <italic>A,B</italic> for SLM. Control, n = 67 inputs, 47 cells, 12 mice; Cre, n = 71 inputs, 49 cells, 12 mice. (<bold>E,G</bold>) Representative EPSC traces and PPR histograms of from SO stimulation in baseline and after applying MK801 (<bold>E</bold>) or AP5 (<bold>G</bold>). (<bold>F,H</bold>) Normalized EPSC amplitudes before and after applying MK801 (<bold>F</bold>) or AP5 (<bold>H</bold>) (shaded area) in SO. Right, summary bar graph. MK801, n = 24 inputs, 12 cells, 6 mice; AP5, n = 20 inputs, 10 cells, 7 mice. * p &lt; 0.05 Mann-Whitney U-test. (<bold>I,K</bold>) Same analysis as in <italic>E,G</italic> for PPRs elicited in SLM in control and MK801 (<bold>I</bold>) or AP5 (<bold>K</bold>). (<bold>J,L</bold>) Same analysis as in <italic>F,H</italic> with MK801 (<bold>J</bold>) or AP5 application (<bold>L</bold>). MK801: n = 26 inputs, 13 cells, 8 mice; AP5, n = 24 inputs, 12 cells, 6 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>MK801 and AP5 do not alter PPR disparity in the <italic>stratum oriens</italic> (SO) or the <italic>stratum lacunosum moleculare</italic> (SLM).</title><p>(<bold>A</bold>) Illustration of the two-input stimulation configuration in SO. (<bold>B,C</bold>) Left: PPR disparity [ΔPPR (|PPR<sub>S1</sub>-PPR<sub>S2</sub>|)] during baseline and in the presence of MK801 (<bold>B</bold>) or AP5 (<bold>C</bold>). Right: Summary plot of ΔPPR. Neither MK801 nor AP5 application influences the PPR disparity. (<bold>D–F</bold>) Same experiments as described for (<bold>A–C</bold>) carried out in SLM. Similarly to SO recordings, MK801 and AP5 have no effects of PPR disparity in SLM. p-Values are the result of Wilcoxon signed rank tests. SO MK801 n = 12 pairs of inputs, 12 cells, 6 mice; SO AP5 n = 10 pairs of inputs, 10 cells, 7 mice; SLM MK801 n = 13 pairs of inputs, 13 cells, 8 mice; SLM AP5 n = 12 pairs of inputs, 12 cells, 6 mice. Data are presented as mean ± s.e.m.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70818-fig7-figsupp1-v2.tif"/></fig></fig-group><p>As a further test of the layer specificity of astrocyte NMDAR-dependent regulation of PPR variability, we assessed PPR disparity by performing two independent pathway analysis in each layer in response to bath applied NMDAR antagonists. Again, in contrast to SR input (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5D</xref>, E), neither MK801 nor AP5 depressed the PPR disparity of the SO and the SLM inputs (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). These observations are consistent with the role for astrocyte NMDARs, and particularly GluN2C NMDARs, for maintaining the diversity of PPR specifically of SR inputs to CA1 pyramidal neurons.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Broad heterogeneity in the efficacy of synaptic transmission is a fundamental feature of small glutamatergic synapses in the mammalian brain (<xref ref-type="bibr" rid="bib33">Dobrunz and Stevens, 1997</xref>; <xref ref-type="bibr" rid="bib7">Atwood and Karunanithi, 2002</xref>; <xref ref-type="bibr" rid="bib15">Branco and Staras, 2009</xref>). A variety of presynaptic parameters contribute to the observed variability, such as the abundance, subtype, and location of presynaptic calcium channels (<xref ref-type="bibr" rid="bib113">Thalhammer et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Brenowitz and Regehr, 2007</xref>; <xref ref-type="bibr" rid="bib34">Éltes et al., 2017</xref>), their positioning with respect to the synaptic vesicles, the active zone size and the number of docked vesicles, the state of vesicle fusion machinery (<xref ref-type="bibr" rid="bib89">Park et al., 2012</xref>; <xref ref-type="bibr" rid="bib76">Marra et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Fulterer et al., 2018</xref>; <xref ref-type="bibr" rid="bib43">Glebov et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Holderith et al., 2012</xref>), as well as the coupling to neuromodulatory signals (<xref ref-type="bibr" rid="bib19">Burke et al., 2018</xref>), and the synapse’s recent history of synaptic plasticity. These determinants of presynaptic release efficacy are influenced by target-specific signals (<xref ref-type="bibr" rid="bib34">Éltes et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Branco et al., 2008</xref>; <xref ref-type="bibr" rid="bib94">Reyes et al., 1998</xref>; <xref ref-type="bibr" rid="bib75">Markram et al., 1998</xref>) and are further subject to activity-dependent modulation (<xref ref-type="bibr" rid="bib113">Thalhammer et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Goda and Stevens, 1998</xref>; <xref ref-type="bibr" rid="bib19">Burke et al., 2018</xref>). Although the basis for presynaptic release probability regulation at individual synapses have been intensively studied, whether and how basal release probability variability is collectively controlled across a synapse population is poorly understood, despite its implications in information processing and memory storage (<xref ref-type="bibr" rid="bib8">Barbour et al., 2007</xref>; <xref ref-type="bibr" rid="bib20">Buzsáki and Mizuseki, 2014</xref>; <xref ref-type="bibr" rid="bib17">Bromer et al., 2018</xref>; <xref ref-type="bibr" rid="bib96">Rotman and Klyachko, 2013</xref>). Our study highlights the novel contribution of astrocyte GluN2C NMDAR signaling in broadening the range of basal release efficacy of Schaffer collateral synapses by effectively maintaining strong synapses stronger and weaker synapses weaker without an overt effect on the mean synaptic strength.</p><p>The present study took advantage of paired-pulse response as a measure of presynaptic efficacy. While PPR – a form of short-term plasticity – is inversely related to presynaptic release probability (<xref ref-type="bibr" rid="bib33">Dobrunz and Stevens, 1997</xref>), it does not necessarily always represent changes in presynaptic release across all conditions. For example, PPR changes can arise from a postsynaptic mechanism involving changes in the extent accumulation of desensitized AMPA receptors at the postsynaptic density (<xref ref-type="bibr" rid="bib52">Heine et al., 2008</xref>; <xref ref-type="bibr" rid="bib37">Frischknecht et al., 2009</xref>). Therefore, in some experiments, presumed changes in release probability as monitored by PPR were further corroborated by the correlated changes in CV<sup>–2</sup> (<xref ref-type="bibr" rid="bib73">Malinow and Tsien, 1990</xref>; <xref ref-type="bibr" rid="bib67">Larkman et al., 1992</xref>). This study extends the concept of NMDAR-mediated glial control of PPR (<xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>) to include populations of synapses within defined hippocampal subregions in the healthy adult mouse brain. Sampling a small number of synapses by a relatively weak stimulation intensity (i.e. mean EPSC amplitude of ~60 ± 6 pA to Schaffer collateral stimulation in control condition) consistently revealed a component of PPR distribution that was regulated by astrocyte NMDARs. Notably, such modulation could be masked when sampling a large synapse population that yields stable ensemble responses (<xref ref-type="bibr" rid="bib70">Lines et al., 2017</xref>). Altogether, results from (i) pharmacological experiments using subtype-specific NMDAR antagonists, which allowed monitoring the effects of NMDAR inhibition in the same synapse population, (ii) the genetic interference specifically of astrocyte NMDARs, and (iii) the cellular expression analysis of NMDAR subunits, collectively point to GluN2C NMDAR as the major astrocyte receptor that regulates synaptic strength variability of Schaffer collateral inputs. The use of methods that allow for a more direct estimate of release probability in hippocampal CA1 neurons as have been reported recently (e.g. <xref ref-type="bibr" rid="bib47">Grillo et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Jensen et al., 2021</xref>) will be informative in further pursuing the underlying mechanisms.</p><sec id="s3-1"><title>Functional significance of the broad distribution of presynaptic strengths</title><p>What might be an advantage in maintaining a highly variable presynaptic efficacy across a synapse population of a given input type? Our mathematical modeling and simulation data indicate that the width of release probability distribution can bias the outcome of activity-dependent synaptic plasticity, and in a generalized spiking neuron model, a larger release probability variance promoted LTP and LTD. Notably, several studies have implicated astrocyte signaling in LTD in hippocampal CA3 to CA1 synapses (<xref ref-type="bibr" rid="bib23">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="bib4">Andrade-Talavera et al., 2016</xref>; <xref ref-type="bibr" rid="bib82">Navarrete et al., 2019</xref>; <xref ref-type="bibr" rid="bib92">Pinto-Duarte et al., 2019</xref>), where spike timing-dependent LTD in slices from young mice is sensitive to inhibitors of GluN2C/D, although the source of GluN2C/D remains to be determined (<xref ref-type="bibr" rid="bib4">Andrade-Talavera et al., 2016</xref>). Astrocyte GluN2C NMDAR-dependent maintenance of variable basal presynaptic strengths of CA3 to CA1 synapses that we have identified here could therefore be linked to astrocyte signaling that promotes LTP and LTD, which in turn, are not only important for learning and memory but also for network stability (<xref ref-type="bibr" rid="bib26">Collingridge et al., 2010</xref>; <xref ref-type="bibr" rid="bib97">Royer and Paré, 2003</xref>; <xref ref-type="bibr" rid="bib119">Zenke and Gerstner, 2017</xref>). Curiously, this GluN2C NMDAR-dependent broadening of the basal presynaptic efficacy in CA1 neurons is confined to the SR inputs and not observed for SO or SLM inputs. This suggests that for dendritic computations in CA1 pyramidal neurons, the broad variability of synaptic strengths at CA3-CA1 synapses is more crucial compared to the synaptic strength variability of basal or apical tuft inputs. Mice deficient in GluN2C, while mostly normal in their behavior, show deficits in acquisition of conditioned fear and working memory and changes in neuronal oscillations (<xref ref-type="bibr" rid="bib53">Hillman et al., 2011</xref>; <xref ref-type="bibr" rid="bib74">Mao et al., 2020</xref>). Some population of interneurons express GluN2C, however (<xref ref-type="bibr" rid="bib48">Gupta et al., 2016</xref>; <xref ref-type="bibr" rid="bib93">Ravikrishnan et al., 2018</xref>), and this confounds the interpretation of the observed effects solely to deficits in astrocyte GluN2C. It would be of interest to determine in the future whether there is a learning performance deficit in mice specifically deficient in astrocyte GluN2C or GluN1 in the hippocampal CA1 subfield.</p><p>The mechanism by which astrocyte GluN2C NMDARs are coupled to the changes in presynaptic efficacy remains to be clarified. The narrowing of the range of PPR upon astrocyte NMDAR inhibition suggests a capacity for astrocytes to impose dual modulatory actions downstream of astrocyte GluN2C NMDARs, in one possibility, involving the release of two types of gliotransmitters with one potentiating and another depressing synaptic transmission (<xref ref-type="bibr" rid="bib105">Schwarz et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Covelo and Araque, 2018</xref>). In some cases, the release of a single molecule may also suffice: astrocyte-mediated release of ATP, which is converted to adenosine by extracellular ATPases, has been implicated in the bi-directional modulation of presynaptic efficacy (<xref ref-type="bibr" rid="bib86">Panatier et al., 2011</xref>; <xref ref-type="bibr" rid="bib90">Pascual et al., 2005</xref>; <xref ref-type="bibr" rid="bib120">Zhang et al., 2003</xref>; <xref ref-type="bibr" rid="bib112">Tan et al., 2017</xref>). The effects of adenosine depend in part on the presynaptic A<sub>2A</sub> or A<sub>1</sub> receptors that either enhance or suppress presynaptic function, respectively (<xref ref-type="bibr" rid="bib86">Panatier et al., 2011</xref>; <xref ref-type="bibr" rid="bib112">Tan et al., 2017</xref>). Importantly, a potential mechanism that expands the range of presynaptic efficacy would favor potentiation of strong synapses and depression of weak synapses. At the neuromuscular junction, where glial cells mediate synaptic competition involving glial purinergic signaling, it has been shown that a stronger synaptic input is preferentially potentiated further by the activation of presynaptic A<sub>2A</sub> receptors while the weaker one remains unchanged or slightly depressed (<xref ref-type="bibr" rid="bib30">Darabid et al., 2018</xref>). Such a mechanism could provide a framework for deciphering the actions of GluN2C NMDARs, where for example, the relative abundance of A<sub>2A</sub> or A<sub>1</sub> receptors at individual presynaptic boutons could determine the polarity of presynaptic efficacy change upon accumulation of extracellular adenosine by the astrocyte GluN2C NMDAR activity, provided that the relative abundance and/or the type of adenosine receptors at individual boutons show correlation to basal release probability. In another scenario, astrocyte GluN2C receptors may influence the release of other gliotransmitters such as glutamate (<xref ref-type="bibr" rid="bib56">Jourdain et al., 2007</xref>) to target presynaptic glutamate receptors and/or GluN2C receptor signaling may influence astrocyte-mediated K<sup>+</sup> clearance to locally shape presynaptic action potential waveforms (<xref ref-type="bibr" rid="bib28">Cui et al., 2018</xref>) to in turn affect presynaptic efficacy. Further understanding of such mechanisms is warranted to identify the basis for how the relative differences in synaptic strengths are promoted to facilitate broadening of the range of presynaptic efficacy.</p></sec><sec id="s3-2"><title>Astrocyte NMDAR subunit mRNAs and implications for layer-specific synapse modulation</title><p>Previous transcriptome analysis of the major cell types in mouse cerebral cortex have suggested that the GluN2C NMDAR subunit mRNA is one of the highly enriched transcripts in astrocytes, whose level can be up to 70-fold of the level found in neurons (<xref ref-type="bibr" rid="bib122">Zhang et al., 2014</xref>). Our single-cell RT-PCR analyses also show robust expression of GluN2C mRNA in astrocytes across the three CA1 layers in contrast to GluN2C mRNA expression in pyramidal neurons. Curiously, despite the high expression of GluN2C mRNA in astrocytes, only low levels of GluN1 mRNA is detected in astrocytes. This finding is unexpected given that GluN1 subunit is required for the surface expression of functional NMDARs (<xref ref-type="bibr" rid="bib38">Fukaya et al., 2003</xref>; <xref ref-type="bibr" rid="bib2">Abe et al., 2004</xref>). Moreover, the observed occlusion of QNZ46 effects on synaptic transmission by astrocyte-specific knock-down of GluN1 also support the presence of functional heteromeric GluN1/GluN2C NMDARs in astrocytes. The whole-cell patch clamp method we used to collect RNAs is biased towards sampling of transcripts that are abundant in the cell body. Given that astrocyte processes are numerous and thin, the discordance between the detected GluN1 and GluN2C mRNA levels could be explained if the mRNAs are differentially localized, with GluN1 mRNA being preferentially targeted to processes compared to the cell body of astrocytes. Such a proposal is consistent with a recent study reporting of GluN1 mRNA in astrocyte processes that is locally translated (<xref ref-type="bibr" rid="bib100">Sakers et al., 2017</xref>). The precise intracellular localization of NMDAR subunit mRNAs in astrocytes remains to be determined.</p><p>The present study revealed synapse regulation by the astrocyte GluN2C NMDARs that is confined to the SR input although GluN2C mRNA is expressed broadly across CA1 astrocyte layers. Therefore, the layer-specificity of synaptic modulation could potentially arise from features of GluN2C NMDAR assembly and trafficking and/or signaling that is unique to SR astrocytes over SO and SLM astrocytes. In support of layer-specific differences in astrocyte NMDAR signaling, the slow astrocyte membrane depolarization triggered by puff applied NMDA-glycine shows significant dependence on astrocyte NMDAR only in SR and not in SO nor in SLM (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Additionally, differences in the properties of presynaptic inputs to CA1 pyramidal neuron dendrites across layers (e.g. <xref ref-type="bibr" rid="bib104">Schroeder et al., 2018</xref>) could also contribute to layer-specific synaptic modulation by astrocyte GluN2C NMDARs.</p><p>The GluN2C subunit forms diheteromeric receptor complexes with the obligate GluN1 subunit and triheteromeric receptor complexes with GluN1 and GluN2A (<xref ref-type="bibr" rid="bib88">Paoletti et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Hansen et al., 2018</xref>). The presence of GluN2C confers NMDAR properties that are distinct from NMDARs containing GluN2A or GluN2B which are abundant in neurons. For example, GluN2C-containing NMDARs show reduced channel open probability, increased glutamate sensitivity, slow receptor deactivation, and a decreased sensitivity to Mg<sup>2+</sup> block (<xref ref-type="bibr" rid="bib88">Paoletti et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Hansen et al., 2018</xref>). Weak Mg<sup>2+</sup> binding would enable open-pore blockers such as MK801, to nonetheless rapidly exert their inhibitory action. Such reduced Mg<sup>2+</sup> sensitivity of astrocyte GluN2C NMDARs could have contributed to the rapid effect observed for MK801 in normalizing presynaptic strengths and reducing the PPR disparity. Moreover, the low EC<sub>50</sub> of GluN2C-containing NMDAR activation to glutamate (<xref ref-type="bibr" rid="bib51">Hansen et al., 2018</xref>) suggests that they may be well suited for detecting synaptic release events at perisynaptic astrocyte processes that can be at some distance from the active zone. Several drugs that target NMDARs have been in clinical use, such as ketamine as an anesthetic and treatment for depression (<xref ref-type="bibr" rid="bib64">Krystal et al., 2019</xref>; <xref ref-type="bibr" rid="bib118">Williams and Schatzberg, 2016</xref>) and memantine for the treatment of moderate to severe dementia in Alzheimer’s disease (<xref ref-type="bibr" rid="bib46">Graham et al., 2017</xref>). Under physiological conditions, GluN2C/GluN2D-containing NMDARs display up to 10-fold higher sensitivity to ketamine and memantine in comparison to GluN2A/GluN2B-containing NMDARs that are highly expressed in neurons (<xref ref-type="bibr" rid="bib62">Kotermanski and Johnson, 2009</xref>; <xref ref-type="bibr" rid="bib50">Hansen et al., 2017</xref>). Therefore, although therapeutics targeting NMDARs to date have largely focused on neuronal NMDARs, it would be crucial to consider also the consequences of interfering with GluN2C NMDARs that are enriched in astrocytes, which is underscored by the increasing recognition of the involvement of astrocytes in a variety of neurological disorders (<xref ref-type="bibr" rid="bib123">Zuchero and Barres, 2015</xref>; <xref ref-type="bibr" rid="bib24">Chung et al., 2015</xref>).</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Slice preparation and whole cell recordings</title><p>Mice (P60-120) were deeply anesthetized with isoflurane and transcardially perfused with ice-cold cutting aCSF containing (in mM) 93 N-methyl D-glucamine, 2.5 KCl, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 30 NaHCO<sub>3</sub>, 20 HEPES, 20 glucose, 5 Na ascorbate, 2 thiourea, 3 sodium pyruvate, 12 N-acetyl L-cysteine, 10 MgSO<sub>4</sub>, 0.5 CaCl<sub>2</sub>, pH adjusted to 7.4 with HCl and bubbled with 95 % O<sub>2</sub>/5 % CO<sub>2</sub>. Brains were extracted and 350 μm transverse hippocampal slices were cut in ice-cold cutting aCSF on a Leica VT1200 vibrating microtome. Slices were incubated for 12 min in cutting aCSF warmed to 34 °C, then placed in holding solution containing (in mM) 81.2 NaCl, 2.5 KCl, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 30 NaHCO<sub>3</sub>, 20 HEPES, 20 D-glucose, 5 Na ascorbate, 2 thiourea, 3 sodium pyruvate, 12 N-acetyl L-cysteine, 2 MgSO<sub>4</sub>, 2 CaCl<sub>2</sub>, pH 7.4, bubbled with 95 % O<sub>2</sub>/5 % CO<sub>2</sub> for up to 8 h. In some cases, slices were incubated in 50 µM sulphorhodamine for 30 min at 34 °C to identify astrocytes for RNA extraction.</p><p>Whole-cell patch clamp recordings were obtained from CA1 pyramidal neurons or astrocytes using an Olympus BX51W1 microscope equipped with IR-DIC optics and a motorized stage. Images were captured with a digital camera (Andor, iXon3) and imaged using MetaMorph software (Molecular Devices). Voltage clamp and current clamp experiments were carried out using Multiclamp 700B amplifiers (Molecular Devices) and up to four micromanipulators (SM5, Luigs and Neumann). Patch pipettes (tip resistance 2–4 MΩ for neurons, 4–6 MΩ for astrocytes) were pulled using a vertical 2-stage puller (PC-10 Narishige). Slices were constantly perfused with recording aCSF containing (in mM) 119 NaCl, 2.5 KCl, 1.3 NaH<sub>2</sub>PO<sub>4</sub>, 26 NaHCO<sub>3</sub>, 1 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 20 D-glucose and 0.5 Na ascorbate pH 7.4, bubbled with 95 % O<sub>2</sub>/5 % CO<sub>2</sub> and maintained at 32–34 °C using an in-line heater (Harvard Instruments). Picrotoxin (100 µM) was added to the recording aCSF to block GABA<sub>A</sub>-receptors and isolate glutamatergic synaptic transmission. Internal pipette solution contained (in mM) 130 CsMeSO<sub>3</sub>, 8 NaCl, 4 Mg-ATP, 0.3 Na-GTP, 0.5 EGTA, 10 HEPES, pH 7.3, 290–295 mOsm for neuron recordings, and 130 K gluconate, 10 HEPES, 4 MgCl<sub>2</sub>, 4 Na<sub>2</sub>-ATP, 0.4 Na<sub>3</sub>-GTP, 10 Na-phosphocreatine, pH 7.3, 290 mOsm for astrocyte recordings. 50 µM AlexaFluor488 or AlexaFluor594 hydrazide (ThermoFisher Scientific) was included in the pipette solution to verify cell identity and to position stimulating and puff pipettes. Neurons were voltage clamped at –70 mV and series resistance (R<sub>s</sub>) was monitored throughout all recordings and left uncompensated. Experiments were discarded if R<sub>s</sub> &lt;30 MΩ and/or changed by &gt;20%. Average R<sub>s</sub> was 25.24 ± 0.27 MΩ (n = 298 cells).</p></sec><sec id="s4-2"><title>Recordings of synaptic transmission</title><p>For all experiments using NMDAR antagonists, 1 mM MK801 was included in the patch pipette solution. Internal solution was allowed to equilibrate into the cell for 10–15 min and inputs were stimulated at a low frequency (0.1 Hz) with pairs of pulses at least 45 times before beginning the experiment to pre-block postsynaptic NMDAR receptors. Effective inhibition of NMDAR currents by internal MK801 was confirmed in a separate set of experiments (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Pipettes were tip filled with ~0.2 µl of internal solution lacking MK801 to avoid its leakage to the extracellular milieu prior to seal formation. Small bundles of axons in the <italic>stratum radiatum</italic>, <italic>oriens</italic>, or <italic>lacunosum moleulare</italic> were stimulated using AgCl bipolar electrodes in theta-glass pipettes (tip diameter ~2–3 µm) filled with recording aCSF, connected to a stimulus isolation unit (A360, WPI). These bundles are identified throughout as ‘input’. Stimulation strengths varied between ~50 and 500 µA and were adjusted to obtain EPSCs of approximately 50–100 pA. Up to three independent inputs were sampled during a single experiment, although a maximum of two independent inputs were activated per input pathway. When multiple stimulation electrodes were used they were positioned on opposite sides of the neuron and/or in different input pathways (i.e. SR and SLM or SR and SO). When sampling two inputs in a single pathway, the independence of the two inputs was confirmed by a cross-paired-pulse stimulation paradigm (<xref ref-type="bibr" rid="bib85">Otani and Connor, 1996</xref>; <xref ref-type="bibr" rid="bib106">Scimemi et al., 2004</xref>); after stimulating one of the two inputs the other input was stimulated in quick succession (50 ms inter-pulse interval). If facilitation or depression was observed in the second pulse, then the position of stimulation electrode was changed and independence of the two inputs was re-assessed. During the experiment, EPSCs from each pathway were sampled with paired pulses every 30 s. Inputs from separate pathways were stimulated at least 5 s apart. EPSCs were sampled over a 10 min baseline period (i.e. 20 sweeps) before the perfusion of drugs and continued for at least an additional 20 min. EPSC amplitudes were averaged over 20 pre-drug baseline sweeps, and 20 post-drug sweeps. The change in EPSCs (ΔEPSCs) was calculated as the ratio of the average post-drug amplitude to the average baseline amplitude. PPRs were calculated based on the average EPSCs of 5 sweep bins (i.e. 2.5 min). Baseline and post-drug averages were calculated as the average of four bins (i.e. over 10 min) before and after drug application, respectively. Changes in PPR (ΔPPR) were calculated as the difference between the drug application value and the baseline value. Values for coefficient of variation (CV) were obtained from 20 baseline, and 20 post-drug sweeps. The change in CV<sup>–2</sup> (ΔCV<sup>–2</sup>) was calculated as the ratio of post-drug CV<sup>–2</sup> to pre-drug CV<sup>–2</sup>. EPSCs and sEPSCs amplitudes in the absence of drug application were stable over the duration of the experiment, and sEPSC amplitudes were stable across all drug conditions tested (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), suggesting that run-down (i.e. non-stationarities) will not substantially influence the outcome of the CV<sup>–2</sup> analysis. All EPSC amplitude, rise-time, and decay measurements were performed in Clampfit 10.6 software. sEPSCs were identified as events outside a 50 ms window following the second stimulation pulse for each pathway using the template matching algorithm in Clampfit 10.6.</p></sec><sec id="s4-3"><title>Astrocyte recordings and NMDA/glycine puff</title><p>Astrocytes were identified in acute slices based on mCherry or sulphorhodamine fluorescence, or on their appearance under IR-DIC observation (small, circular cell bodies in the neuropil). Astrocyte identity was always confirmed by their passive electrical properties (linear I-V relationship), low input resistance ( &lt; 20 MΩ), and low resting membrane potential (&lt; –75 mV), as well as post-hoc labeling by Alexa dyes included in the patch pipette. Recording aCSF contained picrotoxin (100 µM), tetrodotoxin (0.5 µM), and CNQX (10 µM) to reduce network excitability associated with the application of iGluR agonists. Patch pipettes (R<sub>t</sub> = 4–6 MΩ) were used to locally deliver recording aCSF solution containing 1 mM NMDA and 1 mM glycine. Puff pipettes were placed approximately 50 µm from the patched cell and puff pressure (3 psi, 100 ms duration) was controlled with a Picospritzer III (Parker Hannifin) connected to N<sub>2</sub> gas.</p></sec><sec id="s4-4"><title>Whole-cell patch RNA extraction from astrocytes and neurons</title><p>Whole-cell patch clamp recordings from astrocytes and neurons were performed using pipettes containing (in mM) 130 K gluconate, 10 HEPES, 4 MgCl<sub>2</sub>, 4 Na<sub>2</sub>-ATP, 0.4 Na<sub>3</sub>-GTP, 10 Na-phosphocreatine, 1 U/µl RNAase inhibitor, 50 µM AlexaFluor488, pH 7.3, 290 mOsm. Pipettes were tip filled (~0.2 µl) with the same internal solution but lacking RNAase inhibitor in order to facilitate obtaining of GΩ seals. After determining the electrical properties of the patched cell to confirm its identity, RNA was extracted using a previously published protocol (<xref ref-type="bibr" rid="bib40">Fuzik et al., 2016</xref>). The cell was held at –5 mV, and repetitively depolarized to +20 mV for 5 ms at 100 Hz for ~5 min while light negative pressure was applied to the pipette. The AlexaFluor fluorescence signal was visualized to confirm the extraction of cell cytoplasm.</p></sec><sec id="s4-5"><title>Single-cell quantitative PCR</title><p>Individual patched cells were processed following the provider´s recommendation for the Single Cell-to-CT qRT-PCR Kit (ThermoFisher Scientific). cDNAs for <italic>Grin1</italic>, <italic>Grin2a</italic>, <italic>Grin2b</italic>, <italic>Grin2c</italic>, <italic>Grin2d,</italic> and <italic>Rn28s1</italic> were quantified by TAQMAN system using the following probes. The provider’s recommended pre-amplification step was performed for all the genes except for <italic>Rn28s1</italic>.</p><list list-type="bullet"><list-item><p><italic>Grin1</italic>: fw <named-content content-type="sequence">5’GACCGCTTCAGTCCCTTTGG 3’</named-content>, rv <named-content content-type="sequence">5’ CACCTTCCCCAATGCCAGAG 3</named-content>’, probe <named-content content-type="sequence">5’ AGCAGGACGCCCCAGGAAAACCAC 3</named-content>’ (MGBNFQ, 6FAM)</p></list-item><list-item><p><italic>Grin2a</italic>: fw <named-content content-type="sequence">5’ AGACCCCGCTACACACTCTG 3</named-content>’, rv <named-content content-type="sequence">5’TTGCCCACCTTTTCCCATTCC 3</named-content>’, probe <named-content content-type="sequence">5’AGCACGATCACCACAAGCCTGGGG 3</named-content>’ (MGBNFQ, 6FAM)</p></list-item><list-item><p><italic>Grin2b</italic>: fw <named-content content-type="sequence">5’GGCATGATTGGTGAGGTGGTC 3</named-content>’, rv <named-content content-type="sequence">5’GGCTCTAAGAAGGCAGAAGGTG 3</named-content>’, probe <named-content content-type="sequence">5’ATTGCTGCGTGATACCATGACACTGATGCC 3</named-content>’ (MGBNFQ, 6FAM)</p></list-item><list-item><p><italic>Grin2c</italic>: fw <named-content content-type="sequence">5’GGAGGCTTTCTACAGGCATCTG 3</named-content>’, rv <named-content content-type="sequence">5’ATACTTCATGTACAGGACCCCATG 3</named-content>’, probe 5’<named-content content-type="sequence">TCCCACCGTCCCACCATCTCCCAG</named-content> 3’ (MGBNFQ, 6FAM)</p></list-item><list-item><p><italic>Grin2d</italic>: fw <named-content content-type="sequence">5’TCAGCGACCGGAAGTTCCAG 3</named-content>’, rv <named-content content-type="sequence">5’TCCCTGCCTTGAGCTGAGTG 3</named-content>’, probe <named-content content-type="sequence">5’ TCCTCCACTCTTGGCTGGTTGTATCGCA 3</named-content>’(MGBNFQ, 6FAM)</p></list-item><list-item><p><italic>Rn28s1</italic>: fw <named-content content-type="sequence">5’CCTACCTACTATCCAGCGAAACC 3</named-content>’, rev <named-content content-type="sequence">5’AGCTCAACAGGGTCTTCTTTCC 3</named-content>’, probe<named-content content-type="sequence"> 5’ CTGATTCCGCCAAGCCCGTTCCCT 3</named-content>’ (MGBNFQ, VIC)</p></list-item></list><p>RNA levels were normalized by the quantity of <italic>Rn28s1</italic>, and standard curves were prepared for estimating the quantity (in femtograms) of the targeted RNAs after pre-amplification. For making the standard curves, total RNA from mouse brain hippocampal tissue was extracted using TRIZOL reagent. Target cDNAs were amplified by regular PCR, and amplicons were purified, quantity of cDNA was measured and submitted to serial dilutions, used for standard curves in TAQMAN system, in parallel to the single cell derived cDNA samples.</p></sec><sec id="s4-6"><title>Intracranial AAV injections</title><p>Recombinant AAV vectors were targeted to the dorsal CA1 hippocampus of adult (P60-P90) <italic>Grin1<sup>flx/flx</sup></italic> mice as previously described (<xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Cetin et al., 2007</xref>). Bilateral injections (~600 nl/hemisphere at a rate of 200 nl/min) of AAV9.2-GFAP104-nls-mCherry-Cre (6.67⨯10<sup>13</sup> genome copies/ml), AAV9.2-GFAP104-nls-mCherry (i.e. Control; 6.86⨯10<sup>13</sup> genome copies/ml), AAVDJ8-GFAP104-nls-mCherry-Cre (5.95⨯10<sup>13</sup> genome copies/ml), or AAVDJ8-GFAP104-eGFP (also denoted Control for simplicity; 3.98⨯10<sup>13</sup> genome copies/ml) were made using the following coordinates: X (posterior from Bregma) – 1.4 mm, Y (lateral from sagittal suture) ± 1.4 mm, Z (ventral from pia) – 2.1 mm. Viruses were expressed for at least 21 days (max post-surgical duration of 40 days) before mice were used in physiology or imaging experiments. Comparisons were always made between Cre and Control (Cre-lacking) virally infected slices from animals that received the same AAV serotype. While most experiments used the AAV9.2 viruses, the following data used the AAVDJ8: <xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig7">7</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A, B</xref>; see E-phys statistics report for details.</p></sec><sec id="s4-7"><title>Immunohistochemistry</title><p>Slices prepared from <italic>Grin1<sup>flx/flx</sup></italic> mice expressing GFAP104-nls-mCherry-Cre were fixed in 4 % paraformaldehyde (PFA) in 0.1 M phosphate buffer solution (PB) for 1–2 hr, then washed in PB and stored overnight. Alternatively, mice brain tissue was fixed with 4 % PFA in PB (pH7.5) by transcardial perfusion, followed by further overnight incubation of the removed brain. Fixed brains were cryosectioned to a thickness of 40 μm. Slices were permeabilized with 0.3 % Triton X-100 and blocked in 10 % goat serum, then incubated in primary antibody overnight at 4 °C. Slices were washed and incubated in secondary antibodies for 1–2 hr at room temperature. Slices were then washed and mounted in ProLong antifade mounting medium (ThermoFisher Scientific) containing DAPI (1:1000, ThermoFisher Scientific), and visualized on a Zeiss 780, or an Olympus FV1200 or FV3000 confocal microscope. The primary antibodies used were chicken anti-RFP (1: 1000, Rockland #600-901-379), mouse anti-GFAP (1:1000, Synaptic Systems #173011), rabbit anti-GFAP (1:500, Abcam ab48050), rabbit anti-NeuN (1:500, Abcam #ab177487), and guinea pig anti-GluN1 (1:100, Alamone Labs AGP-046). The secondary antibodies used were AlexaFluor555 goat anti-chicken (1:1000, Invitrogen #A32932), AlexaFluor633 goat anti-mouse (1:1000, Invitrogen #A21052), AlexaFluor488 goat anti-rabbit (1:1000, Invitrogen #A11034), and AlexaFluor647 goat anti-guinea pig (1:200, Invitrogen A21450).</p></sec><sec id="s4-8"><title>NMDA receptor immunoprecipitation from mouse brain</title><p>Mouse hippocampal tissues were dissociated using a glass dounce homogenizer in a 50 mM Tris-HCl, pH 9.0 buffer containing protease inhibitors (10% w/v, cOmplete, Merck). Subsequently, 1 % (w/v) sodium deoxycholate was added and incubated for 30 min at 37 °C with mild shaking to solubilize the tissue. Samples were centrifuged at 100,000 rpm at 4 °C for 1 hr. Supernatant was collected, protein concentration was measured by the BCA assay, and stored at –80 °C for later analysis or diluted fivefold in a 50 mM Tris-HCl pH 7.5 buffer containing 0.1 % of Triton X-100 for co-immunoprecipitation experiments.</p><p>To test for co-immunoprecipitation, a mix of Sepharose Fast-Flow protein A and protein G beads was prepared. For each antibody reaction, 40 μl of the mixed resin was incubated with 5 μg of antibody. After at least 2 hr of incubation at 4 °C excess antibody was removed by washing, and 2 mg of protein extract was added to each sample containing the resin beads bound by the antibody and incubated overnight at 4 °C. Resins were washed three times with 10 volumes of 50 mM Tris-HCl pH 7.5 with 0.1 % Triton X-100. Supernatant was carefully removed, and resins were suspended in 2 x SDS-PAGE protein loading buffer containing DTT. The unbound protein extract was treated for a second overnight incubation at 4 °C with a freshly prepared antibody-bound resin under identical conditions as the first overnight incubation, to ensure effective pull-down of soluble NMDA receptor content from the extract. Co-immunoprecipitated proteins from the two rounds of incubation were pooled together.</p><p>Protein samples (inputs and co-immunoprecipitated proteins) were heat denatured for 2 min at 95 °C and subjected to 6 % SDS-PAGE separation followed by western blot. Antibodies used were: mouse anti-NR1 (Synaptic Systems #114011), rabbit anti-GluN2A/2B (Synaptic Systems #244003), rabbit anti-GluN2C (generously provided by Dr. Masahiko Watanabe or purchased from Frontier Institute #GLURE3C-RB-AF270), and mouse anti-Cre (Merck Millipore clone 2D8).</p></sec><sec id="s4-9"><title>FM1-43 experiments for estimating the release probability distributions used for modeling</title><p>Release probability distributions for mathematical modelling were obtained by measurements of readily releasable pool using the styryl dye FM1-43 (Invitrogen, Fisher-Scientific) in rat primary hippocampal neurons co-cultured with astrocytes as described previously (<xref ref-type="bibr" rid="bib44">Goda and Stevens, 1998</xref>; <xref ref-type="bibr" rid="bib69">Letellier et al., 2019</xref>). Images were captured on an inverted Olympus IX71 microscope equipped with an EMCCD camera (Andor Technology, Oxford Instruments) controlled by Metamorph software (Molecular Devices). The extracellular solution consisted of (in mM) 137 NaCl, 5 KCl, 10 D-Glucose, 5 HEPES pH 7.3, 2 CaCl<sub>2</sub>, 2 MgCl<sub>2</sub>, 0.01 CNQX, 0.1 picrotoxin at 300 mOsm. Briefly, neurons (used at DIV11-14) were stimulated by a pair of field electrodes (positioned ~10 mm apart) using 40 action potentials at 20 Hz in the presence of 10 μM FM1-43 and for an additional minute in FM1-43 but without stimulation to allow for completion of endocytosis. Subsequently, cells were washed in extracellular solution containing 1 mM Advasep-7 (Biotium) for 1 min to facilitate dye removal, and then the wash was continued for a total period of 10 min. Images were acquired before and after the unloading stimulation, which was 600 action potentials at 20 Hz. The signal remaining was taken as background. The images were analyzed by OpenView software (<xref ref-type="bibr" rid="bib59">Kaufman et al., 2012</xref>) kindly provided by Dr. Noam Ziv.</p></sec><sec id="s4-10"><title>Mathematical model for the numerical investigation</title><p>We used the synapse model based on the Tsodyks-Pawelzik-Markram model (<xref ref-type="bibr" rid="bib114">Tsodyks et al., 1998</xref>) and the leaky integrate-and-fire neuron model to reproduce ratios of peaks of EPSC waveforms with a 20 Hz spike input. The synaptic dynamics is modeled by [1]:<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mfrac><mml:mo>−</mml:mo><mml:msub><mml:mi>u</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mi>δ</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula><disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mtext> </mml:mtext></mml:mrow></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>u</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mi>δ</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula><disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">c</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>u</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>u</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">f</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>U</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>u</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>δ</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Here, <inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is the portion of available neurotransmitters, <inline-formula><mml:math id="inf25"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> is the portion of neurotransmitters released by pre-synaptic spikes, <inline-formula><mml:math id="inf26"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> is the portion of neurotransmitters being recovered, <inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mi>u</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> is the utilization of available neurotransmitters after each spike. <inline-formula><mml:math id="inf28"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the timescale of neurotransmitter release. <inline-formula><mml:math id="inf29"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the recovery timescale. <inline-formula><mml:math id="inf30"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the timescale of synaptic facilitation. <inline-formula><mml:math id="inf31"><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the initial release probability without the influence of synaptic facilitation. In this model, the dynamical variables are <inline-formula><mml:math id="inf32"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> with <inline-formula><mml:math id="inf33"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula>. <inline-formula><mml:math id="inf34"><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is a number determined by a random number drawn from a gamma distribution. Readily releasable pool size, which is monitored by the FM1-43 labeling as a proxy of release probability at individual synapses, is fitted with a gamma distribution (c.f. <xref ref-type="bibr" rid="bib81">Murthy et al., 1997</xref>):<disp-formula id="equ5"><label>(5)</label><mml:math id="m5"><mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mi>P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>z</mml:mi><mml:mo>;</mml:mo><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>θ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Γ</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:msup><mml:mi>θ</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:mfrac><mml:msup><mml:mi>z</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mfrac><mml:mi>z</mml:mi><mml:mi>θ</mml:mi></mml:mfrac></mml:mrow></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf35"><mml:mi>z</mml:mi></mml:math></inline-formula> is the FM1-43 signal, <inline-formula><mml:math id="inf36"><mml:mi>k</mml:mi></mml:math></inline-formula> is the shape parameter and <inline-formula><mml:math id="inf37"><mml:mi>θ</mml:mi></mml:math></inline-formula> is the scale parameter. The release probability <inline-formula><mml:math id="inf38"><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:msub><mml:mi> </mml:mi><mml:mi> </mml:mi></mml:math></inline-formula> is then given by <inline-formula><mml:math id="inf39"><mml:msub><mml:mrow><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mn>140.0</mml:mn></mml:mrow></mml:mfrac></mml:math></inline-formula> , by normalizing <inline-formula><mml:math id="inf40"><mml:mi>z</mml:mi></mml:math></inline-formula> that is proportional to release probability by an arbitrarily chosen maximal value of FM1-43 signal, which is at most140 in our measurements (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The FM1-43 signal distributions in control and AP5 conditions are modeled by different shapes of the distribution. The fits and observed measurements of the FM1-43 distributions are presented in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. The best fit parameters for different conditions are <inline-formula><mml:math id="inf41"><mml:mfenced separators="|"><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>θ</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mn>1.40,26.5</mml:mn></mml:mrow></mml:mfenced></mml:math></inline-formula> for control, <inline-formula><mml:math id="inf42"><mml:mfenced separators="|"><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>θ</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mn>3.12,10.1</mml:mn></mml:mrow></mml:mfenced></mml:math></inline-formula> for AP5, and <inline-formula><mml:math id="inf43"><mml:mfenced separators="|"><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>θ</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mn>2.94,12.6</mml:mn></mml:mrow></mml:mfenced></mml:math></inline-formula> for AP5 when the mean is fixed to stay the same as for the control (‘AP5 with control mean’).</p><p>In the simulations, the model is based on leaky integrate-and-fire (LIF) neurons. There is a synaptic connection between neurons. The membrane potential V<sub>m</sub> of a LIF neuron is given by<disp-formula id="equ6"><label>(6)</label><mml:math id="m6"><mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf44"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the membrane capacitance, <inline-formula><mml:math id="inf45"><mml:mi>R</mml:mi></mml:math></inline-formula> is the membrane resistance, <inline-formula><mml:math id="inf46"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the input current and <inline-formula><mml:math id="inf47"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the excitatory current triggered by an excitatory input. In this study, we set <inline-formula><mml:math id="inf48"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>150</mml:mn><mml:mi> </mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf49"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:mi> </mml:mi><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">Ω</mml:mi></mml:math></inline-formula>, with the time constant <inline-formula><mml:math id="inf50"><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mn>15</mml:mn></mml:math></inline-formula> ms for the neurons. Additionally, the following values are used: the threshold potential <inline-formula><mml:math id="inf51"><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mn>50.0</mml:mn></mml:math></inline-formula> mV, reversal potential <inline-formula><mml:math id="inf52"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mo>-</mml:mo><mml:mn>65.0</mml:mn></mml:math></inline-formula> mV, and refractory time <inline-formula><mml:math id="inf53"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">f</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:math></inline-formula> ms.</p><p>The excitatory current <inline-formula><mml:math id="inf54"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is given by<disp-formula id="equ7"><label>(7)</label><mml:math id="m7"><mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf55"><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>E</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the conductance and <inline-formula><mml:math id="inf56"><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mi> </mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">V</mml:mi></mml:math></inline-formula> is the reversal potential of the excitatory response. The dynamics of conductance is given by<disp-formula id="equ8"><label>(8)</label><mml:math id="m8"><mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">y</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>w</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>u</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mi>δ</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf57"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">y</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the time constant of the excitatory synaptic response and <inline-formula><mml:math id="inf58"><mml:mi>w</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> is the weight of the connection. Here we set <inline-formula><mml:math id="inf59"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">y</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">E</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> to be 3 ms, which is approximately the weighted average decay time constant of AMPA receptors on dendrite and soma of hippocampal CA1 pyramidal neurons (<xref ref-type="bibr" rid="bib110">Spruston et al., 1995</xref>). With this setting, parameters <inline-formula><mml:math id="inf60"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">f</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf61"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, and <inline-formula><mml:math id="inf62"><mml:mi>w</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:math></inline-formula> can be determined by fitting both EPSC peaks and PPR variance observed in the experiment (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>).</p><p>The spike-time-dependent plasticity (STDP) used to modify <inline-formula><mml:math id="inf63"><mml:mi>w</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> follows the rule used by <xref ref-type="bibr" rid="bib98">Rubin et al., 2001</xref>:<disp-formula id="equ9"><mml:math id="m9"><mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>w</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" columnspacing="1em" displaystyle="false" rowspacing=".2em"><mml:mtr><mml:mtd><mml:mi>λ</mml:mi><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>w</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mtext> </mml:mtext><mml:mtext>exp</mml:mtext><mml:mrow><mml:mo>[</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mfrac><mml:mo>]</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mtext> </mml:mtext><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">f</mml:mi></mml:mrow><mml:mtext> </mml:mtext><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>λ</mml:mi><mml:mi>w</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mtext> </mml:mtext><mml:mtext>exp</mml:mtext><mml:mrow><mml:mo>[</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:msup><mml:mi>τ</mml:mi><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mfrac><mml:mo>]</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mtext> </mml:mtext><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">f</mml:mi></mml:mrow><mml:mtext> </mml:mtext><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mrow></mml:msup><mml:mo>&gt;</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mrow></mml:msup></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf64"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mi>w</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:math></inline-formula> , <inline-formula><mml:math id="inf65"><mml:mi>λ</mml:mi><mml:mo>=</mml:mo><mml:mn>0.1</mml:mn></mml:math></inline-formula>, and <inline-formula><mml:math id="inf66"><mml:msup><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>20</mml:mn><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">s</mml:mi></mml:math></inline-formula>. <inline-formula><mml:math id="inf67"><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> and <inline-formula><mml:math id="inf68"><mml:msup><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> are spike times of presynaptic and postsynaptic neuron respectively.</p></sec><sec id="s4-11"><title>Statistics</title><p>All statistical analyses were performed using OriginPro software (OriginLab Corp.). Datasets were tested for normality using the Shapiro Wilk test. When the criteria for normality was achieved, differences of mean values were examined using paired or unpaired Student’s two-tailed t-tests or one-way ANOVAs. When the criteria for normality was not achieved, differences in mean values were examined using Mann-Whitney or Kruskal Wallis tests. Normalized mean values obtained from recordings (i.e. normalized EPSCs) were compared to values obtained at the same time point in control experiments using Mann-Whitney tests. Variance of PPR distributions were examined using one-tailed f-tests for equal variances or Levene’s test. Box plots represent median and quartile values, whiskers represent maximum and minimum values that are not outliers. p Values are indicated throughout or indicated by * if p &lt; 0.05. Sample sizes for electrophysiology experiments were determined based on PPR disparity obtained in pilot studies and experimental data outlined in <xref ref-type="bibr" rid="bib68">Letellier et al., 2016</xref>. A power analysis was performed using a <inline-formula><mml:math id="inf69"><mml:mi>β</mml:mi></mml:math></inline-formula> value of 0.8 and an <inline-formula><mml:math id="inf70"><mml:mi>α</mml:mi></mml:math></inline-formula> value of 0.05. Standard deviations for PPR disparity data were determined to be ~0.35, and the expected effect size is ~45 %.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf3"><p>Reviewing editor, eLife</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation, Methodology, Visualization</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Methodology, Visualization</p></fn><fn fn-type="con" id="con5"><p>Data curation, Investigation, Methodology, Visualization</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology, Resources, Validation</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology, Resources</p></fn><fn fn-type="con" id="con9"><p>Resources</p></fn><fn fn-type="con" id="con10"><p>Resources</p></fn><fn fn-type="con" id="con11"><p>Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Funding acquisition, Investigation, , Project administration, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments were approved by the RIKEN Animal Experiments Committee and performed in accordance with the RIKEN rules and guidelines. [Animal Experiment Plan Approval no. W2021-2-015(2)].</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-70818-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 3 and 4.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank all members of the Goda laboratory for providing valuable and ongoing feedback throughout the course of this study. We thank Tatjana Tchumatchenko, Thomas Chater and Toru Shinoe for comments on an earlier version of the manuscript, Noam Ziv for kindly sharing the custom written OpenView software, Yun Kyung Park for help with RNA collection for RT-PCR experiments, Toru Shinoe for pilot electrophysiology experiments, Tom McHugh and Shigeyoshi Itohara for kindly providing <italic>Grin1<sup>flx/flx</sup></italic> mice and Ai9 mice, respectively, and Masahiko Watanabe for generously providing GluN2C antibodies. PC was an Overseas Research Fellow of the Japan Society for the Promotion of Science (P14760). This work was supported by the RIKEN Center for Brain Science, the Uehara Memorial Foundation, JSPS Core-to-Core Program (JPJSCCA20170008), Grants-in-Aid for Scientific Research (15H04280, YG; 18H05213, TF; 19K16885, CCAF) from the MEXT, and the Brain/MINDS from the Japan AMED.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>LF</given-names></name><name><surname>Regehr</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Synaptic computation</article-title><source>Nature</source><volume>431</volume><fpage>796</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1038/nature03010</pub-id><pub-id pub-id-type="pmid">15483601</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>M</given-names></name><name><surname>Fukaya</surname><given-names>M</given-names></name><name><surname>Yagi</surname><given-names>T</given-names></name><name><surname>Mishina</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Sakimura</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>NMDA receptor GluRepsilon/NR2 subunits are essential for postsynaptic localization and protein stability of GluRzeta1/NR1 subunit</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>7292</fpage><lpage>7304</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1261-04.2004</pub-id><pub-id pub-id-type="pmid">15317856</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsaad</surname><given-names>HA</given-names></name><name><surname>DeKorver</surname><given-names>NW</given-names></name><name><surname>Mao</surname><given-names>Z</given-names></name><name><surname>Dravid</surname><given-names>SM</given-names></name><name><surname>Arikkath</surname><given-names>J</given-names></name><name><surname>Monaghan</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons</article-title><source>Neurochemical Research</source><volume>44</volume><fpage>61</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s11064-018-2526-7</pub-id><pub-id pub-id-type="pmid">29651654</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Talavera</surname><given-names>Y</given-names></name><name><surname>Duque-Feria</surname><given-names>P</given-names></name><name><surname>Paulsen</surname><given-names>O</given-names></name><name><surname>Rodríguez-Moreno</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Presynaptic Spike Timing-Dependent Long-Term Depression in the Mouse Hippocampus</article-title><source>Cerebral Cortex</source><volume>26</volume><fpage>3637</fpage><lpage>3654</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhw172</pub-id><pub-id pub-id-type="pmid">27282393</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araque</surname><given-names>A</given-names></name><name><surname>Carmignoto</surname><given-names>G</given-names></name><name><surname>Haydon</surname><given-names>PG</given-names></name><name><surname>Oliet</surname><given-names>SHR</given-names></name><name><surname>Robitaille</surname><given-names>R</given-names></name><name><surname>Volterra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gliotransmitters travel in time and space</article-title><source>Neuron</source><volume>81</volume><fpage>728</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.02.007</pub-id><pub-id pub-id-type="pmid">24559669</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attwell</surname><given-names>D</given-names></name><name><surname>Buchan</surname><given-names>AM</given-names></name><name><surname>Charpak</surname><given-names>S</given-names></name><name><surname>Lauritzen</surname><given-names>M</given-names></name><name><surname>Macvicar</surname><given-names>BA</given-names></name><name><surname>Newman</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Glial and neuronal control of brain blood flow</article-title><source>Nature</source><volume>468</volume><fpage>232</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1038/nature09613</pub-id><pub-id pub-id-type="pmid">21068832</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atwood</surname><given-names>HL</given-names></name><name><surname>Karunanithi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Diversification of synaptic strength: presynaptic elements</article-title><source>Nature Reviews. Neuroscience</source><volume>3</volume><fpage>497</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1038/nrn876</pub-id><pub-id pub-id-type="pmid">12094207</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbour</surname><given-names>B</given-names></name><name><surname>Brunel</surname><given-names>N</given-names></name><name><surname>Hakim</surname><given-names>V</given-names></name><name><surname>Nadal</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>What can we learn from synaptic weight distributions?</article-title><source>Trends in Neurosciences</source><volume>30</volume><fpage>622</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2007.09.005</pub-id><pub-id pub-id-type="pmid">17983670</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazargani</surname><given-names>N</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Astrocyte calcium signaling: the third wave</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>182</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1038/nn.4201</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>KJ</given-names></name><name><surname>Allen</surname><given-names>CB</given-names></name><name><surname>Bender</surname><given-names>VA</given-names></name><name><surname>Feldman</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Synaptic basis for whisker deprivation-induced synaptic depression in rat somatosensory cortex</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>4155</fpage><lpage>4165</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0175-06.2006</pub-id><pub-id pub-id-type="pmid">16624936</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindocci</surname><given-names>E</given-names></name><name><surname>Savtchouk</surname><given-names>I</given-names></name><name><surname>Liaudet</surname><given-names>N</given-names></name><name><surname>Becker</surname><given-names>D</given-names></name><name><surname>Carriero</surname><given-names>G</given-names></name><name><surname>Volterra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Three-dimensional Ca2+ imaging advances understanding of astrocyte biology</article-title><source>Science</source><volume>356</volume><elocation-id>eaai8185</elocation-id><pub-id pub-id-type="doi">10.1126/science.aai8185</pub-id><pub-id pub-id-type="pmid">28522470</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bliss</surname><given-names>TV</given-names></name><name><surname>Collingridge</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A synaptic model of memory: Long-term potentiation in the hippocampus</article-title><source>Nature</source><volume>361</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/361031a0</pub-id><pub-id pub-id-type="pmid">8421494</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boisvert</surname><given-names>MM</given-names></name><name><surname>Erikson</surname><given-names>GA</given-names></name><name><surname>Shokhirev</surname><given-names>MN</given-names></name><name><surname>Allen</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain</article-title><source>Cell Reports</source><volume>22</volume><fpage>269</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.039</pub-id><pub-id pub-id-type="pmid">29298427</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branco</surname><given-names>T</given-names></name><name><surname>Staras</surname><given-names>K</given-names></name><name><surname>Darcy</surname><given-names>KJ</given-names></name><name><surname>Goda</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Local Dendritic Activity Sets Release Probability at Hippocampal Synapses</article-title><source>Neuron</source><volume>59</volume><fpage>475</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.07.006</pub-id><pub-id pub-id-type="pmid">18701072</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Branco</surname><given-names>T</given-names></name><name><surname>Staras</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The probability of neurotransmitter release: variability and feedback control at single synapses</article-title><source>Nature Reviews. Neuroscience</source><volume>10</volume><fpage>373</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1038/nrn2634</pub-id><pub-id pub-id-type="pmid">19377502</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenowitz</surname><given-names>SD</given-names></name><name><surname>Regehr</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Reliability and Heterogeneity of Calcium Signaling at Single Presynaptic Boutons of Cerebellar Granule Cells</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>7888</fpage><lpage>7898</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1064-07.2007</pub-id><pub-id pub-id-type="pmid">17652580</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bromer</surname><given-names>C</given-names></name><name><surname>Bartol</surname><given-names>TM</given-names></name><name><surname>Bowden</surname><given-names>JB</given-names></name><name><surname>Hubbard</surname><given-names>DD</given-names></name><name><surname>Hanka</surname><given-names>DC</given-names></name><name><surname>Gonzalez</surname><given-names>PV</given-names></name><name><surname>Kuwajima</surname><given-names>M</given-names></name><name><surname>Mendenhall</surname><given-names>JM</given-names></name><name><surname>Parker</surname><given-names>PH</given-names></name><name><surname>Abraham</surname><given-names>WC</given-names></name><name><surname>Sejnowski</surname><given-names>TJ</given-names></name><name><surname>Harris</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Long-term potentiation expands information content of hippocampal dentate gyrus synapses</article-title><source>PNAS</source><volume>115</volume><fpage>E2410</fpage><lpage>E2418</lpage><pub-id pub-id-type="doi">10.1073/pnas.1716189115</pub-id><pub-id pub-id-type="pmid">29463730</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunel</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Is cortical connectivity optimized for storing information?</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>749</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1038/nn.4286</pub-id><pub-id pub-id-type="pmid">27065365</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>KJ</given-names></name><name><surname>Keeshen</surname><given-names>CM</given-names></name><name><surname>Bender</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Two Forms of Synaptic Depression Produced by Differential Neuromodulation of Presynaptic Calcium Channels</article-title><source>Neuron</source><volume>99</volume><fpage>969</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.07.030</pub-id><pub-id pub-id-type="pmid">30122380</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzsáki</surname><given-names>G</given-names></name><name><surname>Mizuseki</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The log-dynamic brain: how skewed distributions affect network operations</article-title><source>Nature Reviews. Neuroscience</source><volume>15</volume><fpage>264</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1038/nrn3687</pub-id><pub-id pub-id-type="pmid">24569488</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cetin</surname><given-names>A</given-names></name><name><surname>Komai</surname><given-names>S</given-names></name><name><surname>Eliava</surname><given-names>M</given-names></name><name><surname>Seeburg</surname><given-names>PH</given-names></name><name><surname>Osten</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Stereotaxic gene delivery in the rodent brain</article-title><source>Nature Protocols</source><volume>1</volume><fpage>3166</fpage><lpage>3173</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.450</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>H</given-names></name><name><surname>Diaz-Castro</surname><given-names>B</given-names></name><name><surname>Shigetomi</surname><given-names>E</given-names></name><name><surname>Monte</surname><given-names>E</given-names></name><name><surname>Octeau</surname><given-names>JC</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Cohn</surname><given-names>W</given-names></name><name><surname>Rajendran</surname><given-names>PS</given-names></name><name><surname>Vondriska</surname><given-names>TM</given-names></name><name><surname>Whitelegge</surname><given-names>JP</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Khakh</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Neural Circuit-Specialized Astrocytes: Transcriptomic, Proteomic, Morphological, and Functional Evidence</article-title><source>Neuron</source><volume>95</volume><fpage>531</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.029</pub-id><pub-id pub-id-type="pmid">28712653</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Bu</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Heterosynaptic long-term depression mediated by ATP released from astrocytes</article-title><source>Glia</source><volume>61</volume><fpage>178</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1002/glia.22425</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>WS</given-names></name><name><surname>Welsh</surname><given-names>CA</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Stevens</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Do glia drive synaptic and cognitive impairment in disease?</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>1539</fpage><lpage>1545</lpage><pub-id pub-id-type="doi">10.1038/nn.4142</pub-id><pub-id pub-id-type="pmid">26505565</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>LE</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Emerging roles of astrocytes in neural circuit development</article-title><source>Nature Reviews. Neuroscience</source><volume>14</volume><fpage>311</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1038/nrn3484</pub-id><pub-id pub-id-type="pmid">23595014</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collingridge</surname><given-names>GL</given-names></name><name><surname>Peineau</surname><given-names>S</given-names></name><name><surname>Howland</surname><given-names>JG</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Long-term depression in the CNS</article-title><source>Nature Reviews. Neuroscience</source><volume>11</volume><fpage>459</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1038/nrn2867</pub-id><pub-id pub-id-type="pmid">20559335</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covelo</surname><given-names>A</given-names></name><name><surname>Araque</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuronal activity determines distinct gliotransmitter release from a single astrocyte</article-title><source>eLife</source><volume>7</volume><elocation-id>e32237</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.32237</pub-id><pub-id pub-id-type="pmid">29380725</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Foncelle</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Sang</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Berry</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression</article-title><source>Nature</source><volume>554</volume><fpage>323</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/nature25752</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dallérac</surname><given-names>G</given-names></name><name><surname>Zapata</surname><given-names>J</given-names></name><name><surname>Rouach</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Versatile control of synaptic circuits by astrocytes: where, when and how?</article-title><source>Nature Reviews. Neuroscience</source><volume>19</volume><fpage>729</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1038/s41583-018-0080-6</pub-id><pub-id pub-id-type="pmid">30401802</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darabid</surname><given-names>H</given-names></name><name><surname>St-Pierre-See</surname><given-names>A</given-names></name><name><surname>Robitaille</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Purinergic-dependent glial regulation of synaptic plasticity of competing terminals and synapse elimination at the neuromuscular junction</article-title><source>Cell Reports</source><volume>25</volume><fpage>2070</fpage><lpage>2082</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.10.075</pub-id><pub-id pub-id-type="pmid">30463006</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deemyad</surname><given-names>T</given-names></name><name><surname>Lüthi</surname><given-names>J</given-names></name><name><surname>Spruston</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Astrocytes integrate and drive action potential firing in inhibitory subnetworks</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4336</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06338-3</pub-id><pub-id pub-id-type="pmid">30337521</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Castro</surname><given-names>MA</given-names></name><name><surname>Chuquet</surname><given-names>J</given-names></name><name><surname>Liaudet</surname><given-names>N</given-names></name><name><surname>Bhaukaurally</surname><given-names>K</given-names></name><name><surname>Santello</surname><given-names>M</given-names></name><name><surname>Bouvier</surname><given-names>D</given-names></name><name><surname>Tiret</surname><given-names>P</given-names></name><name><surname>Volterra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Local Ca2+ detection and modulation of synaptic release by astrocytes</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>1276</fpage><lpage>1284</lpage><pub-id pub-id-type="doi">10.1038/nn.2929</pub-id><pub-id pub-id-type="pmid">21909085</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobrunz</surname><given-names>LE</given-names></name><name><surname>Stevens</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Heterogeneity of release probability, facilitation, and depletion at central synapses</article-title><source>Neuron</source><volume>18</volume><fpage>995</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80338-4</pub-id><pub-id pub-id-type="pmid">9208866</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Éltes</surname><given-names>T</given-names></name><name><surname>Kirizs</surname><given-names>T</given-names></name><name><surname>Nusser</surname><given-names>Z</given-names></name><name><surname>Holderith</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Target cell type-dependent differences in Ca2+ channel function underlie distinct release probabilities at hippocampal glutamatergic terminals</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>1910</fpage><lpage>1924</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2024-16.2017</pub-id><pub-id pub-id-type="pmid">28115484</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>DE</given-names></name><name><surname>Brecht</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Map plasticity in somatosensory cortex</article-title><source>Science</source><volume>310</volume><fpage>810</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1126/science.1115807</pub-id><pub-id pub-id-type="pmid">16272113</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>G</given-names></name><name><surname>Mutel</surname><given-names>V</given-names></name><name><surname>Trube</surname><given-names>G</given-names></name><name><surname>Malherbe</surname><given-names>P</given-names></name><name><surname>Kew</surname><given-names>JN</given-names></name><name><surname>Mohacsi</surname><given-names>E</given-names></name><name><surname>Heitz</surname><given-names>MP</given-names></name><name><surname>Kemp</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit</article-title><source>Characterization in Vitro. J. Pharmacol. Exp. Ther</source><volume>283</volume><fpage>1285</fpage><lpage>1292</lpage></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frischknecht</surname><given-names>R</given-names></name><name><surname>Heine</surname><given-names>M</given-names></name><name><surname>Perrais</surname><given-names>D</given-names></name><name><surname>Seidenbecher</surname><given-names>CI</given-names></name><name><surname>Choquet</surname><given-names>D</given-names></name><name><surname>Gundelfinger</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>897</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1038/nn.2338</pub-id><pub-id pub-id-type="pmid">19483686</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukaya</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>A</given-names></name><name><surname>Lovett</surname><given-names>C</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice</article-title><source>PNAS</source><volume>100</volume><fpage>4855</fpage><lpage>4860</lpage><pub-id pub-id-type="doi">10.1073/pnas.0830996100</pub-id><pub-id pub-id-type="pmid">12676993</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulterer</surname><given-names>A</given-names></name><name><surname>Andlauer</surname><given-names>TFM</given-names></name><name><surname>Ender</surname><given-names>A</given-names></name><name><surname>Maglione</surname><given-names>M</given-names></name><name><surname>Eyring</surname><given-names>K</given-names></name><name><surname>Woitkuhn</surname><given-names>J</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name><name><surname>Matkovic-Rachid</surname><given-names>T</given-names></name><name><surname>Geiger</surname><given-names>JRP</given-names></name><name><surname>Walter</surname><given-names>AM</given-names></name><name><surname>Nagel</surname><given-names>KI</given-names></name><name><surname>Sigrist</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Active Zone Scaffold Protein Ratios Tune Functional Diversity across Brain Synapses</article-title><source>Cell Reports</source><volume>23</volume><fpage>1259</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.126</pub-id><pub-id pub-id-type="pmid">29719243</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuzik</surname><given-names>J</given-names></name><name><surname>Zeisel</surname><given-names>A</given-names></name><name><surname>Máté</surname><given-names>Z</given-names></name><name><surname>Calvigioni</surname><given-names>D</given-names></name><name><surname>Yanagawa</surname><given-names>Y</given-names></name><name><surname>Szabó</surname><given-names>G</given-names></name><name><surname>Linnarsson</surname><given-names>S</given-names></name><name><surname>Harkany</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1038/nbt.3443</pub-id><pub-id pub-id-type="pmid">26689544</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasparini</surname><given-names>F</given-names></name><name><surname>Lingenhöhl</surname><given-names>K</given-names></name><name><surname>Stoehr</surname><given-names>N</given-names></name><name><surname>Flor</surname><given-names>PJ</given-names></name><name><surname>Heinrich</surname><given-names>M</given-names></name><name><surname>Vranesic</surname><given-names>I</given-names></name><name><surname>Biollaz</surname><given-names>M</given-names></name><name><surname>Allgeier</surname><given-names>H</given-names></name><name><surname>Heckendorn</surname><given-names>R</given-names></name><name><surname>Urwyler</surname><given-names>S</given-names></name><name><surname>Varney</surname><given-names>MA</given-names></name><name><surname>Johnson</surname><given-names>EC</given-names></name><name><surname>Hess</surname><given-names>SD</given-names></name><name><surname>Rao</surname><given-names>SP</given-names></name><name><surname>Sacaan</surname><given-names>AI</given-names></name><name><surname>Santori</surname><given-names>EM</given-names></name><name><surname>Veliçelebi</surname><given-names>G</given-names></name><name><surname>Kuhn</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist</article-title><source>Neuropharmacology</source><volume>38</volume><fpage>1493</fpage><lpage>1503</lpage><pub-id pub-id-type="doi">10.1016/s0028-3908(99)00082-9</pub-id><pub-id pub-id-type="pmid">10530811</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giaume</surname><given-names>C</given-names></name><name><surname>Koulakoff</surname><given-names>A</given-names></name><name><surname>Roux</surname><given-names>L</given-names></name><name><surname>Holcman</surname><given-names>D</given-names></name><name><surname>Rouach</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Astroglial networks: a step further in neuroglial and gliovascular interactions</article-title><source>Nature Reviews. Neuroscience</source><volume>11</volume><fpage>87</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1038/nrn2757</pub-id><pub-id pub-id-type="pmid">20087359</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glebov</surname><given-names>OO</given-names></name><name><surname>Jackson</surname><given-names>RE</given-names></name><name><surname>Winterflood</surname><given-names>CM</given-names></name><name><surname>Owen</surname><given-names>DM</given-names></name><name><surname>Barker</surname><given-names>EA</given-names></name><name><surname>Doherty</surname><given-names>P</given-names></name><name><surname>Ewers</surname><given-names>H</given-names></name><name><surname>Burrone</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nanoscale Structural Plasticity of the Active Zone Matrix Modulates Presynaptic Function</article-title><source>Cell Reports</source><volume>18</volume><fpage>2715</fpage><lpage>2728</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.02.064</pub-id><pub-id pub-id-type="pmid">28297674</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goda</surname><given-names>Y</given-names></name><name><surname>Stevens</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Readily releasable pool size changes associated with long term depression</article-title><source>PNAS</source><volume>95</volume><fpage>1283</fpage><lpage>1288</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.3.1283</pub-id><pub-id pub-id-type="pmid">9448323</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname><given-names>M</given-names></name><name><surname>Matute</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia</article-title><source>Journal of Cerebral Blood Flow and Metabolism</source><volume>17</volume><fpage>290</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1097/00004647-199703000-00006</pub-id><pub-id pub-id-type="pmid">9119902</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>WV</given-names></name><name><surname>Bonito-Oliva</surname><given-names>A</given-names></name><name><surname>Sakmar</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Update on Alzheimer’s Disease Therapy and Prevention Strategies</article-title><source>Annual Review of Medicine</source><volume>68</volume><fpage>413</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1146/annurev-med-042915-103753</pub-id><pub-id pub-id-type="pmid">28099083</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grillo</surname><given-names>FW</given-names></name><name><surname>Neves</surname><given-names>G</given-names></name><name><surname>Walker</surname><given-names>A</given-names></name><name><surname>Vizcay-Barrena</surname><given-names>G</given-names></name><name><surname>Fleck</surname><given-names>RA</given-names></name><name><surname>Branco</surname><given-names>T</given-names></name><name><surname>Burrone</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Distance-Dependent Distribution of Presynaptic Boutons Tunes Frequency-Dependent Dendritic Integration</article-title><source>Neuron</source><volume>99</volume><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.06.015</pub-id><pub-id pub-id-type="pmid">29983327</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>SC</given-names></name><name><surname>Ravikrishnan</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Mao</surname><given-names>Z</given-names></name><name><surname>Pavuluri</surname><given-names>R</given-names></name><name><surname>Hillman</surname><given-names>BG</given-names></name><name><surname>Gandhi</surname><given-names>PJ</given-names></name><name><surname>Stairs</surname><given-names>DJ</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Ugale</surname><given-names>RR</given-names></name><name><surname>Monaghan</surname><given-names>DT</given-names></name><name><surname>Dravid</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>38321</elocation-id><pub-id pub-id-type="doi">10.1038/srep38321</pub-id><pub-id pub-id-type="pmid">27922130</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>KB</given-names></name><name><surname>Traynelis</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>3650</fpage><lpage>3661</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5565-10.2011</pub-id><pub-id pub-id-type="pmid">21389220</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>KB</given-names></name><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Perszyk</surname><given-names>RE</given-names></name><name><surname>Menniti</surname><given-names>FS</given-names></name><name><surname>Traynelis</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NMDA Receptors in the Central Nervous System</article-title><source>Methods in Molecular Biology</source><volume>1677</volume><fpage>1</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7321-7_1</pub-id><pub-id pub-id-type="pmid">28986865</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>KB</given-names></name><name><surname>Yi</surname><given-names>F</given-names></name><name><surname>Perszyk</surname><given-names>RE</given-names></name><name><surname>Furukawa</surname><given-names>H</given-names></name><name><surname>Wollmuth</surname><given-names>LP</given-names></name><name><surname>Gibb</surname><given-names>AJ</given-names></name><name><surname>Traynelis</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure, function, and allosteric modulation of NMDA receptors</article-title><source>The Journal of General Physiology</source><volume>150</volume><fpage>1081</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1085/jgp.201812032</pub-id><pub-id pub-id-type="pmid">30037851</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heine</surname><given-names>M</given-names></name><name><surname>Groc</surname><given-names>L</given-names></name><name><surname>Frischknecht</surname><given-names>R</given-names></name><name><surname>Béïque</surname><given-names>J-C</given-names></name><name><surname>Lounis</surname><given-names>B</given-names></name><name><surname>Rumbaugh</surname><given-names>G</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>Cognet</surname><given-names>L</given-names></name><name><surname>Choquet</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Surface mobility of postsynaptic AMPARs tunes synaptic transmission</article-title><source>Science</source><volume>320</volume><fpage>201</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1126/science.1152089</pub-id><pub-id pub-id-type="pmid">18403705</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillman</surname><given-names>BG</given-names></name><name><surname>Gupta</surname><given-names>SC</given-names></name><name><surname>Stairs</surname><given-names>DJ</given-names></name><name><surname>Buonanno</surname><given-names>A</given-names></name><name><surname>Dravid</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory</article-title><source>Neurobiology of Learning and Memory</source><volume>95</volume><fpage>404</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.nlm.2011.01.008</pub-id><pub-id pub-id-type="pmid">21295149</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holderith</surname><given-names>N</given-names></name><name><surname>Lorincz</surname><given-names>A</given-names></name><name><surname>Katona</surname><given-names>G</given-names></name><name><surname>Rózsa</surname><given-names>B</given-names></name><name><surname>Kulik</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Nusser</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Release probability of hippocampal glutamatergic terminals scales with the size of the active zone</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>988</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1038/nn.3137</pub-id><pub-id pub-id-type="pmid">22683683</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>TP</given-names></name><name><surname>Kopach</surname><given-names>O</given-names></name><name><surname>Reynolds</surname><given-names>JP</given-names></name><name><surname>Savtchenko</surname><given-names>LP</given-names></name><name><surname>Rusakov</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Release probability increases towards distal dendrites boosting high-frequency signal transfer in the rodent hippocampus</article-title><source>eLife</source><volume>10</volume><elocation-id>e62588</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.62588</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jourdain</surname><given-names>P</given-names></name><name><surname>Bergersen</surname><given-names>LH</given-names></name><name><surname>Bhaukaurally</surname><given-names>K</given-names></name><name><surname>Bezzi</surname><given-names>P</given-names></name><name><surname>Santello</surname><given-names>M</given-names></name><name><surname>Domercq</surname><given-names>M</given-names></name><name><surname>Matute</surname><given-names>C</given-names></name><name><surname>Tonello</surname><given-names>F</given-names></name><name><surname>Gundersen</surname><given-names>V</given-names></name><name><surname>Volterra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Glutamate exocytosis from astrocytes controls synaptic strength</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>331</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1038/nn1849</pub-id><pub-id pub-id-type="pmid">17310248</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Káradóttir</surname><given-names>R</given-names></name><name><surname>Cavelier</surname><given-names>P</given-names></name><name><surname>Bergersen</surname><given-names>LH</given-names></name><name><surname>Attwell</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>NMDA receptors are expressed in oligodendrocytes and activated in ischaemia</article-title><source>Nature</source><volume>438</volume><fpage>1162</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.1038/nature04302</pub-id><pub-id pub-id-type="pmid">16372011</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karavanova</surname><given-names>I</given-names></name><name><surname>Vasudevan</surname><given-names>K</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Buonanno</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice</article-title><source>Molecular and Cellular Neurosciences</source><volume>34</volume><fpage>468</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2006.12.001</pub-id><pub-id pub-id-type="pmid">17276696</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>M</given-names></name><name><surname>Corner</surname><given-names>MA</given-names></name><name><surname>Ziv</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Long-term relationships between cholinergic tone, synchronous bursting and synaptic remodeling</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e40980</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0040980</pub-id><pub-id pub-id-type="pmid">22911726</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakh</surname><given-names>BS</given-names></name><name><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Diversity of astrocyte functions and phenotypes in neural circuits</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>942</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1038/nn.4043</pub-id><pub-id pub-id-type="pmid">26108722</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchhoff</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Analysis of Functional NMDA Receptors in Astrocytes</article-title><source>Methods in Molecular Biology</source><volume>1677</volume><fpage>241</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7321-7_13</pub-id><pub-id pub-id-type="pmid">28986877</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotermanski</surname><given-names>SE</given-names></name><name><surname>Johnson</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer’s drug memantine</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>2774</fpage><lpage>2779</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3703-08.2009</pub-id><pub-id pub-id-type="pmid">19261873</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krebs</surname><given-names>C</given-names></name><name><surname>Fernandes</surname><given-names>HB</given-names></name><name><surname>Sheldon</surname><given-names>C</given-names></name><name><surname>Raymond</surname><given-names>LA</given-names></name><name><surname>Baimbridge</surname><given-names>KG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro</article-title><source>The Journal of Neuroscience</source><volume>23</volume><fpage>3364</fpage><lpage>3372</lpage><pub-id pub-id-type="pmid">12716944</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Abdallah</surname><given-names>CG</given-names></name><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ketamine: A Paradigm Shift for Depression Research and Treatment</article-title><source>Neuron</source><volume>101</volume><fpage>774</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.005</pub-id><pub-id pub-id-type="pmid">30844397</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalo</surname><given-names>U</given-names></name><name><surname>Pankratov</surname><given-names>Y</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name><name><surname>North</surname><given-names>RA</given-names></name><name><surname>Verkhratsky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>NMDA receptors mediate neuron-to-glia signaling in mouse cortical astrocytes</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>2673</fpage><lpage>2683</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4689-05.2006</pub-id><pub-id pub-id-type="pmid">16525046</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanjakornsiripan</surname><given-names>D</given-names></name><name><surname>Pior</surname><given-names>BJ</given-names></name><name><surname>Kawaguchi</surname><given-names>D</given-names></name><name><surname>Furutachi</surname><given-names>S</given-names></name><name><surname>Tahara</surname><given-names>T</given-names></name><name><surname>Katsuyama</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Fukazawa</surname><given-names>Y</given-names></name><name><surname>Gotoh</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Layer-specific morphological and molecular differences in neocortical astrocytes and their dependence on neuronal layers</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1623</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03940-3</pub-id><pub-id pub-id-type="pmid">29691400</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkman</surname><given-names>A</given-names></name><name><surname>Hannay</surname><given-names>T</given-names></name><name><surname>Stratford</surname><given-names>K</given-names></name><name><surname>Jack</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Presynaptic release probability influences the locus of long-term potentiation</article-title><source>Nature</source><volume>360</volume><fpage>70</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/360070a0</pub-id><pub-id pub-id-type="pmid">1331808</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letellier</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>YK</given-names></name><name><surname>Chater</surname><given-names>TE</given-names></name><name><surname>Chipman</surname><given-names>PH</given-names></name><name><surname>Gautam</surname><given-names>SG</given-names></name><name><surname>Oshima-Takago</surname><given-names>T</given-names></name><name><surname>Goda</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Astrocytes regulate heterogeneity of presynaptic strengths in hippocampal networks</article-title><source>PNAS</source><volume>113</volume><fpage>E2685</fpage><lpage>E2694</lpage><pub-id pub-id-type="doi">10.1073/pnas.1523717113</pub-id><pub-id pub-id-type="pmid">27118849</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letellier</surname><given-names>M</given-names></name><name><surname>Levet</surname><given-names>F</given-names></name><name><surname>Thoumine</surname><given-names>O</given-names></name><name><surname>Goda</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Differential role of pre- and postsynaptic neurons in the activity-dependent control of synaptic strengths across dendrites</article-title><source>PLOS Biology</source><volume>17</volume><elocation-id>e2006223</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2006223</pub-id><pub-id pub-id-type="pmid">31166943</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lines</surname><given-names>J</given-names></name><name><surname>Covelo</surname><given-names>A</given-names></name><name><surname>Gómez</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Araque</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Synapse-specific regulation revealed at single synapses is concealed when recording multiple synapses</article-title><source>Frontiers in Cellular Neuroscience</source><volume>11</volume><elocation-id>367</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2017.00367</pub-id><pub-id pub-id-type="pmid">29218000</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Zwingman</surname><given-names>TA</given-names></name><name><surname>Sunkin</surname><given-names>SM</given-names></name><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Zariwala</surname><given-names>HA</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Ng</surname><given-names>LL</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Lein</surname><given-names>ES</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Bear</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>LTP and LTD: an embarrassment of riches</article-title><source>Neuron</source><volume>44</volume><fpage>5</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.09.012</pub-id><pub-id pub-id-type="pmid">15450156</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malinow</surname><given-names>R</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Presynaptic enhancement shown by whole-cell recordings of long-term potentiation in hippocampal slices</article-title><source>Nature</source><volume>346</volume><fpage>177</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1038/346177a0</pub-id><pub-id pub-id-type="pmid">2164158</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Mesnard</surname><given-names>C</given-names></name><name><surname>Synowicki</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chung</surname><given-names>L</given-names></name><name><surname>Wiesman</surname><given-names>AI</given-names></name><name><surname>Wilson</surname><given-names>TW</given-names></name><name><surname>Monaghan</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback</article-title><source>Brain Research</source><volume>1727</volume><elocation-id>146571</elocation-id><pub-id pub-id-type="doi">10.1016/j.brainres.2019.146571</pub-id><pub-id pub-id-type="pmid">31786200</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markram</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tsodyks</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Differential signaling via the same axon of neocortical pyramidal neurons</article-title><source>PNAS</source><volume>95</volume><fpage>5323</fpage><lpage>5328</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.9.5323</pub-id><pub-id pub-id-type="pmid">9560274</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname><given-names>V</given-names></name><name><surname>Burden</surname><given-names>JJ</given-names></name><name><surname>Thorpe</surname><given-names>JR</given-names></name><name><surname>Smith</surname><given-names>IT</given-names></name><name><surname>Smith</surname><given-names>SL</given-names></name><name><surname>Häusser</surname><given-names>M</given-names></name><name><surname>Branco</surname><given-names>T</given-names></name><name><surname>Staras</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A Preferentially Segregated Recycling Vesicle Pool of Limited Size Supports Neurotransmission in Native Central Synapses</article-title><source>Neuron</source><volume>76</volume><fpage>579</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.08.042</pub-id><pub-id pub-id-type="pmid">23141069</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martín</surname><given-names>R</given-names></name><name><surname>Bajo-Grañeras</surname><given-names>R</given-names></name><name><surname>Moratalla</surname><given-names>R</given-names></name><name><surname>Perea</surname><given-names>G</given-names></name><name><surname>Araque</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways</article-title><source>Science</source><volume>349</volume><fpage>730</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1126/science.aaa7945</pub-id><pub-id pub-id-type="pmid">26273054</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Fernandez</surname><given-names>M</given-names></name><name><surname>Jamison</surname><given-names>S</given-names></name><name><surname>Robin</surname><given-names>LM</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Martin</surname><given-names>ED</given-names></name><name><surname>Aguilar</surname><given-names>J</given-names></name><name><surname>Benneyworth</surname><given-names>MA</given-names></name><name><surname>Marsicano</surname><given-names>G</given-names></name><name><surname>Araque</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Synapse-specific astrocyte gating of amygdala-related behavior</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>1540</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1038/nn.4649</pub-id><pub-id pub-id-type="pmid">28945222</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Yamazaki</surname><given-names>M</given-names></name><name><surname>Abe</surname><given-names>M</given-names></name><name><surname>Usui</surname><given-names>H</given-names></name><name><surname>Kano</surname><given-names>M</given-names></name><name><surname>Sakimura</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cav2.1 in cerebellar Purkinje cells regulates competitive excitatory synaptic wiring, cell survival, and cerebellar biochemical compartmentalization</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>1311</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2755-11.2012</pub-id><pub-id pub-id-type="pmid">22279216</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy-Royal</surname><given-names>C</given-names></name><name><surname>Dupuis</surname><given-names>JP</given-names></name><name><surname>Varela</surname><given-names>JA</given-names></name><name><surname>Panatier</surname><given-names>A</given-names></name><name><surname>Pinson</surname><given-names>B</given-names></name><name><surname>Baufreton</surname><given-names>J</given-names></name><name><surname>Groc</surname><given-names>L</given-names></name><name><surname>Oliet</surname><given-names>SHR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Surface diffusion of astrocytic glutamate transporters shapes synaptic transmission</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1038/nn.3901</pub-id><pub-id pub-id-type="pmid">25581361</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>VN</given-names></name><name><surname>Sejnowski</surname><given-names>TJ</given-names></name><name><surname>Stevens</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Heterogeneous release properties of visualized individual hippocampal synapses</article-title><source>Neuron</source><volume>18</volume><fpage>599</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80301-3</pub-id><pub-id pub-id-type="pmid">9136769</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete</surname><given-names>M</given-names></name><name><surname>Cuartero</surname><given-names>MI</given-names></name><name><surname>Palenzuela</surname><given-names>R</given-names></name><name><surname>Draffin</surname><given-names>JE</given-names></name><name><surname>Konomi</surname><given-names>A</given-names></name><name><surname>Serra</surname><given-names>I</given-names></name><name><surname>Colié</surname><given-names>S</given-names></name><name><surname>Castaño-Castaño</surname><given-names>S</given-names></name><name><surname>Hasan</surname><given-names>MT</given-names></name><name><surname>Nebreda</surname><given-names>ÁR</given-names></name><name><surname>Esteban</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Astrocytic p38α MAPK drives NMDA receptor-dependent long-term depression and modulates long-term memory</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>2968</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10830-9</pub-id><pub-id pub-id-type="pmid">31273206</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoll</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A brief history of long-term potentiation</article-title><source>Neuron</source><volume>93</volume><fpage>281</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.12.015</pub-id><pub-id pub-id-type="pmid">28103477</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmerjahn</surname><given-names>A</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name><name><surname>Kerr</surname><given-names>JND</given-names></name><name><surname>Helmchen</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Sulforhodamine 101 as a specific marker of astroglia in the neocortex in vivo</article-title><source>Nature Methods</source><volume>1</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/nmeth706</pub-id><pub-id pub-id-type="pmid">15782150</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otani</surname><given-names>S</given-names></name><name><surname>Connor</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A novel synaptic interaction underlying induction of long-term depression in the area CA1 of adult rat hippocampus</article-title><source>The Journal of Physiology</source><volume>492 (Pt 1)</volume><fpage>225</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1996.sp021303</pub-id><pub-id pub-id-type="pmid">8730597</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panatier</surname><given-names>A</given-names></name><name><surname>Vallée</surname><given-names>J</given-names></name><name><surname>Haber</surname><given-names>M</given-names></name><name><surname>Murai</surname><given-names>KK</given-names></name><name><surname>Lacaille</surname><given-names>JC</given-names></name><name><surname>Robitaille</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Astrocytes Are Endogenous Regulators of Basal Transmission at Central Synapses</article-title><source>Cell</source><volume>146</volume><fpage>785</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.07.022</pub-id><pub-id pub-id-type="pmid">21855979</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pannasch</surname><given-names>U</given-names></name><name><surname>Freche</surname><given-names>D</given-names></name><name><surname>Dallérac</surname><given-names>G</given-names></name><name><surname>Ghézali</surname><given-names>G</given-names></name><name><surname>Escartin</surname><given-names>C</given-names></name><name><surname>Ezan</surname><given-names>P</given-names></name><name><surname>Cohen-Salmon</surname><given-names>M</given-names></name><name><surname>Benchenane</surname><given-names>K</given-names></name><name><surname>Abudara</surname><given-names>V</given-names></name><name><surname>Dufour</surname><given-names>A</given-names></name><name><surname>Lübke</surname><given-names>JHR</given-names></name><name><surname>Déglon</surname><given-names>N</given-names></name><name><surname>Knott</surname><given-names>G</given-names></name><name><surname>Holcman</surname><given-names>D</given-names></name><name><surname>Rouach</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Connexin 30 sets synaptic strength by controlling astroglial synapse invasion</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>549</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1038/nn.3662</pub-id><pub-id pub-id-type="pmid">24584052</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paoletti</surname><given-names>P</given-names></name><name><surname>Bellone</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</article-title><source>Nature Reviews. Neuroscience</source><volume>14</volume><fpage>383</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1038/nrn3504</pub-id><pub-id pub-id-type="pmid">23686171</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Influence of Synaptic Vesicle Position on Release Probability and Exocytotic Fusion Mode</article-title><source>Science</source><volume>335</volume><fpage>1362</fpage><lpage>1366</lpage><pub-id pub-id-type="doi">10.1126/science.1216937</pub-id><pub-id pub-id-type="pmid">22345401</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>O</given-names></name><name><surname>Casper</surname><given-names>KB</given-names></name><name><surname>Kubera</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Revilla-Sanchez</surname><given-names>R</given-names></name><name><surname>Sul</surname><given-names>JY</given-names></name><name><surname>Takano</surname><given-names>H</given-names></name><name><surname>Moss</surname><given-names>SJ</given-names></name><name><surname>McCarthy</surname><given-names>K</given-names></name><name><surname>Haydon</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Astrocytic Purinergic Signaling Coordinates Synaptic Networks</article-title><source>Science</source><volume>310</volume><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1126/science.1116916</pub-id><pub-id pub-id-type="pmid">16210541</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perea</surname><given-names>G</given-names></name><name><surname>Araque</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Astrocytes Potentiate Transmitter Release at Single Hippocampal Synapses</article-title><source>Science</source><volume>317</volume><fpage>1083</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1126/science.1144640</pub-id><pub-id pub-id-type="pmid">17717185</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto-Duarte</surname><given-names>A</given-names></name><name><surname>Roberts</surname><given-names>AJ</given-names></name><name><surname>Ouyang</surname><given-names>K</given-names></name><name><surname>Sejnowski</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Impairments in remote memory caused by the lack of Type 2 IP3 receptors</article-title><source>Glia</source><volume>67</volume><fpage>1976</fpage><lpage>1989</lpage><pub-id pub-id-type="doi">10.1002/glia.23679</pub-id><pub-id pub-id-type="pmid">31348567</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravikrishnan</surname><given-names>A</given-names></name><name><surname>Gandhi</surname><given-names>PJ</given-names></name><name><surname>Shelkar</surname><given-names>GP</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Pavuluri</surname><given-names>R</given-names></name><name><surname>Dravid</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Region-specific Expression of NMDA Receptor GluN2C Subunit in Parvalbumin-Positive Neurons and Astrocytes: Analysis of GluN2C Expression using a Novel Reporter Model</article-title><source>Neuroscience</source><volume>380</volume><fpage>49</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.03.011</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname><given-names>A</given-names></name><name><surname>Lujan</surname><given-names>R</given-names></name><name><surname>Rozov</surname><given-names>A</given-names></name><name><surname>Burnashev</surname><given-names>N</given-names></name><name><surname>Somogyi</surname><given-names>P</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Target-cell-specific facilitation and depression in neocortical circuits</article-title><source>Nature Neuroscience</source><volume>1</volume><fpage>279</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1038/1092</pub-id><pub-id pub-id-type="pmid">10195160</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Stevens</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Definition of the readily releasable pool of vesicles at hippocampal synapses</article-title><source>Neuron</source><volume>16</volume><fpage>1197</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)80146-4</pub-id><pub-id pub-id-type="pmid">8663996</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotman</surname><given-names>Z</given-names></name><name><surname>Klyachko</surname><given-names>VA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of synaptic dynamics and heterogeneity in neuronal learning of temporal code</article-title><source>Journal of Neurophysiology</source><volume>110</volume><fpage>2275</fpage><lpage>2286</lpage><pub-id pub-id-type="doi">10.1152/jn.00454.2013</pub-id><pub-id pub-id-type="pmid">23926043</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royer</surname><given-names>S</given-names></name><name><surname>Paré</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Conservation of total synaptic weight through balanced synaptic depression and potentiation</article-title><source>Nature</source><volume>422</volume><fpage>518</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1038/nature01530</pub-id><pub-id pub-id-type="pmid">12673250</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>DD</given-names></name><name><surname>Sompolinsky</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Equilibrium properties of temporally asymmetric Hebbian plasticity</article-title><source>Physical Review Letters</source><volume>86</volume><fpage>364</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.86.364</pub-id><pub-id pub-id-type="pmid">11177832</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saab</surname><given-names>AS</given-names></name><name><surname>Tzvetavona</surname><given-names>ID</given-names></name><name><surname>Trevisiol</surname><given-names>A</given-names></name><name><surname>Baltan</surname><given-names>S</given-names></name><name><surname>Dibaj</surname><given-names>P</given-names></name><name><surname>Kusch</surname><given-names>K</given-names></name><name><surname>Möbius</surname><given-names>W</given-names></name><name><surname>Goetze</surname><given-names>B</given-names></name><name><surname>Jahn</surname><given-names>HM</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Steffens</surname><given-names>H</given-names></name><name><surname>Schomburg</surname><given-names>ED</given-names></name><name><surname>Pérez-Samartín</surname><given-names>A</given-names></name><name><surname>Pérez-Cerdá</surname><given-names>F</given-names></name><name><surname>Bakhtiari</surname><given-names>D</given-names></name><name><surname>Matute</surname><given-names>C</given-names></name><name><surname>Löwel</surname><given-names>S</given-names></name><name><surname>Griesinger</surname><given-names>C</given-names></name><name><surname>Hirrlinger</surname><given-names>J</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name><name><surname>Nave</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism</article-title><source>Neuron</source><volume>91</volume><fpage>119</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.05.016</pub-id><pub-id pub-id-type="pmid">27292539</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakers</surname><given-names>K</given-names></name><name><surname>Lake</surname><given-names>AM</given-names></name><name><surname>Khazanchi</surname><given-names>R</given-names></name><name><surname>Ouwenga</surname><given-names>R</given-names></name><name><surname>Vasek</surname><given-names>MJ</given-names></name><name><surname>Dani</surname><given-names>A</given-names></name><name><surname>Dougherty</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Astrocytes locally translate transcripts in their peripheral processes</article-title><source>PNAS</source><volume>114</volume><fpage>E3830</fpage><lpage>E3838</lpage><pub-id pub-id-type="doi">10.1073/pnas.1617782114</pub-id><pub-id pub-id-type="pmid">28439016</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santello</surname><given-names>M</given-names></name><name><surname>Toni</surname><given-names>N</given-names></name><name><surname>Volterra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Astrocyte function from information processing to cognition and cognitive impairment</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>154</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0325-8</pub-id><pub-id pub-id-type="pmid">30664773</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanz-Clemente</surname><given-names>A</given-names></name><name><surname>Nicoll</surname><given-names>RA</given-names></name><name><surname>Roche</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Diversity in NMDA receptor composition: many regulators, many consequences</article-title><source>The Neuroscientist</source><volume>19</volume><fpage>62</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1177/1073858411435129</pub-id><pub-id pub-id-type="pmid">22343826</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schipke</surname><given-names>CG</given-names></name><name><surname>Ohlemeyer</surname><given-names>C</given-names></name><name><surname>Matyash</surname><given-names>M</given-names></name><name><surname>Nolte</surname><given-names>C</given-names></name><name><surname>Kettenmann</surname><given-names>H</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Astrocytes of the mouse neocortex express functional N-methyl-D-aspartate receptors</article-title><source>FASEB Journal</source><volume>15</volume><fpage>1270</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1096/fj.00-0439fje</pub-id><pub-id pub-id-type="pmid">11344110</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname><given-names>A</given-names></name><name><surname>Vanderlinden</surname><given-names>J</given-names></name><name><surname>Vints</surname><given-names>K</given-names></name><name><surname>Ribeiro</surname><given-names>LF</given-names></name><name><surname>Vennekens</surname><given-names>KM</given-names></name><name><surname>Gounko</surname><given-names>NV</given-names></name><name><surname>Wierda</surname><given-names>KD</given-names></name><name><surname>de Wit</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Modular Organization of LRR Protein-Mediated Synaptic Adhesion Defines Synapse Identity</article-title><source>Neuron</source><volume>99</volume><fpage>329</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.06.026</pub-id><pub-id pub-id-type="pmid">29983322</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name><name><surname>Bruns</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Astrocytes control synaptic strength by two distinct v-SNARE-dependent release pathways</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>1529</fpage><lpage>1539</lpage><pub-id pub-id-type="doi">10.1038/nn.4647</pub-id><pub-id pub-id-type="pmid">28945220</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scimemi</surname><given-names>A</given-names></name><name><surname>Fine</surname><given-names>A</given-names></name><name><surname>Kullmann</surname><given-names>DM</given-names></name><name><surname>Rusakov</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>NR2B-containing receptors mediate cross talk among hippocampal synapses</article-title><source>The Journal of Neuroscience</source><volume>24</volume><fpage>4767</fpage><lpage>4777</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0364-04.2004</pub-id><pub-id pub-id-type="pmid">15152037</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano</surname><given-names>A</given-names></name><name><surname>Robitaille</surname><given-names>R</given-names></name><name><surname>Lacaille</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Differential NMDA-dependent activation of glial cells in mouse hippocampus</article-title><source>Glia</source><volume>56</volume><fpage>1648</fpage><lpage>1663</lpage><pub-id pub-id-type="doi">10.1002/glia.20717</pub-id><pub-id pub-id-type="pmid">18618659</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>PY</given-names></name><name><surname>Savtchenko</surname><given-names>LP</given-names></name><name><surname>Kamasawa</surname><given-names>N</given-names></name><name><surname>Dembitskaya</surname><given-names>Y</given-names></name><name><surname>McHugh</surname><given-names>TJ</given-names></name><name><surname>Rusakov</surname><given-names>DA</given-names></name><name><surname>Shigemoto</surname><given-names>R</given-names></name><name><surname>Semyanov</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Retrograde Synaptic Signaling Mediated by K+ Efflux through Postsynaptic NMDA Receptors</article-title><source>Cell Reports</source><volume>5</volume><fpage>941</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.10.026</pub-id><pub-id pub-id-type="pmid">24268779</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simard</surname><given-names>M</given-names></name><name><surname>Nedergaard</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The neurobiology of glia in the context of water and ion homeostasis</article-title><source>Neuroscience</source><volume>129</volume><fpage>877</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.09.053</pub-id><pub-id pub-id-type="pmid">15561405</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spruston</surname><given-names>N</given-names></name><name><surname>Jonas</surname><given-names>P</given-names></name><name><surname>Sakmann</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Dendritic glutamate receptor channels in rat hippocampal CA3 and CA1 pyramidal neurons</article-title><source>The Journal of Physiology</source><volume>482 (Pt 2)</volume><fpage>325</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1995.sp020521</pub-id><pub-id pub-id-type="pmid">7536248</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>McConnell</surname><given-names>E</given-names></name><name><surname>Pare</surname><given-names>JF</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Lovatt</surname><given-names>D</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>Y</given-names></name><name><surname>Nedergaard</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Glutamate-dependent neuroglial calcium signaling differs between young and adult brain</article-title><source>Science</source><volume>339</volume><fpage>197</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1126/science.1226740</pub-id><pub-id pub-id-type="pmid">23307741</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Xi</surname><given-names>W</given-names></name><name><surname>Lou</surname><given-names>HF</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Mei</surname><given-names>L</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Glia-derived ATP inversely regulates excitability of pyramidal and CCK-positive neurons</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>13772</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms13772</pub-id><pub-id pub-id-type="pmid">28128211</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thalhammer</surname><given-names>A</given-names></name><name><surname>Contestabile</surname><given-names>A</given-names></name><name><surname>Ermolyuk</surname><given-names>YS</given-names></name><name><surname>Ng</surname><given-names>T</given-names></name><name><surname>Volynski</surname><given-names>KE</given-names></name><name><surname>Soong</surname><given-names>TW</given-names></name><name><surname>Goda</surname><given-names>Y</given-names></name><name><surname>Cingolani</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Alternative Splicing of P/Q-Type Ca2+ Channels Shapes Presynaptic Plasticity</article-title><source>Cell Reports</source><volume>20</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.06.055</pub-id><pub-id pub-id-type="pmid">28700936</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsodyks</surname><given-names>M</given-names></name><name><surname>Pawelzik</surname><given-names>K</given-names></name><name><surname>Markram</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Neural networks with dynamic synapses</article-title><source>Neural Computation</source><volume>10</volume><fpage>821</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1162/089976698300017502</pub-id><pub-id pub-id-type="pmid">9573407</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrigiano</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The dialectic of Hebb and homeostasis</article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>372</volume><elocation-id>20160258</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2016.0258</pub-id><pub-id pub-id-type="pmid">28093556</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitureira</surname><given-names>N</given-names></name><name><surname>Goda</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cell biology in neuroscience: the interplay between Hebbian and homeostatic synaptic plasticity</article-title><source>The Journal of Cell Biology</source><volume>203</volume><fpage>175</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1083/jcb.201306030</pub-id><pub-id pub-id-type="pmid">24165934</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name><name><surname>Sakimura</surname><given-names>K</given-names></name><name><surname>Mishina</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain</article-title><source>The Journal of Comparative Neurology</source><volume>338</volume><fpage>377</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1002/cne.903380305</pub-id><pub-id pub-id-type="pmid">8113446</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>NR</given-names></name><name><surname>Schatzberg</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>NMDA antagonist treatment of depression</article-title><source>Current Opinion in Neurobiology</source><volume>36</volume><fpage>112</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2015.11.001</pub-id><pub-id pub-id-type="pmid">26687375</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zenke</surname><given-names>F</given-names></name><name><surname>Gerstner</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hebbian plasticity requires compensatory processes on multiple timescales</article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>372</volume><elocation-id>20160259</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2016.0259</pub-id><pub-id pub-id-type="pmid">28093557</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Ge</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Poo</surname><given-names>M</given-names></name><name><surname>Duan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression</article-title><source>Neuron</source><volume>40</volume><fpage>971</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(03)00717-7</pub-id><pub-id pub-id-type="pmid">14659095</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Astrocyte heterogeneity: an underappreciated topic in neurobiology</article-title><source>Current Opinion in Neurobiology</source><volume>20</volume><fpage>588</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2010.06.005</pub-id><pub-id pub-id-type="pmid">20655735</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Sloan</surname><given-names>SA</given-names></name><name><surname>Bennett</surname><given-names>ML</given-names></name><name><surname>Scholze</surname><given-names>AR</given-names></name><name><surname>O’Keeffe</surname><given-names>S</given-names></name><name><surname>Phatnani</surname><given-names>HP</given-names></name><name><surname>Guarnieri</surname><given-names>P</given-names></name><name><surname>Caneda</surname><given-names>C</given-names></name><name><surname>Ruderisch</surname><given-names>N</given-names></name><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Liddelow</surname><given-names>SA</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Daneman</surname><given-names>R</given-names></name><name><surname>Maniatis</surname><given-names>T</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Wu</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>11929</fpage><lpage>11947</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1860-14.2014</pub-id><pub-id pub-id-type="pmid">25186741</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuchero</surname><given-names>JB</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Glia in mammalian development and disease</article-title><source>Development</source><volume>142</volume><fpage>3805</fpage><lpage>3809</lpage><pub-id pub-id-type="doi">10.1242/dev.129304</pub-id><pub-id pub-id-type="pmid">26577203</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">strain, strain background (<italic>Mouse</italic>)</td><td align="left" valign="bottom">C57Bl/6 J</td><td align="left" valign="bottom">Nihon SLC</td><td align="left" valign="bottom">C57Bl/6JJmsSlc</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">strain, strain background (<italic>Rat</italic>)</td><td align="left" valign="bottom">Sprague Dawley rat</td><td align="left" valign="bottom">Nihon SLC</td><td align="left" valign="bottom">Slc:SD</td><td align="left" valign="bottom">Time pregnant (pups were used at P0-P3 to harvest tissue for culture)</td></tr><tr><td align="left" valign="bottom">genetic reagent (mouse)</td><td align="left" valign="bottom"><italic>Grin1</italic><sup><italic>flx/flx</italic></sup></td><td align="left" valign="bottom">McHugh Lab (RIKEN CBS)</td><td align="left" valign="bottom">B6.129S4-<italic>Grin1</italic><sup><italic>tm2Stl</italic></sup>/J Jackson Labs 005246</td><td align="left" valign="bottom">(Tsien et al. Cell 87, 1327–1338, 1996)</td></tr><tr><td align="left" valign="bottom">genetic reagent (mouse)</td><td align="left" valign="bottom">Ai9</td><td align="left" valign="bottom">Itohara Lab (RIKEN CBS)</td><td align="left" valign="bottom">B6.Cg-<italic>Gt(ROSA)26Sor</italic><sup><italic>tm9(CAG-tdTomato)Hze</italic></sup>/J Jackson Labs 007909</td><td align="left" valign="bottom">(Madisen et al. Nat Neurosci 13, 133–140, 2010)</td></tr><tr><td align="left" valign="bottom">genetic reagent (mouse)</td><td align="left" valign="bottom"><italic>Grin2c</italic><sup><italic>iCre/+</italic></sup></td><td align="left" valign="bottom">Sakimura Lab (Niigata U)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">(Miyazaki et al., J Neurosci 32, 1311–1328, 2012)</td></tr><tr><td align="left" valign="bottom">cell line (<italic>Homo-sapiens</italic>)</td><td align="left" valign="bottom">293FT (derived from embryonic kidney)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">CAT# R70007</td><td align="left" valign="bottom">Used in AAV production; authenticated by STR anaylsis using GenePrint10 System (Promega)(Further details will be provided by the lead contact upon request.)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-RFP (Chiken polyclonal)</td><td align="left" valign="bottom">Rockland</td><td align="left" valign="bottom">CAT# 600-901-379</td><td align="left" valign="bottom">(IF 1:1000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-GFAP (Mouse monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">CAT# 173011 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2232308">AB_2232308</ext-link></td><td align="left" valign="bottom">(IF 1:1000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-GFAP (Rabbit polyoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">CAT# ab48050 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_941765">AB_941765</ext-link></td><td align="left" valign="bottom">(IF 1:500)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-NeuN (Recombiinant rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">CAT# ab177487 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2532109">AB_2532109</ext-link></td><td align="left" valign="bottom">(IF 1:500)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-GluN1 (Guinea pig polyclonal)</td><td align="left" valign="bottom">Alamone Labs</td><td align="left" valign="bottom">CAT# AGP-046</td><td align="left" valign="bottom">(IF 1:100)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Chicken AlexaFluor-555 (Goat polyclona)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">CAT# A32932</td><td align="left" valign="bottom">(IF 1:1000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Mouse AlexaFluor 633 (Goat polyclona)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">CAT# A21052 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535719">AB_2535719</ext-link></td><td align="left" valign="bottom">(IF 1:1000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Rabbit AlexaFluor 488 (Goat polyclona)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">CAT# A11034</td><td align="left" valign="bottom">(IF 1:1000)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Guinea pig AlexaFluor 647 (Goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">CAT# A21450 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_141882">AB_141882</ext-link></td><td align="left" valign="bottom">(IF 1:200)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-GluN1 (Mouse monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">CAT# 114011 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_887750">AB_887750</ext-link></td><td align="left" valign="bottom">(WB 1:1000) (IP 5 μg / 40 μl ProteinA/G resin)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-GluN2A/B (Rabbit polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">CAT# 244003 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10804284">AB_10804284</ext-link></td><td align="left" valign="bottom">(WB 1:1000) (IP 5 μg / 40 μl ProteinA/G resin)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-GluN2C (Rabbit polyclonal)</td><td align="left" valign="bottom">Frontier Institute Co.</td><td align="left" valign="bottom">CAT# GLURE3C-RB-AF270 RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2571763">AB_2571763</ext-link></td><td align="left" valign="bottom">(WB 1:200) (IP 5 μg / 40 μl ProteinA/G resin)</td></tr><tr><td align="left" valign="bottom">antibody</td><td align="left" valign="bottom">Anti-Cre, clone 2D8 (Mouse monoclonal)</td><td align="left" valign="bottom">Merck Millipore</td><td align="left" valign="bottom">mouse anti-Cre (Merck Millipore clone 2D8)</td><td align="left" valign="bottom">(IP 5 μg / 40 μl ProteinA/G resin)</td></tr><tr><td align="left" valign="bottom">Biological sample (AAV)</td><td align="left" valign="bottom">AAV9.2 GFAP104-nls-mCherry-Cre</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Further information will be provided by the Lead Contact upon request.</td></tr><tr><td align="left" valign="bottom">Biological sample (AAV)</td><td align="left" valign="bottom">AAV9.2-GFAP104-nls-mCherry</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Further information will be provided by the Lead Contact upon request.</td></tr><tr><td align="left" valign="bottom">Biological sample (AAV)</td><td align="left" valign="bottom">AAVDJ8-GFAP104-nls-mCherry-Cre</td><td align="left" valign="bottom">Goda Lab</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">(Letellier et al., PNAS 2016)</td></tr><tr><td align="left" valign="bottom">Biological sample (AAV)</td><td align="left" valign="bottom">AAVDJ8-GFAP104-eGFP</td><td align="left" valign="bottom">Goda Lab</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">(Letellier et al., PNAS 2016)</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin1</italic> fw</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GACCGCTTCAGTCCCTTTGG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin1</italic> rv</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CACCTTCCCCAATGCCAGAG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin2a</italic> fw</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGACCCCGCTACACACTCTG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin2a</italic> rv</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTGCCCACCTTTTCCCATTCC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin2b</italic> fw</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGCATGATTGGTGAGGTGGTC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin2b</italic> rv</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGCTCTAAGAAGGCAGAAGGTG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin2c</italic> fw</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGAGGCTTTCTACAGGCATCTG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin2c</italic> rv</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATACTTCATGTACAGGACCCCATG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin2d</italic> fw</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCAGCGACCGGAAGTTCCAG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Grin2d</italic> rv</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCCCTGCCTTGAGCTGAGTG</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Rn28s1</italic> fw</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCTACCTACTATCCAGCGAAACC</td></tr><tr><td align="left" valign="bottom">sequence-based reagent</td><td align="left" valign="bottom"><italic>Rn28s1</italic> rv</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGCTCAACAGGGTCTTCTTTCC</td></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">Single Cell-to-CT qRT-PCR Kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">CAT# 4458236</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">BCA Protein Assay Kit</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">CAT# 23,227</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">commercial assay or kit</td><td align="left" valign="bottom">TaqMan Universal PCR Master Mix</td><td align="left" valign="bottom">Roche Applied Biosystems</td><td align="left" valign="bottom">CAT# 4304437</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">AlexaFluor 488</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">CAT# A10436</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">AlexaFluor 594</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">CAT# A10438</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">NMDA</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="left" valign="bottom">CAT# 0114</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">(+)-MK 801 maleate</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="left" valign="bottom">CAT# 0924</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">D-AP5</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="left" valign="bottom">CAT# 0106</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">QNZ46</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="left" valign="bottom">CAT# 4,810</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">R025-6981</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="left" valign="bottom">CAT# 1,594</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">MPEP</td><td align="left" valign="bottom">Tocris Bioscience</td><td align="left" valign="bottom">CAT# 1,212</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">chemical compound, drug</td><td align="left" valign="bottom">Picrotoxin</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">CAT# P1675</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">Metamorph</td><td align="left" valign="bottom">Molecular Devices</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002368">SCR_002368</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">pClamp</td><td align="left" valign="bottom">Molecular Devices</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011323">SCR_011323</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">software, algorithm</td><td align="left" valign="bottom">OpenView</td><td align="left" valign="bottom">Ziv Lab (Technion)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Kindly provided by Noam Ziv for use in the analysis of FM data (Kaufman et al., PLoSOne 7:e40980, 2012)</td></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">DAPI stain</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">D9564</td><td align="left" valign="bottom">(1 µg/mL)</td></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">FM1-43 Dye</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">CAT# T35356</td><td align="left" valign="bottom">(10 µM)</td></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">ADVASEP-7-</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">CAT# A3723</td><td align="left" valign="bottom">(1 mM)</td></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">TRIzol Reagent</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">CAT# T9424</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">cOmplete protease inhibitors</td><td align="left" valign="bottom">Merck (Roche Diagnostics GmbH)</td><td align="left" valign="bottom">CAT# 11873580001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">EMCCD camera</td><td align="left" valign="bottom">Andor Technology</td><td align="left" valign="bottom">iXon</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">Inverted Fluorescence microscope</td><td align="left" valign="bottom">Olympus</td><td align="left" valign="bottom">IX71</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">Upright Fluorescence microscope</td><td align="left" valign="bottom">Olympus</td><td align="left" valign="bottom">IX51WI</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">other</td><td align="left" valign="bottom">Confocal Laser Scanning Microscope</td><td align="left" valign="bottom">Olympus</td><td align="left" valign="bottom">FV3000</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70818.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group></front-stub><body><p>This paper provides evidence that NMDA receptors containing the GluN2C subunit are expressed in hippocampal astrocytes and are involved in maintaining a wide distribution of presynaptic release probabilities at local excitatory synapses. Theoretical modelling suggests this wide distribution of synaptic efficacy is conducive to the expression of the synaptic plasticity. It will be interesting to see if future studies support a role for astrocytic NMDA receptors in memory storage.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70818.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Gray</surname><given-names>John A</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Davis</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Astrocyte GluN2C NMDA receptors control basal synaptic strengths of hippocampal CA1 pyramidal neurons in the stratum radiatum&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Lu Chen as the Senior Editor. The other reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>The full reviews are included below to help clarify the concerns. Each of the concerns raised should be addressed, however many of these simply require clarification, minor figure edits, or additional discussion. Key revisions are related to clarifying the physiological relevance of the primary findings:</p><p>1) Addressing reviewer 2's comment #7: &quot;A clearer hypothesis on how a NMDAR-mediated molecular signal could both reduce and increase release probability depending on its current state, or otherwise just shift synaptic Pr randomly up or down, needs to be put forward. The authors are encouraged to find some material evidence for this type of phenomenon in the literature.&quot;</p><p>2) Each reviewer had concerns regarding the modeling as presented and are in agreement that significant revision of the modeling is required. The modeling and simulations are important for providing some physiological framework for the counterintuitive result of a change in the variance but not the mean of the presynaptic release probability. The authors should focus on reviewer 2's comment #8, and reviewer 3's concerns regarding the modeling.</p><p><italic>Reviewer #1:</italic></p><p>In the current manuscript, Chipman et al. present evidence that GluN2C-containing NMDA receptors in hippocampal astrocytes tune synaptic strengths in CA1 pyramidal neurons by helping to maintain a wide distribution of presynaptic release probabilities. This work was an extension of the lab's previous work (Letellier et al. 2016) where they first showed that astrocytic calcium and NMDA receptors regulate presynaptic release probability. Here they add genetic data supporting these earlier findings and provide a model for how a narrowing of the distribution of presynaptic release probability might affect synaptic plasticity. The go on to provide strong evidence that astrocytic NMDA receptors largely contain the GluN2C subunit and provide evidence that these GluN2C-containing receptors are involved in the effect on presynaptic release probability. The conclusions of this paper are mostly supported by the data and the combination of pharmacological and genetic approaches are a major strength of this manuscript.</p><p>There are some concerns about the selectivity of some of the manipulations allowing the possibility that neuronal NMDA receptors may be involved. Further, not much new insight is provided into the mechanisms for how astrocytes might regulate the variation of presynaptic release probability, leaving this as a more descriptive work. Also, while the modeling is interesting, it was not tested experimentally using the findings presented.</p><p>Comments for the authors:</p><p>1) The combination of pharmacological and genetic approaches to blocking astrocytic NMDA receptors and GluN2C-containing receptors is a major strength of this manuscript. However, there are a few reasons to question selectivity of these manipulations on astrocytes.</p><p>First, following Cre-mediated GluN1 deletion in astrocytes a complete loss of response to the puff of NMDA/glycine would be expected, but the response was only reduced by about half (though completely eliminated by AP5) (Figure 2—figure supplement 1) raising concerns about the effectiveness of the genetic deletion.</p><p>Second, they utilize intracellular MK801 in the patch pipette to block postsynaptic NMDA receptors. It has recently been shown (Sun et al. Neuropharmacology 2018) that intracellular MK801 incompletely inhibits NMDA receptors due to an ~30,000-fold lower affinity compared to extracellular application. Indeed, they see some remaining current in Figure 1—figure supplement 1.</p><p>Furthermore, the conclusions of this paper would be better supported by a set of experiments increasing GluN2C activity rather than just reducing – perhaps with the positive allosteric modulator CIQ (Mullasseril et al. Nature Communications, 2010), or by a GluN2C replacement approach. Indeed, the statement on lines 182-193, that &quot;these findings support the idea NMDARs play a role in bi-directionally regulating presynaptic strengths to broaden the variability of PPR&quot; is not fully supported.</p><p>2) The modeling is interesting, but its value is limited as it was not tested experimentally using the most selective manipulations they have identified (e.g. GluN2C blockade/deletion)</p><p>3) This work remains quite descriptive without much progress in the mechanism of astrocytic control of presynaptic release probability. The authors discuss some possible mechanism, including through astrocyte-mediated release of ATP and action at adenosine receptors, release of other putative gliotransmitters, or modulation of local K<sup>+</sup> dynamics. Observing GluN2C mediated effects on any of these processes would strengthen the conclusions.</p><p><italic>Reviewer #2:</italic></p><p>The present work deals with a timely and potentially important subject, the role of astroglial NMDA receptors in regulating release efficacy at local excitatory synapses. The authors combine refined electrophysiology methods with pharmacological dissection, genetic targeting, and theoretical simulations to conclude that signals mediated by astroglial NDMARs help widen the range of release probability values among CA3-CA1 synapses in the hippocampus. Modelling suggests that such widening should be conducive to the expression of synaptic plasticity. There are several issues, which the authors may want to address.</p><p>1. Whilst changes in PPR are normally inversely correlated with changes in Pr, it does not mean that PPR represents faithfully Pr across various connections, in various conditions. Slice condition, afferent excitability, retrograde messaging or network influences post-stimulus, etc. can affect PPR without affecting Pr. This has to be at least discussed, in the context.</p><p>2. Figure 1: One has to dig into the Methods to understand how PPR values were sampled. It would help the reader to mention the sampling design (number of slices / independent inputs) in the figures or in the main text. Methods: it seems that the 'cross-paired-pulse stimulation paradigm' to gauge input independence was introduced by Scimemi et al. (2004 J Neurosci).</p><p>3. The classical 'regression to the mean' phenomenon means that the random variable once sampled close to the top of its range will tend to show smaller values upon next sampling, and vice versa. This is the origin of the regression lines shown as delta-PPR plots, throughout the paper. This type of regression depends on multiple, poorly controlled concomitants, so its use for statistical inference is highly ambiguous. The authors are encouraged to focus on direct comparisons of the PPR dispersion values using appropriate, possibly non-parametric statistical tests (since some of their histograms do not look Gaussian).</p><p>4. After the NMDAR blockade in one postsynaptic cell, all other neurons will still operate their NMDARs. Their subsequent blockade might involve changes in retrograde messaging, the dynamics of extracellular potassium, etc. This has to be addressed or at least discussed.</p><p>5. Figure 3: Direct readouts of Pr and/or PPR at excitatory synapses along both apical and basal dendrites of CA1 pyramidal cells have recently been reported (Grillo et al., Nat Neurosci 2018; Jensen et al. <italic>eLife</italic> 2021). It would surely make sense to either adopt or at least discuss those most recent data sets in the context of the present experiments and simulations.</p><p>6. Figure 3: LTP induction by its virtue refers to a sub-population of potentiated synapses (rather than all available synapses), which is supposed to be followed by a re-distribution of synaptic weights, to avoid runaway excitation. Whether this notion is compatible with the present simulation paradigm needs explaining.</p><p>7. A clearer hypothesis on how a NMDAR-mediated molecular signal could both reduce and increase release probability depending on its current state, or otherwise just shift synaptic Pr randomly up or down, needs to be put forward. The authors are encouraged to find some material evidence for this type of phenomenon in the literature.</p><p>8. The modeling appears unnecessarily complicated yet narrow in scope. In their model, BCM plasticity reflects STDP but with uncorrelated, Poisson-process pre and postsynaptic spiking at 20 Hz, which is hardly universal. This type of models deals with a 'fractional' neurotransmitter release as a representation of Pr, and whether this could be readily combined with explicit Pr distributions to reflect reality is not clear. Perhaps a more transparent and robust, 'threshold-type' plasticity approach, such as HFS or theta-burst LTP would be helpful. Regarding the model setting per se, another recent model (https://elifesciences.org/articles/62588) gave experimentally-probed stochastic synapses with distributed Pr that are scattered along realistic CA1 pyramid dendrites. This model might be considered as the context is pretty similar.</p><p><italic>Reviewer #3:</italic></p><p>Chipman et al. conducted a battery of experiments to demonstrate that astrocytes in the CA1 area of the mouse hippocampus express NMDA-type glutamate receptors (NMDARs) containing the subunits GluN1 and GluN2C, and that signaling through these receptors influences presynaptic neurotransmitter release probability at excitatory synapses onto CA1 pyramidal neurons in the stratum radiatum region of CA1. In acute brain slices, the authors electrically stimulated presynaptic axons and recorded intracellular postsynaptic currents to monitor changes in the mean and variance of presynaptic release probability under various conditions. To isolate the effects of NMDARs not expressed in the recorded cell, the authors applied a use-dependent blocker of NMDARs intracellularly to recorded CA1 pyramidal neurons and stimulated afferent fibers until all synaptic NMDARs were silenced. On that background, application of extracellular blockers of NMDARs decreased the variance, but not the mean, of the distribution of presynaptic release probabilities measured across stimulation pathways, cells, and animals. These effects were occluded when GluN1-containing NMDARs were genetically removed specifically from hippocampal astrocytes. The authors then used single-cell RT-PCR to show that the NMDAR subunit GluN2C is expressed at higher levels in astrocytes than pyramidal neurons. A selective antagonist of GluN2C-containing NMDARs also increased the variance of presynaptic release probability in pyramidal cells, but not when GluN1-containing NMDARs were genetically removed specifically from hippocampal astrocytes. This paper replicates, corroborates, and extends previous findings from a prior publication, Letellier et al., PNAS, 2016. The rigor of these new experiments provides important additional support for an intriguing model of glial-neuronal interactions that highlights new questions regarding possible mechanisms.</p><p>To explore the functional consequences of the observed specific effect on the variance, but not the mean, of presynaptic release probability, the authors simulated models of long-term synaptic plasticity and suggested that the variance of release probability affects changes in synaptic weight, and by implication, memory storage. This paper could, in principle, be enhanced by the inclusion of this type of modeling. However, in the current form, the modeling component is incompletely motivated, insufficiently described and interpreted, and may suffer from technical errors.</p><p>Comments for the authors:</p><p>Please find below comments, questions, constructive criticism, and suggestions to potentially improve the manuscript and enhance its clarity, interpretability, and impact for a broad readership.</p><p>Major commentary on Figure 3:</p><p>Ideally a model of synaptic transmission with use-dependent release probability would first be fit to and compared to the experimental data, and then used to explore the implications of the experimental findings. It is indeed a counter-intuitive result that signaling in hippocampal astrocytes alters the variance, but not the mean, of the distribution of presynaptic release probabilities at excitatory synapses onto CA1 pyramidal neurons, and it is not obvious how this would influence information processing. This is a great opportunity to use modeling to gain insight into how such a change would impact circuit function and/or memory storage. If done well, it could potentially greatly elevate the impact of the paper. However, in current form, the text does not sufficiently motivate the use of the specific plasticity models chosen, the presentation of the modeling data is confusing and hard to relate to the experimental results, and there appears to be a technical error that confounds the results. Please find below suggestions to improve this component of the paper.</p><p>1) In the experiments presented in Figures 1B – D, a small number of fibers are stimulated, and the ratio of responses to a 50 ms paired-pulse stimulation is measured. Each measurement reflects the compound effect of multiple synapses that themselves might have different initial release probabilities (Pr), and different degrees of facilitation or depression. Across many stimulation pathways, cells, and animals, a distribution of these paired-pulse ratios (PPR) is obtained and analyzed. These distributions appear to be fit by a normal distribution. However, in Figure 3A, a population of synapses is simulated, with their individual release probabilities sampled from a log-normal distribution. The first step should be to select random groups of these synapses with release probabilities sampled from the modeled distribution, probe them with a paired-pulse protocol, and verify that indeed a normal distribution of PPRs are obtained that recapitulate the experimental data in Figure 1B. Then, an appropriate distribution of release probabilities with a lower variance can be calibrated to simulate the AP5 condition. Again a paired-pulse protocol should be used to verify that the resulting PPR distribution is normal, has the same mean as the control condition, but a lower variance recapitulating the data shown in Figure 1D.</p><p>Currently, the way that the authors have constructed their release probability distributions, there is a parameter U<sub>max</sub> that sets the value of U<sub>SE</sub> where the distribution is maximal. A Control distribution with large variance (σ<sub>max</sub>) and a given U<sub>max</sub> can be compared to an AP5 distribution with lower variance (σ<sub>max</sub> / 2), but the same U<sub>max</sub>. However, the mean U<sub>SE</sub> sampled from these two distributions with the same U<sub>max</sub> are not equal. The mean U<sub>SE</sub> sampled from the Control log-normal distribution is higher than the mean U<sub>SE</sub> sampled from the AP5 distribution. So the authors have not succeeded in modeling the situation where AP5 changes only the variance, but not the mean Pr. As an aside, the definition of &quot;SE&quot; in U<sub>SE</sub> is never provided in the paper.</p><p>2) The Equations 5, 6, and 7 must contain an error. I was not able to reproduce exactly the distributions shown in Figure 1A with U<sub>max</sub> = 0.1. Also the value of the &quot;a&quot; term in Equation 6 is not provided.</p><p>3) Currently, the choice to test the BCM plasticity model is not motivated at all in the text. On the surface, this is an odd choice of model to test because it has both a Hebbian component that depends on coincidence of pre- and post-synaptic activity, but also a homeostatic, meta-plastic component that adjusts the transition point from potentiation to depression depending on the recent history of post-synaptic activation. While most implementations of the BCM model assume an effective presynaptic release probability of 1, here the authors would like to investigate how a dynamic release probability affects the changes in synaptic weight produced by this plasticity model. So the first test should be to compare what happens when the stimulated synapses with the same initial weight have a low U<sub>SE</sub> vs. a high U<sub>SE</sub>. Traces for all relevant model intermediates over time should be shown: presynaptic rate r(t), successful release event rate x(t), post-synaptic current I(t), dynamic plasticity threshold Theta(t), and the synaptic weight w(t). My intuition is that synapses with a lower U<sub>SE</sub> will result in a lower mean x(t), resulting in a lower mean I(t), and initially favor synaptic depression. However, over time, this will cause Theta(t) to decrease, causing potentiation to be preferred over depression. It is possible that, given enough time to equilibrate, the final target weight will be identical for low U<sub>SE</sub> vs. high U<sub>SE</sub>, as long as the BCM rule is given enough time to equilibrate.</p><p>Once it has been established how the BCM rule is sensitive to U<sub>SE</sub>, then the behavior of the learning rule can be probed with a random group of synapses with variable U<sub>SE</sub> sampled from an appropriate distribution. However, I suspect that as long as the mean U<sub>SE</sub> is truly equal between two distributions, then the average equilibrium weight across the sample of synapses will be equal, regardless of the variance of the U distribution. The changes at low and high U<sub>SE</sub> will cancel each other out. It is critical that the authors ensure that they are comparing distributions with equal mean U<sub>SE</sub>. If there truly is an effect of the variance of the distribution separately from the mean, then the authors are advised to provide substantially more interpretation and discussion of how or why this is the case. It is not sufficient to simply show the modeling results and state that variance matters without explaining the mechanism.</p><p>4) In Figure 3B, the value of alpha is varied, but this parameter is not sufficiently described in the text, figure legend, or Methods. This should not be used as a parameter to shift the balance between potentiation and depression. Instead, it should be the Pr (U<sub>SE</sub>) that determines x(t) and I(t), and then it is the relative value of I(t) and Theta(t) determines the balance between potentiation and depression. An alternative could be to compare different initial values of Theta(t), though this will quickly equilibrate to differences in the mean I(t) that result from differences in U<sub>SE</sub>.</p><p>5) In Figure 3B, the sigma symbol with a subscript of 0.1 is used in the figure label but not anywhere in the text, figure legend, or Methods. I believe this is meant to indicate the value of σ<sub>max</sub> when U<sub>max</sub> = 0.1. This should be made explicit in the text.</p><p>6) In Figure 3C, what variable was changed to generate different values for the absolute changes in synaptic weight in the Control condition (the x-axis)? Was it the value of &quot;alpha&quot;? This was not explained sufficiently. This plot does not have an obvious interpretation, and one is not provided in the text. It does not help the reader understand how the variance of the U<sub>SE</sub> distribution would cause this particular change in long-term plasticity.</p><p>7) With regards to the use of an STDP model in Figure 3D – again, there is not sufficient description the text to understand how this model is implemented. Why is the x-axis labeled &quot;Δt / ms&quot;? The use of the variable postsynaptic current A<sub>2</sub>, or why the y-axis is labeled &quot;A<sub>2</sub> / ms&quot; is not clear at all.</p><p>A classical phenomenological STDP model would stimulate presynaptic spikes at defined times relative to postsynaptic spikes, and update the synaptic weight(s) accordingly. Inclusion of a dynamic release probability would simply cause some fraction of the presynaptic spikes to be failures and therefore to not be paired with a postsynaptic spike within the plasticity window, and therefore not result in any change in weight. Again my intuition is that for a synapse with a low Pr (U<sub>SE</sub>), it will take more spike pairings over a longer time to equilibrate compared to a synapse with a high Pr. So the first test should be to compare the final weights of synapses with low U<sub>SE</sub> to those of synapses with high U<sub>SE</sub> after a period of Poisson pre- and post-synaptic spiking. However, it is again not clear that changes in the variance of the U<sub>SE</sub> distribution in the absence of any changes in the mean would have any impact on the relative degree of potentiation or depression.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Astrocyte GluN2C NMDA receptors control basal synaptic strengths of hippocampal CA1 pyramidal neurons in the stratum radiatum&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Lu Chen as the Senior Editor and John Gray as the Reviewing Editor in consultation with the original peer reviewers.</p><p>The authors have made a significant effort in addressing most of the concerned expressed by the reviewers and the manuscript has been improved, but there are some remaining issues that need to be addressed, as outlined below:</p><p>1) At the suggestion of the reviewers, the authors have revised their modeling of the potential impact of changing Pr distribution (but not mean) on synaptic plasticity. Appropriately, they removed the BCM modeling and focused on STDP and provided experimentally collected estimates of Pr using FM1-43 imaging of the RRP from hippocampal neurons co-cultured with astrocytes. However, the reviewers found the text related to Figure 3 to be confusing and poorly described. Specifically, it took some discussion for all the reviewers to understand how Figure 3 actually tests the impact of Pr distribution based on the A<sub>2</sub> injection amplitude. That is, if you have two distributions of Pr with the same mean, but one has a wide variance and one has a narrow variance – if you set a threshold above the mean, the probability that the threshold will be crossed is higher for the distribution with wider variance. This needs to be explicitly described and explained by the authors in the manuscript text and in the figure legend. Figure revisions are not necessary, but could also benefit the readers if there is improved clarity.</p><p>2) The authors are also urged to mention explicitly that their delta PPR graphs contain a regression-to-the-mean component which is however effectively cancelled out when making direct graph comparisons, within the same parametric space</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70818.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>[…] There are some concerns about the selectivity of some of the manipulations allowing the possibility that neuronal NMDA receptors may be involved. Further, not much new insight is provided into the mechanisms for how astrocytes might regulate the variation of presynaptic release probability, leaving this as a more descriptive work. Also, while the modeling is interesting, it was not tested experimentally using the findings presented.</p><p>Comments for the authors:</p><p>1) The combination of pharmacological and genetic approaches to blocking astrocytic NMDA receptors and GluN2C-containing receptors is a major strength of this manuscript. However, there are a few reasons to question selectivity of these manipulations on astrocytes.</p><p>First, following Cre-mediated GluN1 deletion in astrocytes a complete loss of response to the puff of NMDA/glycine would be expected, but the response was only reduced by about half (though completely eliminated by AP5) (Figure 2—figure supplement 1) raising concerns about the effectiveness of the genetic deletion.</p></disp-quote><p>The NMDA/glycine puff is expected to activate nearby neuronal NMDARs that are not targeted by the Cre-mediated knockdown. Postsynaptic NMDA receptor activation has been shown to be the major source of K<sup>+</sup> efflux (Shin et al., Cell Rep 2013), which will alter the local extracellular ionic milieu, and in turn, impact astrocyte ionic currents. In our prior work (Letellier et al., 2016), we demonstrated that the slow depolarization of astrocyte membrane potential induced by NMDA/glycine puff could be partially blocked by extracellular application of nifedipine or nimodipine, and intracellular loading into astrocytes of QX-314 or D-890, an L-VGCC antagonist. Therefore, other voltage-gated currents, including calcium channels contribute to the NMDA/glycine puff responses in astrocytes. We have clarified the sentence in lines 223-227:</p><p>“The efficacy of GluN1 knock-down in astrocytes was assessed electrophysiologically by patch-clamping astrocytes and monitoring slow depolarizing responses elicited by puff applying NMDA and glycine (1mM each) (Figure 2—figure supplement 1) which were mediated by NMDARs but were also contributed in part by voltage-gated calcium channels in astrocytes (Letellier et al., 2016)”.</p><p>Please note that we have included the NMDA/glycine puff response data in the present manuscript to demonstrate the ability to detect AP5-dependent responses across astrocytes in all three layers in the CA1 subfield, which is in line with the RT-PCR results. Importantly, the data highlight the differences in sensitivity of the NMDA/glycine puff responses to astrocyte NMDAR knock-down across the three layers, which suggest that signaling downstream of NMDAR activation underlying the slow depolarization differs across the three layers, specifically for astrocytes in the <italic>stratum radiatum</italic>.</p><disp-quote content-type="editor-comment"><p>Second, they utilize intracellular MK801 in the patch pipette to block postsynaptic NMDA receptors. It has recently been shown (Sun et al. Neuropharmacology 2018) that intracellular MK801 incompletely inhibits NMDA receptors due to an ~30,000-fold lower affinity compared to extracellular application. Indeed, they see some remaining current in Figure 1—figure supplement 1.</p></disp-quote><p>We acknowledge that MK-801 may not always result in 100% block of postsynaptic NMDAR currents. After confirming the paucity of expression of GluN2C in pyramidal neurons and GluN2D in hippocampal extracts, and the robust expression of GluN2C in astrocytes, we find that application of GluN2C/D-specific inhibitor is sufficient to alter PPR. This points to the involvement of astrocyte GluN2C NMDAR. Moreover, the effect on PPR is occluded by the genetic knock-down of GluN1 in astrocytes. Collectively, these observations support the sufficiency of astrocyte NMDARs in affecting PPR.</p><disp-quote content-type="editor-comment"><p>Furthermore, the conclusions of this paper would be better supported by a set of experiments increasing GluN2C activity rather than just reducing – perhaps with the positive allosteric modulator CIQ (Mullasseril et al. Nature Communications, 2010), or by a GluN2C replacement approach. Indeed, the statement on lines 182-193, that &quot;these findings support the idea NMDARs play a role in bi-directionally regulating presynaptic strengths to broaden the variability of PPR&quot; is not fully supported.</p></disp-quote><p>We agree with the reviewer that expanding the pharmacological manipulation of GluN2C activity by using CIQ to enhance its activity and genetically manipulating GluN2C expression might provide additional experimental support to the present findings. Nevertheless, gain of function experiments require careful considerations. We plan to capitalize on such tools for our future work in pursuing the mechanisms underlying GluN2C-NMDAR-dependent presynaptic modulation. We have toned down the statement on lines 204-206 to read:</p><p>“Collectively, these findings support the idea that NMDARs play a role in regulating presynaptic strengths to broaden the variability of PPR without appreciably impacting the mean PPR”.</p><disp-quote content-type="editor-comment"><p>2) The modeling is interesting, but its value is limited as it was not tested experimentally using the most selective manipulations they have identified (e.g. GluN2C blockade/deletion)</p><p>3) This work remains quite descriptive without much progress in the mechanism of astrocytic control of presynaptic release probability. The authors discuss some possible mechanism, including through astrocyte-mediated release of ATP and action at adenosine receptors, release of other putative gliotransmitters, or modulation of local K<sup>+</sup> dynamics. Observing GluN2C mediated effects on any of these processes would strengthen the conclusions.</p></disp-quote><p>We respectfully disagree with the reviewer that the modeling is of limited value. The modeling provides a framework to demonstrate the impact of directly altering the width of release probability variance on synaptic plasticity. The experimental test of GluN2C manipulation on synaptic plasticity involving careful characterization of the underlying mechanisms, including the determination of glial signaling and putative gliotransmitters, are aspects of the study that we will pursue in the future and are beyond the scope of the present work. Please note that we have made major changes to the modelling section in the revised manuscript as described in detail in the replies to Reviewer #3.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>The present work deals with a timely and potentially important subject, the role of astroglial NMDA receptors in regulating release efficacy at local excitatory synapses. The authors combine refined electrophysiology methods with pharmacological dissection, genetic targeting, and theoretical simulations to conclude that signals mediated by astroglial NDMARs help widen the range of release probability values among CA3-CA1 synapses in the hippocampus. Modelling suggests that such widening should be conducive to the expression of synaptic plasticity. There are several issues, which the authors may want to address.</p><p>1. Whilst changes in PPR are normally inversely correlated with changes in Pr, it does not mean that PPR represents faithfully Pr across various connections, in various conditions. Slice condition, afferent excitability, retrograde messaging or network influences post-stimulus, etc. can affect PPR without affecting Pr. This has to be at least discussed, in the context.</p><p>We fully acknowledge the fact that PPR may not necessarily always relate to Pr. We have amended the discussion as follows in lines 484-491:</p></disp-quote><p>“The present study took advantage of paired-pulse response as a measure of presynaptic efficacy. […] Therefore, in some experiments, presumed changes in release probability as monitored by PPR were further corroborated by the correlated changes in CV<sup>-2</sup> (Malinow and Tsien, 1990; Larkman et al., 1992).”</p><disp-quote content-type="editor-comment"><p>2. Figure 1: One has to dig into the Methods to understand how PPR values were sampled. It would help the reader to mention the sampling design (number of slices / independent inputs) in the figures or in the main text. Methods: it seems that the 'cross-paired-pulse stimulation paradigm' to gauge input independence was introduced by Scimemi et al. (2004 J Neurosci).</p></disp-quote><p>Number of inputs, cells and mice are stated in the bottom of figure legend. Cross-paired pulse stimulation has been used as a standard test for input independence for quite some time (e.g. Otani and Connor, J Physiol 1996). We now cite Otani and Connor (1996) and Scimemi et al. (2004) as example references in line 669.</p><disp-quote content-type="editor-comment"><p>3. The classical 'regression to the mean' phenomenon means that the random variable once sampled close to the top of its range will tend to show smaller values upon next sampling, and vice versa. This is the origin of the regression lines shown as delta-PPR plots, throughout the paper. This type of regression depends on multiple, poorly controlled concomitants, so its use for statistical inference is highly ambiguous. The authors are encouraged to focus on direct comparisons of the PPR dispersion values using appropriate, possibly non-parametric statistical tests (since some of their histograms do not look Gaussian).</p></disp-quote><p>We thank the reviewer for the important point. We included the delta-PPR data in order to consider the present results relative to data in our previous study that used delta-PPR comparisons (Letellier et al., 2016). In the present work we sought to compare PPR distributions directly as such an analysis could be more informative, as the reviewer indicated. The datasets were tested for normality using the Shapiro-Wilk test. Details of statistical analyses are described in Materials and methods section, and the statistics of individual datasets are included in the excel file labelled “E-phys statistics report”.</p><disp-quote content-type="editor-comment"><p>4. After the NMDAR blockade in one postsynaptic cell, all other neurons will still operate their NMDARs. Their subsequent blockade might involve changes in retrograde messaging, the dynamics of extracellular potassium, etc. This has to be addressed or at least discussed.</p></disp-quote><p>We acknowledge the fact that we cannot exclude the possible contribution of NMDARs present in neurons that we are not recording from nor of NMDARs in the recorded neuron should there be incomplete block of NMDARs from intracellularly applied MK801. Please see the reply to reviewer 1, second comment of part 1.</p><disp-quote content-type="editor-comment"><p>5. Figure 3: Direct readouts of Pr and/or PPR at excitatory synapses along both apical and basal dendrites of CA1 pyramidal cells have recently been reported (Grillo et al., Nat Neurosci 2018; Jensen et al. eLife 2021). It would surely make sense to either adopt or at least discuss those most recent data sets in the context of the present experiments and simulations.</p></disp-quote><p>For the mathematical modelling in the revised manuscript, we experimentally obtained the Pr distribution. Our Pr estimate was based on direct measurements using the FM1-43 styryl dye, of readily releasable vesicle pool (RRP) at individual boutons formed on dendrites of hippocampal pyramidal neurons in primary culture. FM dye experiments have been carried out following standard procedures in the presence of 10 μM CNQX to block AMPA receptors so as to prevent recurrent network activity. Under such conditions, neuronal NMDARs do not experience the efficient removal of Mg block which is facilitated by membrane depolarization from AMPAR activation. In contrast, GluN2C-NMDARs have reduced Mg block compared to neuronally expressed NMDARs, and given the expression of GluN2C in hippocampal astrocytes, any effect of AP5 (added on top of CNQX), if observed, could be associated with astrocyte NMDAR inhibition. Notably, the distribution of RRP monitored in the presence of AP5 and CNQX was less variable compared to the distribution observed in CNQX alone.</p><p>With respect to Grillo et al. (2018) and Jensen et al. (2021) studies, we refer to the work in the discussion (lines 503-506):</p><p>“The use of methods that allow for a more direct estimate of release probability in hippocampal CA1 neurons as have been reported recently (e.g. Grillo et al., 2018; Jensen et al., 2021) will be informative in further pursuing the underlying mechanisms.”</p><disp-quote content-type="editor-comment"><p>6. Figure 3: LTP induction by its virtue refers to a sub-population of potentiated synapses (rather than all available synapses), which is supposed to be followed by a re-distribution of synaptic weights, to avoid runaway excitation. Whether this notion is compatible with the present simulation paradigm needs explaining.</p></disp-quote><p>We have not considered homeostatic compensation across space in the present simulation. Please note that in the Poisson spike model where presynaptic and postsynaptic neurons are not fixed to spike in any particular order or frequency to favor LTP or LTD induction, both forms of plasticity are observed across trials. Thus potentiation could be countered by depression and vice versa across time at minimum. Importantly, the extent expression of both LTP and LTD are compromised by reducing the variability of presynaptic release probability.</p><disp-quote content-type="editor-comment"><p>7. A clearer hypothesis on how a NMDAR-mediated molecular signal could both reduce and increase release probability depending on its current state, or otherwise just shift synaptic Pr randomly up or down, needs to be put forward. The authors are encouraged to find some material evidence for this type of phenomenon in the literature.</p></disp-quote><p>We apologize for the lack of clarity in our original discussion of how astrocyte NMDAR activity could expand the range of release probability. The relevant section (lines 533-560) has been reworded with an additional reference (Darabid et al., Cell Rep 2018):</p><p>“The mechanism by which astrocyte GluN2C NMDARs are coupled to the changes in presynaptic efficacy remains to be clarified. […] Further understanding of such mechanisms is warranted to identify the basis for how the relative differences in synaptic strengths are promoted to facilitate broadening of the range of presynaptic efficacy.”</p><disp-quote content-type="editor-comment"><p>8. The modeling appears unnecessarily complicated yet narrow in scope. In their model, BCM plasticity reflects STDP but with uncorrelated, Poisson-process pre and postsynaptic spiking at 20 Hz, which is hardly universal. This type of models deals with a 'fractional' neurotransmitter release as a representation of Pr, and whether this could be readily combined with explicit Pr distributions to reflect reality is not clear. Perhaps a more transparent and robust, 'threshold-type' plasticity approach, such as HFS or theta-burst LTP would be helpful. Regarding the model setting per se, another recent model (https://elifesciences.org/articles/62588) gave experimentally-probed stochastic synapses with distributed Pr that are scattered along realistic CA1 pyramid dendrites. This model might be considered as the context is pretty similar.</p></disp-quote><p>We have decided to forego the BCM model in the present study given the concerns raised by the reviewers, and instead, we have sought to simplify the modelling by focusing on leaky integrate-and-fire neurons under two different conditions: first, by applying the commonly used STDP paradigm, and second, for exploring a more general condition by applying Poisson spike trains with an average spike rate of 10 Hz. Moreover, we took advantage of an experimentally determined Pr distributions which were obtained under the control condition and in the presence of AP5 that yielded less variable Pr as explained above. In the improved version of the STDP modeling study, we found a clear picture that the reduction of variance in release probability can suppress the efficacy of long-term potentiation and depression.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>Chipman et al. conducted a battery of experiments to demonstrate that astrocytes in the CA1 area of the mouse hippocampus express NMDA-type glutamate receptors (NMDARs) containing the subunits GluN1 and GluN2C, and that signaling through these receptors influences presynaptic neurotransmitter release probability at excitatory synapses onto CA1 pyramidal neurons in the stratum radiatum region of CA1. In acute brain slices, the authors electrically stimulated presynaptic axons and recorded intracellular postsynaptic currents to monitor changes in the mean and variance of presynaptic release probability under various conditions. To isolate the effects of NMDARs not expressed in the recorded cell, the authors applied a use-dependent blocker of NMDARs intracellularly to recorded CA1 pyramidal neurons and stimulated afferent fibers until all synaptic NMDARs were silenced. On that background, application of extracellular blockers of NMDARs decreased the variance, but not the mean, of the distribution of presynaptic release probabilities measured across stimulation pathways, cells, and animals. These effects were occluded when GluN1-containing NMDARs were genetically removed specifically from hippocampal astrocytes. The authors then used single-cell RT-PCR to show that the NMDAR subunit GluN2C is expressed at higher levels in astrocytes than pyramidal neurons. A selective antagonist of GluN2C-containing NMDARs also increased the variance of presynaptic release probability in pyramidal cells, but not when GluN1-containing NMDARs were genetically removed specifically from hippocampal astrocytes. This paper replicates, corroborates, and extends previous findings from a prior publication, Letellier et al., PNAS, 2016. The rigor of these new experiments provides important additional support for an intriguing model of glial-neuronal interactions that highlights new questions regarding possible mechanisms.</p><p>To explore the functional consequences of the observed specific effect on the variance, but not the mean, of presynaptic release probability, the authors simulated models of long-term synaptic plasticity and suggested that the variance of release probability affects changes in synaptic weight, and by implication, memory storage. This paper could, in principle, be enhanced by the inclusion of this type of modeling. However, in the current form, the modeling component is incompletely motivated, insufficiently described and interpreted, and may suffer from technical errors.</p></disp-quote><p>We thank the reviewer for acknowledging that our new experiments extend our previous work and provide “important additional support for an intriguing model of glial-neuronal interactions”. The reviewer has also indicated several major concerns for the results presented in Figure 3 of the original submission. Following his/her suggestions, we have substantially revised the modelling part of the study.</p><disp-quote content-type="editor-comment"><p>Comments for the authors:</p><p>Please find below comments, questions, constructive criticism, and suggestions to potentially improve the manuscript and enhance its clarity, interpretability, and impact for a broad readership.</p><p>Major commentary on Figure 3:</p><p>Ideally a model of synaptic transmission with use-dependent release probability would first be fit to and compared to the experimental data, and then used to explore the implications of the experimental findings. It is indeed a counter-intuitive result that signaling in hippocampal astrocytes alters the variance, but not the mean, of the distribution of presynaptic release probabilities at excitatory synapses onto CA1 pyramidal neurons, and it is not obvious how this would influence information processing. This is a great opportunity to use modeling to gain insight into how such a change would impact circuit function and/or memory storage. If done well, it could potentially greatly elevate the impact of the paper. However, in current form, the text does not sufficiently motivate the use of the specific plasticity models chosen, the presentation of the modeling data is confusing and hard to relate to the experimental results, and there appears to be a technical error that confounds the results. Please find below suggestions to improve this component of the paper.</p><p>1) In the experiments presented in Figures 1B – D, a small number of fibers are stimulated, and the ratio of responses to a 50 ms paired-pulse stimulation is measured. Each measurement reflects the compound effect of multiple synapses that themselves might have different initial release probabilities (Pr), and different degrees of facilitation or depression. Across many stimulation pathways, cells, and animals, a distribution of these paired-pulse ratios (PPR) is obtained and analyzed. These distributions appear to be fit by a normal distribution. However, in Figure 3A, a population of synapses is simulated, with their individual release probabilities sampled from a log-normal distribution. The first step should be to select random groups of these synapses with release probabilities sampled from the modeled distribution, probe them with a paired-pulse protocol, and verify that indeed a normal distribution of PPRs are obtained that recapitulate the experimental data in Figure 1B. Then, an appropriate distribution of release probabilities with a lower variance can be calibrated to simulate the AP5 condition. Again a paired-pulse protocol should be used to verify that the resulting PPR distribution is normal, has the same mean as the control condition, but a lower variance recapitulating the data shown in Figure 1D.</p><p>Currently, the way that the authors have constructed their release probability distributions, there is a parameter U<sub>max</sub> that sets the value of U<sub>SE</sub> where the distribution is maximal. A Control distribution with large variance (σ<sub>max</sub>) and a given U<sub>max</sub> can be compared to an AP5 distribution with lower variance (σ<sub>max</sub> / 2), but the same U<sub>max</sub>. However, the mean U<sub>SE</sub> sampled from these two distributions with the same U<sub>max</sub> are not equal. The mean U<sub>SE</sub> sampled from the Control log-normal distribution is higher than the mean U<sub>SE</sub> sampled from the AP5 distribution. So the authors have not succeeded in modeling the situation where AP5 changes only the variance, but not the mean Pr. As an aside, the definition of &quot;SE&quot; in U<sub>SE</sub> is never provided in the paper.</p></disp-quote><p>We thank the reviewer for the criticisms and helpful suggestions. We have completely revamped our approach in the numerical modeling section. One of the major changes is in the way we obtained the Pr distribution, which was based on our own experimental measurements that used a styryl dye FM1-43 to label the readily releasable pool at individual boutons in cultured hippocampal pyramidal neurons. The readily releasable pool provides a more direct estimate Pr compared to PPR. As an advantage of this approach, we could obtain the Pr distributions experimentally under both control condition and in the presence of AP5, and particularly in AP5, the distribution showed a reduced variance (Figure 3—figure supplement 1). This result was consistent with acute slice experiments presented. Given that FM1-43 experiments were performed under conditions that did not favor the activation of neuronal NMDARs (i.e. in the continuous presence of CNQX), the effect of AP5 suggested the consequences of blocking astrocyte NMDARs. Furthermore, in our prior study, co-cultures of hippocampal neurons and astrocytes preserved aspects of astrocyte NMDAR signaling-dependent regulation of PPR (Letellier et al., 2016). Therefore, collectively, the FM1-43 data support the main conclusions and provide experimental Pr distributions for both the control and the AP5 cases. In the revised manuscript, we obtained gamma distribution fits to the FM1-43 experimental data, which were then used to perform numerical simulations. Following the suggestions, the simulations have been tested for the fits to experimentally obtained EPSC peaks, and simulated PPR has been compared to data reported in Figure 1B-D in control and AP5 (Figure 3—figure supplement 2).</p><disp-quote content-type="editor-comment"><p>2) The Equations 5, 6, and 7 must contain an error. I was not able to reproduce exactly the distributions shown in Figure 1A with U<sub>max</sub> = 0.1. Also the value of the &quot;a&quot; term in Equation 6 is not provided.</p></disp-quote><p>In the revised manuscript, we have used the gamma distributions for simulations, and therefore the equations referred to are not included. The parameters for the gamma distributions are obtained from fitting the FM1-43 signal as explained above, and the values are stated in the legend of Figure 3—figure supplement 1 and in Materials and methods.</p><disp-quote content-type="editor-comment"><p>3) Currently, the choice to test the BCM plasticity model is not motivated at all in the text. On the surface, this is an odd choice of model to test because it has both a Hebbian component that depends on coincidence of pre- and post-synaptic activity, but also a homeostatic, meta-plastic component that adjusts the transition point from potentiation to depression depending on the recent history of post-synaptic activation. While most implementations of the BCM model assume an effective presynaptic release probability of 1, here the authors would like to investigate how a dynamic release probability affects the changes in synaptic weight produced by this plasticity model. So the first test should be to compare what happens when the stimulated synapses with the same initial weight have a low U<sub>SE</sub> vs. a high U<sub>SE</sub>. Traces for all relevant model intermediates over time should be shown: presynaptic rate r(t), successful release event rate x(t), post-synaptic current I(t), dynamic plasticity threshold Theta(t), and the synaptic weight w(t). My intuition is that synapses with a lower U<sub>SE</sub> will result in a lower mean x(t), resulting in a lower mean I(t), and initially favor synaptic depression. However, over time, this will cause Theta(t) to decrease, causing potentiation to be preferred over depression. It is possible that, given enough time to equilibrate, the final target weight will be identical for low U<sub>SE</sub> vs. high U<sub>SE</sub>, as long as the BCM rule is given enough time to equilibrate.</p><p>Once it has been established how the BCM rule is sensitive to U<sub>SE</sub>, then the behavior of the learning rule can be probed with a random group of synapses with variable U<sub>SE</sub> sampled from an appropriate distribution. However, I suspect that as long as the mean U<sub>SE</sub> is truly equal between two distributions, then the average equilibrium weight across the sample of synapses will be equal, regardless of the variance of the U distribution. The changes at low and high U<sub>SE</sub> will cancel each other out. It is critical that the authors ensure that they are comparing distributions with equal mean U<sub>SE</sub>. If there truly is an effect of the variance of the distribution separately from the mean, then the authors are advised to provide substantially more interpretation and discussion of how or why this is the case. It is not sufficient to simply show the modeling results and state that variance matters without explaining the mechanism.</p></disp-quote><p>We acknowledge the issues concerning the BCM model. To present a clearer simulation study we removed the BCM model in the revised manuscript. We focused on the model of spiking neurons with STDP to demonstrate how the range of release probability variability could affect the efficacy of STDP.</p><disp-quote content-type="editor-comment"><p>4) In Figure 3B, the value of alpha is varied, but this parameter is not sufficiently described in the text, figure legend, or Methods. This should not be used as a parameter to shift the balance between potentiation and depression. Instead, it should be the Pr (U<sub>SE</sub>) that determines x(t) and I(t), and then it is the relative value of I(t) and Theta(t) determines the balance between potentiation and depression. An alternative could be to compare different initial values of Theta(t), though this will quickly equilibrate to differences in the mean I(t) that result from differences in U<sub>SE</sub>.</p></disp-quote><p>As the BCM model is removed, original Figure 3B is no longer shown. However, to address the comments in general, we have included more descriptions of the model. Also, as explained above, we have included the FM1-43 data and the corresponding fits to justify the parameters of the gamma distributions used in simulations.</p><disp-quote content-type="editor-comment"><p>5) In Figure 3B, the sigma symbol with a subscript of 0.1 is used in the figure label but not anywhere in the text, figure legend, or Methods. I believe this is meant to indicate the value of σ<sub>max</sub> when U<sub>max</sub> = 0.1. This should be made explicit in the text.</p></disp-quote><p>Original Figure 3B has been deleted.</p><disp-quote content-type="editor-comment"><p>6) In Figure 3C, what variable was changed to generate different values for the absolute changes in synaptic weight in the Control condition (the x-axis)? Was it the value of &quot;alpha&quot;? This was not explained sufficiently. This plot does not have an obvious interpretation, and one is not provided in the text. It does not help the reader understand how the variance of the U<sub>SE</sub> distribution would cause this particular change in long-term plasticity.</p></disp-quote><p>Original Figure 3C has been deleted.</p><disp-quote content-type="editor-comment"><p>7) With regards to the use of an STDP model in Figure 3D – again, there is not sufficient description the text to understand how this model is implemented. Why is the x-axis labeled &quot;Δt / ms&quot;? The use of the variable postsynaptic current A<sub>2</sub>, or why the y-axis is labeled &quot;A<sub>2</sub> / ms&quot; is not clear at all.</p><p>A classical phenomenological STDP model would stimulate presynaptic spikes at defined times relative to postsynaptic spikes, and update the synaptic weight(s) accordingly. Inclusion of a dynamic release probability would simply cause some fraction of the presynaptic spikes to be failures and therefore to not be paired with a postsynaptic spike within the plasticity window, and therefore not result in any change in weight. Again my intuition is that for a synapse with a low Pr (U<sub>SE</sub>), it will take more spike pairings over a longer time to equilibrate compared to a synapse with a high Pr. So the first test should be to compare the final weights of synapses with low U<sub>SE</sub> to those of synapses with high U<sub>SE</sub> after a period of Poisson pre- and post-synaptic spiking. However, it is again not clear that changes in the variance of the U<sub>SE</sub> distribution in the absence of any changes in the mean would have any impact on the relative degree of potentiation or depression.</p></disp-quote><p>Figure 3D in the original submission is now presented as Figure 3B in the revision. We apologize for the typo in the vertical axis of the previous version, which has now been corrected. This plot shows the resulting synaptic weight after spike pairing, with different postsynaptic current injection (A<sub>2</sub>) and spike-pairing time difference (Δt) with the aim to demonstrate how the change in Pr distribution can impact the sensitivity of STDP expression. As pointed out by the reviewer, we acknowledge that there could be some chance that the presynaptic spike has no effect due to the small initial release probability. Here we present the mean of 10,000 simulations, and the result shows the differences in the general tendency of undergoing potentiation associated with Pr distributions representing three different conditions: control, AP5, and AP5 condition in which the mean is constrained to the mean of the control Pr distribution. The third condition has been implemented to address the concerns related to the contribution of the mean of distribution. We have made extensive changes to the text to clarify the model implementations shown in Figures 3 and 4 with added descriptions. Specifically with respect to Figure 3B, in order to highlight the difference between three conditions shown, we now include a bar plot (new Figure 3C) which shows the average maximum change of synaptic weight when the extra input to the post-synaptic neuron is small. We feel that these changes have substantially clarified the key consequences of altering the Pr variance on the expression of plasticity.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The authors have made a significant effort in addressing most of the concerned expressed by the reviewers and the manuscript has been improved, but there are some remaining issues that need to be addressed, as outlined below:</p><p>1) At the suggestion of the reviewers, the authors have revised their modeling of the potential impact of changing Pr distribution (but not mean) on synaptic plasticity. Appropriately, they removed the BCM modeling and focused on STDP and provided experimentally collected estimates of Pr using FM1-43 imaging of the RRP from hippocampal neurons co-cultured with astrocytes. However, the reviewers found the text related to Figure 3 to be confusing and poorly described. Specifically, it took some discussion for all the reviewers to understand how Figure 3 actually tests the impact of Pr distribution based on the A2 injection amplitude. That is, if you have two distributions of Pr with the same mean, but one has a wide variance and one has a narrow variance – if you set a threshold above the mean, the probability that the threshold will be crossed is higher for the distribution with wider variance. This needs to be explicitly described and explained by the authors in the manuscript text and in the figure legend. Figure revisions are not necessary, but could also benefit the readers if there is improved clarity.</p></disp-quote><p>Additional explanations to clarify Figure 3B have been added in the main text and in the legend. Moreover, color coding used in Figure 3B has been adjusted to improve clarity. Please note that a finer color gradation scheme allowed for visualization of small synaptic weight changes that were not previously visible. For this reason, relative to the previous Figure 3B, there are very small shifts in the position of the arrows, although the shifts do not affect the conclusions.</p><disp-quote content-type="editor-comment"><p>2) The authors are also urged to mention explicitly that their delta PPR graphs contain a regression-to-the-mean component which is however effectively cancelled out when making direct graph comparisons, within the same parametric space</p></disp-quote><p>The statement regarding delta PPR plots has been added to the Results section when we first introduce the delta PPR plots.</p></body></sub-article></article>